id,evidence_inference_prompt_id,pmcid,outcome,intervention,comparator,outcome_type,intervention_events,intervention_group_size,comparator_events,comparator_group_size,intervention_mean,intervention_standard_deviation,comparator_mean,comparator_standard_deviation,standardized_mean_difference,smd_sampling_variance,log_odds_ratio,lor_sampling_variance,log_risk_ratio,lrr_sampling_variance,notes,is_data_complete,tiktoken_with_attributes_xml_token_num,tiktoken_without_attributes_xml_token_num,split,tiktoken_without_attributes_markdown_token_num,chunk_num_tokens,output,is_chunked
562,9836,3496170,P3a latency,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,[],"intervention:
    mean: 120
    standard_deviation: 20
    group_size: 8
comparator:
    mean: 110
    standard_deviation: 20
    group_size: 8
outcome:
    mean: 300
    standard_deviation: 50
    group_size:",False
213,2913,5459456,lateral bending for the C2-C4 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,5.8,0.5,5.9,0.7,-0.1554,0.2508,,,,,,TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 12
    standard_deviation: 3
    group_size: 10
comparator:
    mean: 68
    standard_deviation: 10
    group_size: 10

YAML:
<assistant>:
intervention:
    mean: 10.6
    standard
---
intervention:
    mean: 6.5
    standard_deviation: 1.1
    group_size: 26
comparator:
    mean: 9.2
    standard_deviation: 1.3
    group_size: 28

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 6.2
    standard_deviation: 1.8
    group_size: 14
comparator:
    mean: 9.2
    standard_deviation: 2.0
    group_size: 14
C2-C4_lateral_bending:
    
---
intervention:
    mean: 135.0
    standard_deviation: 14.1
    group_size: 20
comparator:
    mean: 101.8
    standard_deviation: 17.2
    group_size: 20

intervention:
    mean: 10.56
    standard_
---
",True
82,3745,3546023,CD4+/CD8+ ratio,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,29,1.19,0.43,1.03,0.53,0.3277,0.0687,,,,,Values are for week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1053, 1432, 1540, 941, 1509, 986, 1381]","intervention:
    mean: 10.42
    standard_deviation: 2.17
    group_size: 30
comparator:
    mean: 6.39
    standard_deviation: 3.06
    group_size: 28

intervention:
    mean: 14.22
    standard_
---
intervention:
    mean: 104.6
    standard_deviation: 12.2
    group_size: 56
comparator:
    mean: 87.3
    standard_deviation: 9.8
    group_size: 56

y:
post-intervention:
 mean: NUMBER

---
intervention:
    mean: 64.67
    standard_deviation: 7.54
    group_size: 64
comparator:
    mean: 39.83
    standard_deviation: 6.77
    group_size: 43

YAML:
<|assistant>;
intervention:

---
intervention:
    mean: 8.32
    standard_deviation: 1.55
    group_size: 29
comparator:
    mean: 7.29
    standard_deviation: 2.10
    group_size: 27

YAML:
<assistant>>
intervention:
    
---
intervention:
    mean: 67.67
    standard_deviation: 8.14
    group_size: 17
comparator:
    mean: 64.24
    standard_deviation: 6.28
    group_size: 17

outcome:
    CD4+/CD8+ ratio:
---
intervention:
    mean: 25.59
    standard_deviation: 9.44
    group_size: 27
comparator:
    mean: 24.72
    standard_deviation: 7.94
    group_size: 29
intervention:
    mean: 31.38
    standard_dev
---
intervention:
    mean: 104.3
    standard_deviation: 24.1
    group_size: 12
comparator:
    mean: 85.4
    standard_deviation: 18.1
    group_size: 12
CD4+/CD8+ ratio:
    mean: 90.
---
",True
92,10164,4173437,Postoperatively hematocrit,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. Data is in table in graphic format.,FALSE,854,745,TEST,637,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    postoperatively_hematocrit: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    preoperatively_hemat",False
366,12887,5976949,leptin/adiponectin ratio (LAR),"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)",control group- normal glucose tolerance,continuous,,20,,25,0.97,1.31,0.72,0.46,0.2624,0.0908,,,,,found in table,TRUE,4402,2905,TEST,2274,"[1223, 766]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

Leptin/adiponectin ratio (LAR):
  
---
intervention:
    mean: 8.7
    standard_deviation: 3.3
    group_size: 20
comparator:
    mean: 5.4
    standard_deviation: 2.3
    group_size: 21

YAML:
<|assistant>
intervention:

---
",True
165,615,5062234,The 24 h morphine requirement,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,continuous,,21,,21,34.57,14.64,32.76,14.34,0.1225,0.0954,,,,,,TRUE,1345,1148,TEST,971,[],"intervention:
    mean: 34.57
    standard_deviation: 14.64
    group_size: 42
comparator:
    mean: 32.76
    standard_deviation: 14.34
    group_size: 42

The data for the primary outcome (24 h morphine requirement) was",False
322,4726,5539943,Motivational Interviewing (MI) knowledge,Language Enhanced Attention and Focus MI training condition (MI-LEAF),baseline,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"[1580, 1384]","intervention:
    mean: 0.703
    standard_deviation: 0.121
    group_size: NUMBER
comparator:
    mean: 0.43
    standard_deviation: 0.109
    group_size: NUMBER

Note that the provided sample size (n = 190)
---
intervention:
    mean: 103.3
    standard_deviation: 16.7
    group_size: 21
comparator:
    mean: 84.8
    standard_deviation: 13.6
    group_size: 35

YAML:
intervention:
    mean: 109.2
---
",True
574,8565,2952311,Verbal rating scale pain intensity,Acupressure at distal points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[1302],"intervention:
    mean: 3
    standard_deviation: 1
    group_size: 33
comparator:
    mean: 10
    standard_deviation: 3
    group_size: 33

YAML:
intervention:
    mean: 95.0
    standard_deviation: 6
---
",True
663,13295,4987981,percentage of patients achieving 75 % reduction in PASI and ESI scores,metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,5779,"[518, 1670, 1662, 743]","intervention:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER
    METFORMIN: NUMBER_NOT_AVAILABLE_SKIP
    PIGLITIZONE: NUMBER_NOT_AVAILABLE_SKIP
    PLACEBO: NUMBER_
---
intervention:
    mean: 97.6
    standard_deviation: 35.7
    group_size: NUMBER
comparator:
    mean: 101.9
    standard_deviation: 35.1
    group_size: NUMBER

outcome:
    mean: 3.4

---
 intervention:
    mean: 125
    standard_deviation: 23.1
    group_size: 23
 comparator:
    mean: 81.4
    standard_deviation: 14.6
    group_size: 21
< | assistant |
intervention:
    mean: 94.6
    standard
---
intervention:
    mean: 90.0
    standard_deviation: 15.0
    group_size: 284
comparator:
    mean: 57.2
    standard_deviation: 15.9
    group_size: 286

YAML:
<|assistant>
intervention:

---
",True
271,2991,3214395,laryngoscopy failure,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 48",group 3 involved bispectral index (BIS) of 38,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,880,[],"intervention:
    mean: 76.67
    standard_deviation: 8.33
    group_size: 15
comparator:
    mean: 72.67
    standard_deviation: 8.33
    group_size: 15

outcome:
    laryngoscopy failure:
        mean",False
11,9681,2363753,Glomerular filtration rate fall,Amifostine,Control,continuous,,20,,20,10,,37,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,725,[],"intervention:
    mean: 105
    standard_deviation: 10
    group_size: 40
comparator:
    mean: 67
    standard_deviation: 10
    group_size: 40
intervention:
    mean: 96.5
    standard_deviation: 11.3
    group",False
480,4801,5515881,VO2peak,demanding balance training program,relaxation group,continuous,,,,,32.07,6.52,31.947,7.89,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"[1607, 510]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  balance:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_dev
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  VO2peak:
    mean: NUMBER.2
    standard_deviation: NUMBER.2
    group_size: TWO
comparator:
    mean: NUMBER
    
---
",True
293,6104,4215531,MCCB performance : Verbal Learning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,47.1,10,47.3,10.4,-0.0192,0.1053,,,,,used post values and Treatment as Usual as Baseline,TRUE,7352,5561,TEST,4156,"[1623, 1169, 760]","intervention:
    mean: 115.9
    standard_deviation: 14.8
    group_size: 13
comparator:
    mean: 111.4
    standard_deviation: 14.3
    group_size: 13

witing: x x
verbal_learning:
    
---
intervention:
    mean: 70.7
    standard_deviation: 59.0
    group_size: 19
comparator:
    mean: 59.0
    standard_deviation: 67.5
    group_size: 6
MCCB_Verbal_Learning:
    post: 70
---
intervention:
    mean: 44.6
    standard_deviation: 12.2
    group_size: 19
comparator:
    mean: 40.1
    standard_deviation: 14.4
    group_size: 19
verbal_learning:
    mean: 41.7
    
---
",True
471,4803,5515881,spatial score,demanding balance training program,relaxation group,continuous,,,,,0.443,0.75,0.04,0.91,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"[1607, 510]","intervention:
    mean: 7.50
    standard_deviation: 0.80
    group_size: N/A
comparator:
    mean: 7.67
    standard_deviation: 0.84
    group_size: N/A

 intervention:
    mean: 9.44
---
intervention:
    mean: 94.54
    standard_deviation: 12.22
    group_size: 12
comparator:
    mean: 89.16
    standard_deviation: 13.20
    group_size: 12

Sensitivity analysis:
intervention:
    mean: 93.
---
",True
544,7792,3508963,Pain score after 5 minutes,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,3.18,2.27,4.45,2.16,-0.5713783,0.01734682,,,,,,TRUE,3561,2387,TEST,1552,[],"intervention:
    mean: 65
    standard_deviation: N/A
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A

pain_score:
    intervention: N/A",False
274,6419,3654355,Body weight,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-17.5,6.1,-0.5,2.8,-3.1892,0.0933,,,,,,TRUE,18948,9604,TEST,6664,"[1123, 1035, 883, 1927, 1235]","intervention:
    mean: 177.0
    standard_deviation: 23.5
    group_size: 39
comparator:
    mean: 176.4
    standard_deviation: 23.8
    group_size: 39

Waiting list control:
    mean: 176.6

---
intervention:
    mean: 128.9
    standard_deviation: 19.4
    group_size: 71
comparator:
    mean: 127.1
    standard_deviation: 21.6
    group_size: 33

YAML:
<|assistant>
intervention:

---
intervention:
    mean: −20.3
    standard_deviation: −0.1
    group_size: 71
comparator:
    mean: −17.5
    standard_deviation: 0.1
    group_size: 88

YAML:
<|assistant>

---
intervention:
    mean: 130.4
    standard_deviation: 8.8
    group_size: 57
comparator:
    mean: 133.2
    standard_deviation: 7.6
    group_size: 70

intervention:
    mean: 83.7
    standard_
---
intervention:
    mean: 9.3
    standard_deviation: 2.9
    group_size: 43
comparator:
    mean: 6.9
    standard_deviation: 1.0
    group_size: 47

intervention:
    mean: 43.2
    standard_
---
",True
577,8567,2952311,Salivary alpha-amylase,Acupressure at distal points,Acupressure at local points,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[1302],"intervention:
    mean: 55.0
    standard_deviation: 11.5
    group_size: 11
comparator:
    mean: 45.2
    standard_deviation: 9.0
    group_size: 11
salivary_alpha_amylase:
    mean: 1
---
",True
310,7833,4541185,onset of motor block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,9.83,1.12,10.85,0.79,-1.0388,0.0757,,,,,found in abstract,TRUE,1359,1043,TEST,907,[],"intervention:
    mean: 4.36
    standard_deviation: 0.81
    group_size: 30
comparator:
    mean: 9.83
    standard_deviation: 0.65
    group_size: 30

outcome: onset of motor block",False
406,2803,5781260,Movement induced pain (VAS),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,"[1670, 506]","intervention:
    mean: 107
    standard_deviation: 27
    group_size: 44
comparator:
    mean: 83
    standard_deviation: 26
    group_size: 46
movement_induced_pain:
    intervention:
        mean: 11.2
        standard_
---
intervention:
    mean: 9.0
    standard_deviation: 3.2
    group_size: 30
comparator:
    mean: 11.1
    standard_deviation: 4.1
    group_size: 30

YAML:
<|assistant>
intervention:

---
",True
316,9843,4928400,Postoperative pain,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,4.3,1,3.6,1.2,0.619,0.1,,,,,,TRUE,4037,2288,TEST,1670,[],"intervention:
    mean: 70.0
    standard_deviation: 10.0
    group_size: 14
comparator:
    mean: 50.0
    standard_deviation: 10.0
    group_size: 12

YAML:
<|assistant>
intervention:
",False
635,12290,5777645,Mean BMI change,to peer-led structured patient education,conventional care alone,continuous,,,,,-1.65,2.5,0.05,3.2,,,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,3738,"[1499, 1358, 551]","intervention:
    mean: 1.06
    standard_deviation: 2.0
    group_size: 76
comparator:
    mean: 1.15
    standard_deviation: 1.7
    group_size: 75

intervention:
    mean: 44.67
    standard_
---
intervention:
    mean: 5.5
    standard_deviation: 2.2
    group_size: 40
comparator:
    mean: 5.8
    standard_deviation: 2.3
    group_size: 40

The requested table of mean outcome and standard deviation in YAML format
---
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x

# Replace 'x' with the corresponding values from the table above:
YAML:
intervention:
---
",True
334,5081,5617873,Inappropriate speech,Aripiprazole,Placbeo,continuous,,45,,47,-2.2,0.4,-1.5,0.4,-1.7354,0.0599,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,4396,"[1661, 1650, 579]","intervention:
    mean: 26.8
    standard_deviation: 6.5
    group_size: N/A
comparator:
    mean: 27.1
    standard_deviation: 7.2
    group_size: N/A

outcome:
    mean: x

---
intervention:
    mean: 9
    standard_deviation: 3
    group_size: N/A
comparator:
    mean: x
    standard_deviation: x
    group_size: N/A
outcome:
    mean: x
    standard_deviation: x
    
---
intervention:
    mean: 6.7
    standard_deviation: 6.8
    group_size: 33
comparator:
    mean: 4.1
    standard_deviation: 4.2
    group_size: 34

YAML:
<assistant/>
intervention:
    
---
",True
22,3245,2972614,Shoulder Pain and Disability Index score,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,48.13,22.1,40.99,20.98,0.325,0.0798,,,,,,TRUE,7041,2968,TEST,1931,[1525],"intervention:
    mean: 7.16
    standard_deviation: 1.64
    group_size: NUMBER
comparator:
    mean: 4.59
    standard_deviation: 1.76
    group_size: NUMBER

The total size of Group I and Group II is specified
---
",True
392,1120,3577738,efficiency,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[],"intervention:
    mean: 4.9
    standard_deviation: 0.38
    group_size: N/A # This will be determined based on the number of participants who completed the follow-up measures.
comparator:
    mean: 4.4
    standard_deviation: 0.38
",False
44,6986,3169777,Plasma endothelin-1 concentrations,macitentan dose of 600 mg,placebo,continuous,,6,,14,,,,,cannot calculate,cannot calculate,,,,,The mean and SD are in bar chart (figure),FALSE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
    mean: 2.7
    standard_deviation: 0.7
    group_size: 6
comparator:
    mean: 1.1
    standard_deviation: 0.7
    group_size: 6

In the given trial article, macitentan dose of 600
---
intervention:
    mean: 931
    standard_deviation: 104
    group_size: 48
comparator:
    mean: 114
    standard_deviation: 77.8
    group_size: 33

This YAML format represents the arithmetic mean (± standard deviation) of plasma endothelin
---
",True
99,929,4183415,patient adherence,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,68.3,23.4,69.8,20.9,-0.0668,0.0521,,,,,"Data found in Table 6. Used same values as ""completed treatment",TRUE,10420,7106,TEST,5310,"[1574, 1105, 1423, 643]","intervention:
    mean: 68.3
    standard_deviation: 10.8
    group_size: 904
comparator:
    mean: 69.8
    standard_deviation: 9.2
    group_size: 527

YAML:
<|assistant>
intervention:
---
intervention:
    mean: 123
    standard_deviation: 23.1
    group_size: 53
comparator:
    mean: 95
    standard_deviation: 20.9
    group_size: 59

YAML:
<assistant>:
    mean: 584
    standard
---
 intervention:
    mean: 78.4
    standard_deviation: 13.2
    group_size: 37
comparator:
    mean: 90.0
    standard_deviation: 12.8
    group_size: 40

YAML:
 intervention:
    mean: 63.5
---
intervention:
    mean: 68.2
    standard_deviation: 33.3
    group_size: 37
comparator:
    mean: 68.3
    standard_deviation: 23.4
    group_size: 40
<|assistant>
intervention:
    mean: 73.
---
",True
168,2797,5079604,incremental area under the curve for insulin (AUCi),subjects who remained in remission,patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si),continuous,,28,,20,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"[1656, 1646]","intervention:
    mean: 480
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

YAML:
intervention:
    mean: 1,000
    standard
---
intervention:
    mean: 105.9
    standard_deviation: 20.2
    group_size: 28
comparator:
    mean: 97.0
    standard_deviation: 19.6
    group_size: 28

intervention:
    mean: 1047).5
    standard
---
",True
320,4724,5539943,"sustain talk"" (ST)",Language Enhanced Attention and Focus MI training condition (MI-LEAF),baseline,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"[1580, 1384]","intervention:
    mean: 0.25
    standard_deviation: 0.109
    group_size: NUMBER
comparator:
    mean: 0.22
    standard_deviation: 0.138
    group_size: NUMBER

YAML:
intervention:
    mean: 7
---
intervention:
    mean: 0
    standard_deviation: 0
    group_size: 60
comparator:
    mean: 0
    standard_deviation: 0
    group_size: 60
st:
    mean: 0.0
    standard_deviation: 0.0
    group
---
",True
438,3261,3475525,Scores on sodium quiz,MTL group,choices group,continuous,,98,,98,93.5,16.4,47.1,21.1,2.44594908,0.03567007,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: N/A
comparator:
    mean: 65.8
    standard_deviation: 10.3
    group_size: N/A

YAML:
intervention:
    mean
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    mean: NUMBER
    standard_deviation: NUMBER
    
---
",True
554,9720,3648394,pNN50,10-week yoga program,Control,continuous,,18,,19,20.7,25.3,19.4,18.4,0.05775336,0.10823221,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,4261,"[1647, 1622, 64]","intervention:
    mean: 0.045
    standard_deviation: 0.013
    group_size: N/A
comparator:
    mean: 0.214
    standard_deviation: 0.023
    group_size: N/A
outcome:
    mean: 0.236
---
 intervention:
   mean: NUMBER
   standard_deviation: NUMBER
   group_size: NUMBER
comparator:
   mean: NUMBER
   standard_deviation: NUMBER
   group_size: NUMBER
 pNN50:
  intervention: NUMBER.7
  compar
---
intervention:
    mean: 78.57
    standard_deviation: 10.43
    group_size: 13
post-intervention:
    mean: 15.16
    standard_deviation: 2.39
    group_size: 13
comparator:
    mean: 14.14
    standard
---
",True
327,5374,5559992,Anxiety,Buprenophine 96 mg,No treatment,continuous,,5,,5,0,0,23.8,13.82,-2.1985,0.6417,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,721,[],"intervention:
    mean: 11.11
    standard_deviation: 3.13
    group_size: 14
comparator:
    mean: 7.27
    standard_deviation: 3.61
    group_size: 14

figure:
  graph_type: bar
  title:",False
111,9522,4319071,High-energy snack intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,2.5,2.76,2.84,2.71,-0.1242,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"[781, 1626, 1619, 1304, 1094, 1600, 944]","intervention:
    mean: 123.45
    standard_deviation: 23.08
    group_size: 456
comparator:
    mean: 127.89
    standard_deviation: 24.21
    group_size: 434

intervention:
    mean: 123.45
    standard_
---
intervention:
    mean: 3.34
    standard_deviation: 1.29
    group_size: 1.85
comparator:
    mean: 1.80
    standard_deviation: 0.97
    group_size: 1.81

## Loss to Follow Up A total of 134
---
intervention:
    mean: 2.25
    standard_deviation: 0.07
    group_size: NUMBER
comparator:
    mean: 2.05
    standard_deviation: 0.07
    group_size: NUMBER

YAML:
<|assistant>
intervention
---
intervention:
    mean: 3.43
    standard_deviation: 1.03
    group_size: 19
comparator:
    mean: 2.53
    standard_deviation: 1.11
    group_size: 18

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 1.56
    standard_deviation: 0.07
    group_size: N/A
comparator:
    mean: 1.41
    standard_deviation: 0.08
    group_size: N/A
intervention:
    mean: 4.75

---
intervention:
    mean: 120
    standard_deviation: 20
    group_size: 30
comparator:
    mean: 90
    standard_deviation: 15
    group_size: 40

intervention:
    mean: 15
    standard_deviation: 3
    group_size:
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
high-energy-snack-intake:
  post-
---
",True
613,11584,115849,Serum C-reactive protein,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 93.05
    standard_deviation: 13.63
    group_size: 317
comparator:
    mean: 106.45
    standard_deviation: 14.29
    group_size: 329

empty_ intervention:
    mean: 0.00
    
---
intervention:
    mean: 1.11
    standard_deviation: 1.00
    group_size: N/A
comparator:
    mean: 1.00
    standard_deviation: 0.87
    group_size: N/A

In the given trial article, serum C-
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
comparator:
    mean: 106.9
    standard_deviation: 23.1
    group_size: N/A

YAML:
intervention:
    mean
---
",True
589,11583,115849,Patient global assessment of disease activity,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 65.5
    standard_deviation: 13.1
    group_size: 367
comparator:
    mean: 76.0
    standard_deviation: 14.2
    group_size: 375

intervention:
    mean: 66.0
    standard_
---
intervention:
    mean: -9.93
    standard_deviation: 0.09
    group_size: NUMBER
comparator:
    mean: -10.46
    standard_deviation: 0.28
    group_size: NUMBER
patient_global_assessment_of_d
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 178
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 178
patient_global_assessment_of_disease_activity:
---
",True
216,2915,5459456,new bone formation around the screws and bone-implant contact (BIC) in both sections,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating,ACVC,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 84.0
    standard_deviation: 13.7
    group_size: 4
comparator:
    mean: 79.3
    standard_deviation: 13.6
    group_size: 4

intervention:
    mean: 42.5
    standard_
---
intervention:
    mean: 102
    standard_deviation: 11
    group_size: 21
comparator:
    mean: 85.4
    standard_deviation: 12.7
    group_size: 21
intervention:
    mean: 13.4
    standard_deviation: 1.
---
intervention:
    mean: 7.5
    standard_deviation: 1.8
    group_size: 6
comparator:
    mean: 6.1
    standard_deviation: 1.3
    group_size: 6

 intervention:
    mean: 2.74
    standard_
---
intervention:
    mean: 105.2
    standard_deviation: 20.8
    group_size: 16
comparator:
    mean: 75.0
    standard_deviation: 19.4
    group_size: 16

new_bone_formation:
    intervention: 15.3
---
",True
243,8057,5534041,composite z-scores in autism spectrum disorder (ASD),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,0.13,0.82,-0.25,0.71,0.4783,0.1714,,,,,,TRUE,6951,5679,TEST,4357,"[738, 1561, 1405]","intervention:
    mean: 0.71
    standard_deviation: 0.27
    group_size: 12
comparator:
    mean: 0.53
    standard_deviation: 0.23
    group_size: 12

Explanation: The provided article does not include numerical data or specific
---
intervention:
    mean: 0.15
    standard_deviation: 0.87
    group_size: NUMBER
comparator:
    mean: 0.09
    standard_deviation: 0.93
    group_size: NUMBER

This YAML represents the given information as follows:

---
intervention:
    mean: 7.0
    standard_deviation: 1.8
    group_size: 14
comparator:
    mean: 6.0
    standard_deviation: 1.6
    group_size: 14

data:
  mean: 7.1
  standard_
---
",True
650,13097,5976307,awake time,etomidate,propofol based on midazolam,continuous,,62,,62,15.08,10.06,17.07,11.83,-0.1801099,0.03238887,,,,,found in table 2,TRUE,2560,2044,TEST,1751,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  etomidate:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_",False
597,11583,115849,Discontinuation due to lack of efficacy,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 65.5
    standard_deviation: 13.3
    group_size: 387
comparator:
    mean: 76.0
    standard_deviation: 15.3
    group_size: 382

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 9.6
    standard_deviation: 4.3
    group_size: N/A # Includes all patients who received at least 1 dose of study medication
comparator:
    mean: 3.0
    standard_deviation: 1.3
    group_size:
---
intervention:
    mean: 12.0
    standard_deviation: 6.1
    group_size: 353
comparator:
    mean: 7.9
    standard_deviation: 4.8
    group_size: 353

YAML:
<assistant again>
intervention:

---
",True
306,7831,4541185,duration of sensory block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,703.83,42.9,556.38,37.96,3.5929,0.1742,,,,,found in text,TRUE,1359,1043,TEST,907,[],"intervention:
    mean: 603.15
    standard_deviation: 110.53
    group_size: 30
comparator:
    mean: 555.08
    standard_deviation: 110.23
    group_size: 30

outcome:
    duration of sensory block:
        ",False
351,4494,5874317,Knee flexion (1-rep Max),Bilateral training,Unilateral training,continuous,,9,,9,99.8,10.2,86.8,2.9,1.6509,0.2979,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"[616, 2442, 806]","intervention:
    mean: 83
    standard_deviation: 15
    group_size: 9
comparator:
    mean: 95
    standard_deviation: 15
    group_size: 9

 intervention:
    mean: 100
    standard_deviation: 15
    group_size:
---
When compared to a ""merge"". It seems silly. If you have to produce the correct in every single time point of interest or the very last one. If you like to produce the correct in every single timepoint of interest or ""merge"". It is time to make it a ""make"": YAML:
If you like the correct in pre
---
 intervention:
    mean: 80.0
    standard_deviation: 10.0
    group_size: 9
comparator:
    mean: 75.5
    standard_deviation: 10.3
    group_size: 10
<|assistant>
YAML:
<assistant>
---
",True
419,3262,3475525,intent of purchase,MTL+caloric intake group,choices group,continuous,,90,,98,3.6,1.5,4.1,1.7,-0.3098034,0.02157045,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: 480
comparator:
    mean: 67.8
    standard_deviation: 10.3
    group_size: 355

YAML:
intervention:
    mean: 73.3
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  intent_to_purchase:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    
---
",True
346,10233,5686687,Need for dipyrone,Resveratrol,Placebo,continuous,,22,,22,1944,1793,625,250,1.0119,0.1025,,,,,found in table,TRUE,7451,3515,TEST,2366,"[1656, 156]","intervention:
    mean: 5.4
    standard_deviation: 2.6
    group_size: N/A
comparator:
    mean: 5.7
    standard_deviation: 2.6
    group_size: N/A

output:
    mean: 6.4
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 30
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 30

need_for_dipyrone:
    intervention:
---
",True
282,6422,3654355,baseline skeletal muscle mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,38.4,7.9,37.9,7.4,0.0641,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"[1123, 1035, 883, 1927, 1235]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

YAML:
intervention:
    mean: 90
    
---
intervention:
    mean: 68.3
    standard_deviation: 13.2
    group_size: 64
comparator:
    mean: 67.1
    standard_deviation: 12.8
    group_size: 62
intervention:
    mean: 128.9
    standard_dev
---
intervention:
    mean: 97.1
    standard_deviation: 13.7
    group_size: 71
comparator:
    mean: 65.5
    standard_deviation: 12.9
    group_size: 138

YAML:
<|assistant>
intervention:

---
::: table wrap
::: table yaml
intervention:
  mean: 130.4
  standard_deviation: 10.7
  group_size: 57
comparator:
  mean: 132.3
  standard_deviation: 8.8
  group_size: 60
outcome:
---
intervention:
    mean: 80.0
    standard_deviation: 8.3
    group_size: 15
comparator:
    mean: 76.8
    standard_deviation: 7.4
    group_size: 15

YAML:
<|assistant>
intervention:

---
",True
634,12289,5777645,HbA1c levels,to peer-led structured patient education,conventional care alone,continuous,,70,,70,1.05,2,0.15,1.7,0.48225433,0.02940203,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,3738,"[1499, 1358, 551]","intervention:
    mean: 1.05
    standard_deviation: 2.0
    group_size: N/A
comparator:
    mean: 1.7
    standard_deviation: 1.8
    group_size: N/A

intervention:
    mean: 76.2
---
intervention:
    mean: 101.05
    standard_deviation: 8.42
    group_size: 70
comparator:
    mean: 106.11
    standard_deviation: 8.51
    group_size: 70

Based on the given trial article, the mean HbA1c levels
---
intervention:
    mean: 8.1
    standard_deviation: 1.2
    group_size: 50
comparator:
    mean: 7.9
    standard_deviation: 1.1
    group_size: 50

YAML:
<assistant />
intervention:
    
---
",True
620,11603,1863515,absolute neutrophil count at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,5639,,6150,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,3103,"[1640, 851]","intervention:
    mean: 12.0
    standard_deviation: 3.1
    group_size: 283
comparator:
    mean: 8.0
    standard_deviation: 2.0
    group_size: 283

outcome:
    mean: NUMBER
    standard_
---
intervention:
    mean: 105
    standard_deviation: 18
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A

expert_notes_yaml:
intervention:
    mean
---
",True
288,6102,4215531,alpha power,facial affect training (FAT) in 20 daily 1-hour sessions,treatment as usual (TAU),continuous,,19,,19,,,,,cannot calculate,cannot calculate,,,,,"F-values given, not sure how to use them",FALSE,7350,5561,TEST,4156,"[1623, 1169, 760]","intervention:
    mean: 102.10
    standard_deviation: 10.71
    group_size: 17
comparator:
    mean: 92.05
    standard_deviation: 9.60
    group_size: 18

This YAML is correct because it includes the required information for the
---
intervention:
    mean: 43.5
    standard_deviation: 9.1
    group_size: 19
comparator:
    mean: 36.0
    standard_deviation: 6.6
    group_size: 15

This YAML represents the mean value, standard deviation, and group
---
intervention:
    mean: 44.6
    standard_deviation: 12.2
    group_size: 19
comparator:
    mean: 40.1
    standard_deviation: 14.4
    group_size: 19

YAML:
<|assistant>
intervention:

---
",True
223,2914,5459456,Rotation stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.02,0,1.62,0.47,-4.5509,0.8972,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 110.0
    standard_deviation: 11.7
    group_size: 5
comparator:
    mean: 99.0
    standard_deviation: 12.1
    group_size: 5

outcome:
    rotation_stiffness_C2
---
intervention:
    mean: 10.4
    standard_deviation: 1.3
    group_size: 36
comparator:
    mean: 8.8
    standard_deviation: 1.1
    group_size: 36

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 0.70
    standard_deviation: 0.06
    group_size: 24
comparator:
    mean: 0.64
    standard_deviation: 0.06
    group_size: 24
rotation_stiffness:
    intervention:
        mean:
---
intervention:
    mean: 52.17
    standard_deviation: 8.43
    group_size: 14
comparator:
    mean: 28.96
    standard_deviation: 7.14
    group_size: 14
rotation_stiffness_C2-4:
    mean
---
",True
160,7711,5056957,BMI z-score at 12months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,0.61,1.8,0.66,1.69,-0.0285,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"[1500, 261, 1439, 763]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
weight:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
bmi_z_score:
    mean: NUMBER
    standard_dev
---
intervention:
    mean: NaN
    standard_deviation: NaN
    group_size: NaN
comparator:
    mean: 85.5
    standard_deviation: 15.0
    group_size: 487
bmi_z_score:
    intervention: NaN
    comparator:
---
intervention:
    mean: 94.58
    standard_deviation: 12.51
    group_size: 456

comparator:
    mean: 99.11
    standard_deviation: 11.24
    group_size: 459

< The YAML above provides the table of mean outcome and
---
intervention:
    mean: 55.91
    standard_deviation: 8.40
    group_size: 580
comparator:
    mean: 61.08
    standard_deviation: 9.37
    group_size: 560

YAML:
<|assistant>
intervention:

---
",True
472,5710,3343759,improvment in ANELT by day 21,higher level of education (>12 years),<12 years of education,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Median is reported. Group sizes are only available in methods section.,FALSE,3838,2633,TEST,2065,[1638],"intervention:
    mean: 1.3
    standard_deviation: 0.83
    group_size: 20
comparator:
    mean: 1.2
    standard_deviation: 0.86
    group_size: 20

YAML:
intervention:
    mean: 14
    
---
",True
418,3262,3475525,intent of purchase,MTL group,choices group,continuous,,98,,98,3.8,1.4,4.1,1.7,-0.1919025,0.02050211,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: NUMBER.4
    standard_deviation: NUMBER.4
    group_size: NUMBER
comparator:
    mean: NUMBER.4
    standard_deviation: NUMBER.4
    group_size: NUMBER

Explanation: This YAML format
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  INTENT_TO_PURCHASE:
    mean
---
",True
618,11603,1863515,haemoglobin level at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,10.7,,11.2,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,3103,"[1640, 851]","intervention:
    mean: >-
            11.4
    standard_deviation: >-
            0.1
    group_size: >-
            874
comparator:
    mean: >-
            10.7
    standard_deviation: >-
            0.1
    
---
intervention:
    mean: 12.5
    standard_deviation: 2.08
    group_size: 540
comparator:
    mean: 11.1
    standard_deviation: 2.1
    group_size: 540

This is the YAML representation of the provided information. There are
---
",True
514,6551,4033571,Seizure median percent improvement in North America,Extended-release oxcarbazepine 1200 mg,Control,continuous,,,,,-34.5,,-13.3,,cannot calculate,cannot calculate,,,,,"Group sizes are only in figure, and SD is not available.",FALSE,8206,5593,TEST,4514,"[1618, 1634, 835]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  1200:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  2400:
    mean: NUMBER
    standard
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  Oxtellar XR (SPN-804) 2400 mg:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
---
extension:
  intervention:
    mean_seizure_percent_improvement: -50.0
    standard_deviation_seizure_percent_improvement: 35.0
    group_size_intervention: 125
  comparator:
    mean_seizure_percent_improvement:
---
",True
141,1272,4880652,the modified Aldrete scores at 60 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean and SD are in table that is in graphic form.,FALSE,1406,1149,TEST,966,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    the modified Aldrete scores at 60 minutes:
    number: NUMBER_VALUE
    standard_deviation: NUMBER_VALUE
    group_size: NUMBER_VALUE
com",False
78,3740,3546023,tocopherol levels,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,14.11,3.89,11.39,3.06,0.7671,0.0716,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1053, 1432, 1540, 941, 1509, 986, 1381]"," intervention:
    mean: 63.50
    standard_deviation: 3.62
    group_size: 30
 comparator:
    mean: 60.42
    standard_deviation: 3.33
    group_size: 28
< Prev:
 intervention:
    mean: 63.50
    
---
intervention:
     mean: 50.00
     standard_deviation: 10.00
     group_size: 60
comparator:
     mean: 40.00
     standard_deviation: 10.00
     group_size: 60
outcome:
     mean: NUMBER
    standard_dev
---
intervention:
    mean: 50).0
    standard_deviation: 15).0
    group_size: 16
comparator:
    mean: 10).0
    standard_deviation: 3).0
    group_size: 16

YAML:
<assistant>:
    mean: NUM
---
intervention:
    mean: 8.32
    standard_deviation: 1.55
    group_size: 29
comparator:
    mean: 7.29
    standard_deviation: 2.10
    group_size: 27
intervention:
    mean: 8.82
    standard_dev
---
intervention:
    mean: 67.67
    standard_deviation: 8.14
    group_size: 3
comparator:
    mean: 69.00
    standard_deviation: 6.08
    group_size: 17
tocopherol:
    intervention: 453.85
    com
---
intervention:
    mean: 1225.0
    standard_deviation: 95.8
    group_size: 29
comparator:
    mean: 1030.6
    standard_deviation: 95.3
    group_size: 28

YAML:
<assistant>
intervention:
---
intervention:
    mean: 1000
    standard_deviation: 100
    group_size: 50
comparator:
    mean: 600
    standard_deviation: 100
    group_size: 50

intervention:
    mean: 50), (mean = (NUMBER, standard deviation = (NUMBER, group
---
",True
436,3261,3475525,Scores on sodium quiz,MTL group,No label group,continuous,,98,,99,93.5,16.4,42.6,20.7,2.71359845,0.03899447,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: NUMBER.8
    standard_deviation: NUMBER.5
    group_size: NUMBER
comparator:
    mean: NUMBER.8
    standard_deviation: NUMBER.5
    group_size: NUMBER

# Results of healthful product quiz
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  sodium:
    mean: NUMBER.0
    standard_deviation: NUMBER.0
    group_size: NUMBER
comparator:
    mean: NUMBER
    
---
",True
102,1886,4188762,heart rate,remifentanil,lidocaine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[],"intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x

YAML:
<|assistant>
intervention:
    mean: 72.5
    ",False
276,6421,3654355,Visceral fat,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-82.3,31.6,4.3,22.7,-2.6604,0.0784,,,,,,TRUE,18948,9604,TEST,6664,"[1123, 1035, 883, 1927, 1235]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  visceral_fat:
    mean: NUMBER.2
    standard_deviation: NUMBER.2
    group_size: NUMBER
comparator:
    mean: NUMBER
---
intervention:
    mean: 60.5
    standard_deviation: 11.0
    group_size: 67
comparator:
    mean: 60.4
    standard_deviation: 13.2
    group_size: 67
visceral_fat:
    mean: 255.7
    
---
intervention:
    mean: 82.0
    standard_deviation: 95.3
    group_size: 71
comparator:
    mean: 66.7
    standard_deviation: 94.4
    group_size: 65
visceral_fat:
    intervention:
        mean: 81
---
intervention:
    mean: 132.3
    standard_deviation: 10.7
    group_size: 57
comparator:
    mean: 130.4
    standard_deviation: 8.8
    group_size: 37

---

To calculate the change in the intervention and comparator groups
---
intervention:
    mean: 110
    standard_deviation: 15
    group_size: 43
comparator:
    mean: 83
    standard_deviation: 11
    group_size: 47
visceral_fat:
    intervention:
        mean: 29.4
        standard_deviation
---
",True
159,7710,5056957,BMI reduction at 12 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,21.07,6.39,21.27,5.9,-0.0323,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"[1500, 261, 1439, 763]","intervention:
    mean: 90.0
    standard_deviation: 11.0
    group_size: N/A
comparator:
    mean: 85.0
    standard_deviation: 12.0
    group_size: N/A
outcome:
    mean: 22.0
---
intervention:
    mean: 110
    standard_deviation: 15
    group_size: 29
comparator:
    mean: 85
    standard_deviation: 10
    group_size: 29

weight_bmi_reduction_at_12_months:
    intervention: 27.0

---
intervention:
    mean: 54.0
    standard_deviation: 8.2
    group_size: 41
comparator:
    mean: 23.0
    standard_deviation: 5.3
    group_size: 39
<::note::>
YAML:
intervention:
    
---
intervention:
    mean: 55.91
    standard_deviation: 9.09
    group_size: 595
comparator:
    mean: 61.08
    standard_deviation: 10.41
    group_size: 560
intervention:
    mean: 50.04
    standard_dev
---
",True
388,1119,3577738,focused on the social presence elements in terms of duration,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[],"intervention:
    mean: 4.9
    standard_deviation: 0.38
    group_size: N/A # Based on total number of participants that completed the intervention (N=458).
comparator:
    mean: 4.4
    standard_deviation: 0.38
    group_",False
446,4002,4879328,waist circumference,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.89,3.32,0.3,3.54,-0.3450435,0.01866038,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"[755, 1623, 1022, 1067, 817]","intervention:
    mean: 94.0
    standard_deviation: 13.1
    group_size: 228
comparator:
    mean: 98.0
    standard_deviation: 11.8
    group_size: 166

intervention:
    mean: 90.0
    standard_
---
intervention:
    mean: 55.5
    standard_deviation: 12.3
    group_size: 114
comparator:
    mean: 51.2
    standard_deviation: 18.9
    group_size: 205

The provided information is insufficient to fill out the table in YAML
---
intervention:
    mean: 130.0
    standard_deviation: 10.0
    group_size: 60
comparator:
    mean: 125.0
    standard_deviation: 10.0
    group_size: 60

YAML:
intervention:
    mean: 93.5
---
intervention:
    mean: 1
    standard_deviation: 0.1
    group_size: 104
comparator:
    mean: 0
    standard_deviation: 0.1
    group_size: 114

YAML:
intervention:
    mean: 7.4
    standard_
---
intervention:
    mean: 1.35
    standard_deviation: 0.46
    group_size: 104
comparator:
    mean: 114.0
    standard_deviation: 22.7
    group_size: 114
waist_circ:
    intervention: 1.87
    
---
",True
211,2913,5459456,inflexion-extension for the C5-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,1.4,0.1,1.4,0.2,0,0.25,,,,,,TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 120°
    standard_deviation: 10°
    group_size: 4
comparator:
    mean: 100°
    standard_deviation: 10°
    group_size: 4

YAML:
intervention:
    mean: 30°
    standard_dev
---
intervention:
    mean: 6.5
    standard_deviation: 0.9
    group_size: 24
comparator:
    mean: 8.0
    standard_deviation: 1.1
    group_size: 24

intervention:
    mean: 3.4
    standard_
---
intervention:
    mean: 0.58
    standard_deviation: 0.08
    group_size: 8
comparator:
    mean: 0.63
    standard_deviation: 0.07
    group_size: 8

treatment:
    mean: 4.1
    standard_
---
intervention:
    mean: 35.53
    standard_deviation: 2.95
    group_size: 16
comparator:
    mean: 25.29
    standard_deviation: 2.53
    group_size: 16

YAML:
<assistant>
intervention:
    
---
",True
579,8566,2952311,State-Trait Anxiety Inventory-I,Acupressure at distal points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[1302],"intervention:
    mean: 82.55
    standard_deviation: 12.42
    group_size: 11
comparator:
    mean: 62.89
    standard_deviation: 10.89
    group_size: 11

YAML:
intervention:
    mean: 106.43
---
",True
278,6422,3654355,Baseline body mass index,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,42.8,4.6,42.8,6.3,0,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"[1123, 1035, 883, 1927, 1235]","intervention:
    mean: 42.6
    standard_deviation: 5.2
    group_size: NUMBER
comparator:
    mean: 35.5
    standard_deviation: 6.0
    group_size: NUMBER

Table 7 in the article reports the mean scores on the
---
intervention:
    mean: 45.2
    standard_deviation: 9.5
    group_size: 71
comparator:
    mean: 38.5
    standard_deviation: 9.8
    group_size: 33

YAML:
<|assistant>
intervention:

---
intervention:
    mean: −6.7
    standard_deviation: −0.8
    group_size: 291
comparator:
    mean: −1.2
    standard_deviation: 0.6
    group_size: 292

YAML:
<|assistant>

---
intervention:
    mean: 130.4
    standard_deviation: 10.7
    group_size: 57
comparator:
    mean: 133.3
    standard_deviation: 9.6
    group_size: 57

total_c:
    mean: 4.7
    
---
intervention:
    mean: Number of participants enrolled in the ILI group
    standard_deviation: Unknown
    group_size: Unknown
comparator:
    mean: Number of participants assigned to the waiting list control group
    standard_deviation: Unknown
    group_size: Unknown
    
wli:
---
",True
665,13296,4987981,FPG,pioglitazone,placebo,continuous,,16,,23,103.4,28.9,97.6,20.8,0.23275367,0.1066728,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"[518, 1670, 1662, 743]","intervention:
    mean: 102.0
    standard_deviation: 15.7
    group_size: 53
comparator:
    mean: 97.5
    standard_deviation: 15.0
    group_size: 53

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 97.6
    standard_deviation: 35.7
    group_size: N/A
comparator:
    mean: 101.9
    standard_deviation: 35.1
    group_size: N/A

outcome: FPG
yaml
---
intervention:
    mean: 90.0
    standard_deviation: 15.0
    group_size: 33
comparator:
    mean: 80.0
    standard_deviation: 10.0
    group_size: 33

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 94.5
    standard_deviation: 15.1
    group_size: 34
comparator:
    mean: 96.3
    standard_deviation: 16.1
    group_size: 35

YAML:
<|assistant>:
intervention:

---
",True
163,7713,5056957,BMI z-score at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,0.69,1.81,0.71,1.63,-0.0115,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"[1500, 261, 1439, 763]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

bmi_z_score:
    intervention: NUMBER
---
intervention:
    mean: 95.5
    standard_deviation: 11.1
    group_size: 503
comparator:
    mean: 87.1
    standard_deviation: 9.7
    group_size: 503
bmi_z_score:
    intervention: 1.43
---
intervention:
    mean: 60.5
    standard_deviation: 9.0
    group_size: 23
comparator:
    mean: 28.4
    standard_deviation: 3.1
    group_size: 12
<|assistant>
 intervention:
    mean: 50.
---
intervention:
    mean: 55.91
    standard_deviation: 10.08
    group_size: 594
comparator:
    mean: 57.55
    standard_deviation: 12.52
    group_size: 576

YAML:
<|assistant>
intervention:

---
",True
172,2790,5079604,Hyperglycemia relapse-free survival,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,continuous,,33,,15,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"[1656, 1646]","intervention:
    mean: 480
    standard_deviation: 131
    group_size: 48
comparator:
    mean: 331
    standard_deviation: 110
    group_size: 15

YAML:
intervention:
    mean: 1,000
    standard_deviation: 235
---
intervention:
    mean: 86
    standard_deviation: 10
    group_size: 28
comparator:
    mean: 77
    standard_deviation: 8
    group_size: 20

yAML:
 intervention:
    mean: 105.0
    standard_deviation: 13
---
",True
430,3261,3475525,Scores on the saturated fat quiz,MTL group,choices group,continuous,,98,,98,90.7,20.4,35.7,15.9,2.99563986,0.04330066,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: N/A
comparator:
    mean: 65.8
    standard_deviation: 10.3
    group_size: N/A

YAML:
intervention:
    mean
---
intervention:
    mean: 70.5
    standard_deviation: 10.8
    group_size: 49
comparator:
    mean: 88.0
    standard_deviation: 13.4
    group_size: 50

YAML:
<|assistant>
intervention:

---
",True
185,4338,5122613,Colonic transit time,Digestion-resistant maltodextrin,Placebo,continuous,,29,,28,39.7,22.3,48,25,-0.3459,0.0712,,,,,,TRUE,6184,3742,TEST,2832,"[1615, 694]","intervention:
    mean: 53.0
    standard_deviation: 21.6
    group_size: NUMBER
comparator:
    mean: 48.4
    standard_deviation: 24.1
    group_size: NUMBER
outcome:
    mean: NaN
    standard_
---
intervention:
    mean: 83.4
    standard_deviation: 27.3
    group_size: N/A
comparator:
    mean: 70.2
    standard_deviation: 26.6
    group_size: N/A
colon_transit_time:
    
---
",True
364,12885,5976949,ANGPTL4 expression,"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)","GDM2 (less tight glycaemic targets, <5.3_mmol/L and <_7.8_mmol/L)",continuous,,20,,21,23.1,25.6,21.5,25.8,0.061,0.0977,,,,,found in table,TRUE,4402,2905,TEST,2274,"[1223, 766]","intervention:
    mean: 23.11
    standard_deviation: 5.29
    group_size: NUMBER
comparator:
    mean: 21.47
    standard_deviation: 5.23
    group_size: NUMBER

intervention:
    mean: 98.33
    
---
intervention:
    mean: 19.9
    standard_deviation: 15.0
    group_size: 14.1
comparator:
    mean: 14.1
    standard_deviation: 4.5
    group_size: 4.5
ANGPTL4:
    intervention: 19
---
",True
662,13294,4987981,"Psoriasis Area and Severity Index (PASI), Erythema, Scaling and Induration (ESI) and Physician global assessment (PGA) scores",metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,5779,"[518, 1670, 1662, 743]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  metformin:
    mean: NUMBER.7
    standard_deviation: NUMBER.3
    group_size: NUMBER 30
  
  pioglitazone:
---
intervention:
    mean: 97.6
    standard_deviation: 35.7
    group_size: 207
comparator:
    mean: 101.9
    standard_deviation: 35.1
    group_size: 206
intervention:
    mean: 45.1
    standard_dev
---
intervention:
    mean: 110
    standard_deviation: 15
    group_size: 23
comparator:
    mean: 87
    standard_deviation: 15
    group_size: 16

intervention:
    mean: 8.43
    standard_deviation: 3.32
    
---
intervention:
    mean: 90.0
    standard_deviation: 11.9
    group_size: 53
comparator:
    mean: 62.5
    standard_deviation: 9.7
    group_size: 53

intervention:
    mean: 92.5
    standard_
---
",True
325,5372,5559992,Anxiety,Buprenophine 32 mg,No treatment,continuous,,5,,5,1,2.23,11,8.63,-1.4322,0.5026,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,721,[],"intervention:
    mean: 9.0
    standard_deviation: 3.3
    group_size: 14
comparator:
    mean: 7.5
    standard_deviation: 3.1
    group_size: 14

Figure 1: Anxiety scores from day 1 to day 7 in",False
302,3878,4357072,improvement in symptom scores,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,continuous,,15,,15,0.2,0.4,0.8,0.6,-1.1448,0.1552,,,,,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,1385,[],"intervention:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER
comparator:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER

{
  ""intervention"": {
    ""mean"": NUMBER,",False
300,5599,4355974,School days missed for asthma,BostonBreathes system,Control,continuous,,28,,14,-0.2,,-0.4,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,3820,"[1193, 1450, 403]","intervention:
    mean: 114.0
    standard_deviation: 23.9
    group_size: 67
comparator:
    mean: 93.0
    standard_deviation: 24.1
    group_size: 50

intervention:
    mean: 3.0
    standard
---
intervention:
    mean: 5.0
    standard_deviation: 1.8
    group_size: 28
comparator:
    mean: 4.2
    standard_deviation: 1.7
    group_size: 28
school_days_missed_asthma:
    intervention
---
intervention:
    mean: 6.5
    standard_deviation: 4.9
    group_size: 14
comparator:
    mean: 4.6
    standard_deviation: 4.4
    group_size: 14

YAML:
<assistant>:
    mean: 6
---
",True
485,5714,3343759,communication ability,very early speech and language therapy (SLT),control,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome.,FALSE,3838,2633,TEST,2065,[1638],"intervention:
    mean: 1.3
    standard_deviation: 0.15
    group_size: 21
comparator:
    mean: 1.2
    standard_deviation: 0.15
    group_size: 55

intervention:
    mean: 3.4
    standard_
---
",True
669,13296,4987981,triglycerides levels,pioglitazone,placebo,continuous,,16,,23,200.1,55.9,181.8,61.3,0.30295813,0.10715497,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"[518, 1670, 1662, 743]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NOUN
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NOUN
triglycerides:
    intervention: NUMBER
    comparator:
---
intervention:
    mean: 97.6
    standard_deviation: 35.7
    group_size: NUMBER
comparator:
    mean: 101.9
    standard_deviation: 35.1
    group_size: NUMBER

outcome:
    triglycerides:
        
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
 Triglycerides:
    mean: NUMBER.2
    standard
---
intervention:
    mean: 110
    standard_deviation: 20
    group_size: 60
comparator:
    mean: 60
    standard_deviation: 10
    group_size: 40

YAML:
intervention:
    mean: 130
    standard_deviation: 20
    
---
",True
433,3261,3475525,Scores on sugar quiz,MTL+caloric intake group,No label group,continuous,,90,,99,92.6,15.5,47.2,19.6,2.54502741,0.03834748,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 70.0
    standard_deviation: 8.6
    group_size: 95
comparator:
    mean: 88.5
    standard_deviation: 8.2
    group_size: 90

YAML:
intervention:
    mean: 95.5
---
intervention:
    mean: 93.5
    standard_deviation: 16.5
    group_size: 95
comparator:
    mean: 105.4
    standard_deviation: 22.1
    group_size: 90

### Note: Since no data was provided for the pre-intervention
---
",True
26,3244,2972614,Motion range - Shoulder abduction,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,166.66,21.38,172.72,16.67,-0.3054,0.0797,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,[1525],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    shoulder_abduction:
        mean: NUMBER
        standard_deviation: NUMBER
        group_size: NUMBER
interventions:
    - intervention: Laser therapy (
---
",True
21,3243,2972614,Severity of pain,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,3.76,1.45,4.63,2.1,-0.4889,0.0811,,,,,,TRUE,7041,2968,TEST,1931,[1525],"intervention:
    mean: 7.16
    standard_deviation: 1.64
    group_size: 33
comparator:
    mean: 4.59
    standard_deviation: 1.76
    group_size: 30

YAML:
intervention:
    mean: 40.0
---
",True
417,3262,3475525,intent of purchase,MTL+caloric intake group,No label group,continuous,,90,,99,3.6,1.4,4.1,1.5,-0.3426709,0.02152276,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: NUMBER
comparator:
    mean: 67.8
    standard_deviation: 10.3
    group_size: NUMBER

YAML:
intervention:
    mean: 73
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
intent_to_purchase:
    mean: NUMBERPost-intervention
---
",True
385,1118,3577738,website use in terms of the number of pages visited,website with social presence elements.,website without social presence elements.,continuous,,,,,7.5,4,8,3.8,cannot calculate,cannot calculate,,,,,Cannot find the group sizes in the text or table.,FALSE,3018,2080,TEST,1653,[]," intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
 comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
outcome:
    mean: NUMBER
    standard_deviation:",False
204,5497,5380326,Th1/Th2 cytokines,Vitamin D supplementation,Control,continuous,,40,,40,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome numerical values in the RCT. Cannot clearly identify the actual metric or measure for the given outcome.,FALSE,10658,5810,TEST,4260,"[1585, 1668, 307]","intervention:
    mean: 83.27
    standard_deviation: 115.08
    group_size: 80
comparator:
    mean: 133.80
    standard_deviation: 84.44
    group_size: 40
outcome:
    mean: NUMBER
    standard_dev
---
::: YAML
intervention:
  mean: 25.05
  standard_deviation: 1.8
  group_size: 40
comparator:
  mean: 21.67
  standard_deviation: 2.1
  group_size: 40
outcome:
  mean: 665
---
intervention:
    mean: -521.79
    standard_deviation: 228.09
    group_size: N/A
comparator:
    mean: 255.46
    standard_deviation: 216.35
    group_size: N/A

Outcome: IP-10, DPP
---
",True
164,617,5062234,The visual analog scale scores at rest and on coughing,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,continuous,,21,,21,,,,,cannot calculate,cannot calculate,,,,,Data found in table in graphic format.,FALSE,1345,1148,TEST,971,[],"intervention:
    mean: 34.57
    standard_deviation: 14.64
    group_size: 42
comparator:
    mean: 32.76
    standard_deviation: 14.34
    group_size: 42

---

Based on the given trial article, here are the",False
513,6549,4033571,Overall seizure median percent reduction,Extended-release oxcarbazepine 1200 mg,Control,continuous,,109,,117,-38.3,,-28.7,,cannot calculate,cannot calculate,,,,,SD was not given,FALSE,8206,5593,TEST,4514,"[1618, 1634, 835]","intervention:
    mean: -13.3
    standard_deviation: 12.1
    group_size: NUMBER
comparator:
    mean: -13.3
    standard_deviation: 12.1
    group_size: NUMBER

# Figure 2
## Data

<
---
intervention:
    mean: 95% CI of the median percent seizure reduction
    standard_deviation:
    group_size: # Number of patients in each group
        placebo: NUMBER
        SPN-804 1200 mg: NUMBER
        SPN-804 2400 mg: NUMBER

comparator
---
intervention:
    mean: 17.9
    standard_deviation: 5.3
    group_size: 53
comparator:
    mean: 27.1
    standard_deviation: 8.7
    group_size: 80

YAML:
 intervention:
    mean: NUMBER

---
",True
298,5597,4355974,Days limited activity from asthma,BostonBreathes system,Control,continuous,,28,,14,-0.2,,-1.8,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,3820,"[1193, 1450, 403]","intervention:
    mean: 6.0
    standard_deviation: 3.2
    group_size: 58
comparator:
    mean: 5.0
    standard_deviation: 3.1
    group_size: 21

The provided YAML is already the correct format for the requested information
---
intervention:
    mean: 10.0
    standard_deviation: 2.0
    group_size: 28
comparator:
    mean: 11.3
    standard_deviation: 3.0
    group_size: 28
dayslimitedactivityfromasthma:
    intervention: 38.
---
intervention:
    mean: 6.5
    standard_deviation: 0.9
    group_size: 14
comparator:
    mean: 4.6
    standard_deviation: 1.1
    group_size: 14

YAML:
<assistant>
intervention:
    
---
",True
564,9838,3496170,N1 latency,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,[],"intervention:
    mean: 122
    standard_deviation: 15
    group_size: 15
comparator:
    mean: 123
    standard_deviation: 15
    group_size: 15
n1_intervention:
    mean: 130
    standard_deviation: 21
    group_",False
67,3041,3321528,wrist flexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"[1121, 1095]","intervention:
    mean: 10.3
    standard_deviation: 3.6
    group_size: 42
comparator:
    mean: 14.0
    standard_deviation: 3.7
    group_size: 42

intervention:
    mean: 29.1
    standard_
---
intervention:
    mean: 5.0
    standard_deviation: 1.0
    group_size: 8
comparator:
    mean: 4.0
    standard_deviation: 1.0
    group_size: 28
wrist_flexion:
    intervention: 14
    com
---
",True
144,1272,4880652,"diastolic blood pressure at 10, 15, 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 4's graphics.,FALSE,1406,1149,TEST,966,[],"intervention:
    mean: 95.5
    standard_deviation: 10.2
    group_size: 76
comparator:
    mean: 88.0
    standard_deviation: 9.5
    group_size: 70

YAML:
<|assistant>:
intervention:
",False
676,13315,4550271,the proportion of patients who tested positive and received (or were prescribed) an ACT,provider-school intervention,control,continuous,,14,,12,56.4,33,64.2,28,-0.2451619,0.15591776,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,"[760, 1198, 1658, 1280, 1564, 949]","intervention:
    mean: 95% CI of the proportion of patients who tested positive and received (or were prescribed) an ACT
    standard_deviation: 6%
    group_size: 5311
comparator:
    mean: 95% CI of the proportion of patients who tested positive and received (or were prescribed)
---
intervention:
    mean: 9.3
    standard_deviation: 3.1
    group_size: 1245
comparator:
    mean: 3.6
    standard_deviation: 1.5
    group_size: 1567

YAML:
<assistant>
intervention:
---
intervention:
    mean: 64.2
    standard_deviation: 11.8
    group_size: NUMBER
comparator:
    mean: 55.6
    standard_deviation: 11.6
    group_size: NUMBER

This YAML format includes the necessary information for a table
---
intervention:
    mean: 6.681818181818182
    standard_deviation: 1.3854301658648675
    group_size: 314
comparator:
    mean: 6.346153846153846
    standard_deviation: 1.55102040816
---
intervention:
    mean: 90.6
    standard_deviation: 8.4
    group_size: 388
comparator:
    mean: 78.4
    standard_deviation: 13.6
    group_size: 294

This YAML specifies that the mean proportion of positive and ACT-
---
intervention:
    mean: 0.7
    standard_deviation: 0.1
    group_size: 190
comparator:
    mean: 0.3
    standard_deviation: 0.1
    group_size: 300

intervention:
    mean: 0.2
    standard_
---
",True
462,4431,5726464,Lipid profile: total cholesterol,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1309, 1402]","intervention:
    mean: 4000
    standard_deviation: 110
    group_size: NUMBER
comparator:
    mean: x
    standard_deviation: x
    group_size: NUMBER

Please note that I couldn't find any information related to pre-intervention values in the provided text
---
intervention:
    mean: 75.0
    standard_deviation: 10.0
    group_size: 83
comparator:
    mean: 61.0
    standard_deviation: 10.0
    group_size: 87

This YAML format is the one for the given trial article:
---
",True
323,4726,5539943,Motivational Interviewing (MI) knowledge,MI training (MI-AU),baseline,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"[1580, 1384]","intervention:
    mean: 0.714
    standard_deviation: 0.227
    group_size: NUMBER
comparator:
    mean: NA
    standard_deviation: NA
    group_size: NUMBER

Note: In the original article, the group size for MI training (MI
---
intervention:
    mean: 93.3
    standard_deviation: 9.9
    group_size: NUMBER
comparator:
    mean: 80.6
    standard_deviation: 10.9
    group_size: NUMBER

YAML:
<|assistant>
intervention
---
",True
656,13176,5773985,subjective onset of action,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,3,1.08,2.92,1.03,0.07461636,0.08005568,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,[1563],"intervention:
    mean: 508.92
    standard_deviation: 63.30
    group_size: 50
comparator:
    mean: 1840.84
    standard_deviation: 819.51
    group_size: 50

outcome:
    mean: 7.40

---
",True
167,2797,5079604,Disposition index (DI),subjects who remained in remission,patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si),continuous,,28,,20,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"[1656, 1646]","intervention:
    mean: 480
    standard_deviation: 61.5
    group_size: 17
comparator:
    mean: 166.5
    standard_deviation: 44.1
    group_size: 15

YAML:
intervention:
    mean: 1,000
    
---
intervention:
    mean: 79.7
    standard_deviation: 8.9
    group_size: 26
comparator:
    mean: 80.0
    standard_deviation: 8.3
    group_size: 26

YAML:
<|assistant>
intervention:

---
",True
273,2991,3214395,awakening,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 50",group 3 involved bispectral index (BIS) of 40,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,880,[],"intervention:
  mean: 80).2
  standard_deviation: 7.77
  group_size: 23
comparator:
  mean: 75).2
  standard_deviation: 7.41
  group_size: 24

outcome: awakening
intervention:
  mean: 82).",False
528,6919,4411165,diastolic BP,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,2336,"[1630, 211]","intervention:
    mean: 102.0
    standard_deviation: 11.5
    group_size: 12
comparator:
    mean: 99.5
    standard_deviation: 12.2
    group_size: 12

outcome:
    mean: 80.9
    standard
---
intervention:
    mean: 121.8
    standard_deviation: 11.8
    group_size: 7
comparator:
    mean: 115.7
    standard_deviation: 9.1
    group_size: 7

wbc:
    mean: 121.8
    standard
---
",True
610,11584,115849,Swollen joint count,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 29
    standard_deviation: 12
    group_size: 68
comparator:
    mean: 28
    standard_deviation: 12
    group_size: 67

For comparison, the table in the article can be represented as follows:

|  | Swollen
---
intervention:
    mean: 6
    standard_deviation: 3
    group_size: 35
comparator:
    mean: 5
    standard_deviation: 2
    group_size: 35

intervention:
    mean: 10
    standard_deviation: 3
    group_size:
---
intervention:
    mean: NA
    standard_deviation: NA
    group_size: 186
comparator:
    mean: 11.0
    standard_deviation: 4.5
    group_size: 182

This YAML represents the data requested without mean values for the intervention group since there is
---
",True
356,4710,5884950,objective-SCORAD score,extensively hydrolyzed whey-based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,extensively hydrolyzed whey-based formula without (control) short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,continuous,,13,,13,,,,,cannot calculate,cannot calculate,,,,,"mean and std not given, only median and interquartile range",FALSE,11712,6635,TEST,5281,"[1620, 1659, 1126]","intervention:
    mean: 26.53
    standard_deviation: 4.307
    group_size: 31
comparator:
    mean: 24.94
    standard_deviation: 5.221
    group_size: 26

intervention:
    mean: 2.761
    standard_
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  SCORAD:
    mean: 13
    standard_deviation: 4
    group_size: 30
comparator:
    mean: NUMBER
    standard_deviation: NUM
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  SCORAD: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  SCORAD: NUMBER

---
",True
404,2805,5781260,Glutathione peroxidase (GPxP),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,"[1670, 506]","intervention:
    mean: 100
    standard_deviation: 20
    group_size: 20
comparator:
    mean: 90
    standard_deviation: 10
    group_size: 20
gpxp:
    intervention:
        mean: NUMBER
        standard_deviation: NUM
---
intervention:
    mean: 105
    standard_deviation: 13
    group_size: 29
comparator:
    mean: 81
    standard_deviation: 11
    group_size: 29
glutathione peroxidase:
    intervention: 14.9
    comparator: 88.1

---
",True
390,950,3278655,subsidence,The trabecular metal tibial monoblock component (TM),cemented component.,continuous,,27,,18,-0.38,0.37,-0.04,0.11,-1.1288,0.1068,,,,,Used numerical values for Superior/inferior translation (SD). Numerical values are from 5-year follow up.,TRUE,5463,3510,TEST,2857,"[1308, 1167]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    subsidence: NUMBER
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    subsidence:
---
intervention:
    mean: 0.85
    standard_deviation: 0.13
    group_size: 30
comparator:
    mean: 1.0
    standard_deviation: 0.14
    group_size: 24

intervention:
    mean: 0.54
    standard_
---
",True
522,6698,5154016,Total drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,248.5,18.8,318.5,26.7,-2.9921679,0.14127557,,,,,,TRUE,3046,2156,TEST,1642,[],"intervention:
    mean: 202.5
    standard_deviation: 25.0
    group_size: 32
comparator:
    mean: 259.8
    standard_deviation: 37.0
    group_size: 32

YAML:
<|assistant>
intervention:
",False
156,13481,5055753,The mean ¬± SD of intraoperatively administered fentany,0.2 mg oral clonidine,2 mg oral midazolam,continuous,,40,,40,105,30.8,165,34.5,-1.817,0.0706,,,,,,TRUE,3292,2470,TEST,2114,"[1649, 100]","intervention:
    mean: 105.6
    standard_deviation: 30.8
    group_size: 40
comparator:
    mean: 165.6
    standard_deviation: 34.1
    group_size: 40

outcome:
    mean: NUMBER
    standard_
---
intervention:
    mean: 65.0
    standard_deviation: 13.4
    group_size: 31
comparator:
    mean: 95.5
    standard_deviation: 14.8
    group_size: 31

Note: The provided information only mentions morphine consumption after the surgery,
---
",True
464,4431,5726464,Lipid profile: LDL-c,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1309, 1402]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  LDL-c:
    mean: NUMBER.2
    standard_deviation: NUMBER.2
    group_size: NUMBER.2
comparator:
    mean: NUM
---
",True
444,8802,4467620,differences in the accuracy,Hot + Cooling conditions,Hot conditions,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,3858,"[1378, 1156]","intervention:
    mean: 45.02
    standard_deviation: 5.2
    group_size: 8
comparator:
    mean: 38.91
    standard_deviation: 4.6
    group_size: 8

# Table of mean outcome and standard deviation in YAML format

---
intervention:
    mean: 11.1
    standard_deviation: 0.9
    group_size: 10
comparator:
    mean: 12.3
    standard_deviation: 1.1
    group_size: 10

YAML:
<assistant>
intervention:
    
---
",True
573,8561,5541727,lateral tibial cartilage volume loss,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-3.7,3.4,-0.8,3.5,-0.8015134,0.27647057,,,,,Values are from 24 months,TRUE,6118,5345,TEST,4032,"[1437, 1673, 201]","intervention:
    mean: 3548
    standard_deviation: 401
    group_size: 6
comparator:
    mean: 3271
    standard_deviation: 401
    group_size: 6
lateral_tb_chg:
    group_size: 2
    mean: -
---
intervention:
    mean: 95%CI of the change from baseline in tibial cartilage volume
    standard_deviation: 95%CI of the change from baseline in tibial cartilage volume
    group_size: Number of patients in each group
comparator:
    mean: 95%CI of the change from baseline in tibial cartilage volume
---
intervention:
    mean: 0.024
    standard_deviation: 0.013
    group_size: 22
comparator:
    mean: 0.046
    standard_deviation: 0.024
    group_size: 19

intervention:
    mean: 7.71
    standard_
---
",True
571,8559,5541727,SF-36 bodily pain score improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,"[1437, 1673, 201]","intervention:
    mean: 75000000
    standard_deviation: 1000000
    group_size: NUMBER
comparator:
    mean: 1000000
    standard_deviation: 1000000
    group_size: NUMBER

## Results
The given trial article reports the mean improvements in the SF-36 bodily pain
---
 intervention:
    mean: 11.0
    standard_deviation: 3.2
    group_size: NUMBER
comparator:
    mean: 39.8
    standard_deviation: 3.9
    group_size: NUMBER

/*[Table of mean outcome and standard deviation in Y
---
intervention:
    mean: 0.4
    standard_deviation: 0.1
    group_size: 40
comparator:
    mean: 8.0
    standard_deviation: 2.0
    group_size: 20

Outcome: SF-36 bodily pain score improvement
YAML
---
",True
455,4422,4483334,Amount of calcium and phosphate on enamel surface,CPP-ACP plus laser (group D),Distilled and deionized water (group A),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,1068,[]," intervention:
    mean: 111.71
    standard_deviation: 14.73
    group_size: 80
comparator:
    mean: 80.50
    standard_deviation: 12.62
    group_size: 80

outcome:
    mean: NUMBER
    standard_",False
79,3740,3546023,tocotrienol levels,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,587.68,87.5,59.49,4.21,8.4162,0.6569,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1053, 1432, 1540, 941, 1509, 986, 1381]","intervention:
    mean: 63.50
    standard_deviation: 3.62
    group_size: 30
comparator:
    mean: 60.42
    standard_deviation: 3.05
    group_size: 28

intervention:
    mean: 1.48
    standard_
---
intervention:
    mean: 200
    standard_deviation: NA
    group_size: NA
comparator:
    mean: NA
    standard_deviation: NA
    group_size: NA
tocotrienol:
    intervention: 86.10
    comparator: 14.54
---
intervention:
    mean: 58.00
    standard_deviation: 39.30
    group_size: 57
comparator:
    mean: 12.00
    standard_deviation: 32.65
    group_size: 17
intervention:
    mean: 58.00
    standard_dev
---
intervention:
    mean: 8.32
    standard_deviation: 1.55
    group_size: 27
comparator:
    mean: 7.29
    standard_deviation: 2.10
    group_size: 27

YAML:
<assistant ->
intervention:
    
---
intervention:
    mean: 67.67
    standard_deviation: 8.14
    group_size: 17
comparator:
    mean: 65.00
    standard_deviation: 6.28
    group_size: 17

intervention:
    mean: 6.87
    standard_
---
intervention:
    mean: 18.48
    standard_deviation: 6.32
    group_size: 28
comparator:
    mean: 32.20
    standard_deviation: 5.56
    group_size: 30

YAML:
<assistant>
intervention:
    
---
intervention:
    mean: 1000
    standard_deviation: 100
    group_size: 10
comparator:
    mean: 100
    standard_deviation: 10
    group_size: 10
outcome:
    mean: NUMBER
    standard_deviation: NUMBER
intervention:

---
",True
363,12884,5976949,ANGPTL4 expression,"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)",control group- normal glucose tolerance,continuous,,20,,25,23.1,25.6,98.3,104.6,-0.9238,0.0995,,,,,found in table,TRUE,4402,2905,TEST,2274,"[1223, 766]","intervention:
    mean: 23.11
    standard_deviation: 5.51
    group_size: N/A # based on original study, this group included 18-20 women
comparator:
    mean: 21.47
    standard_deviation: 5.64
    group_size: N
---
intervention:
    mean: 19.9
    standard_deviation: 14.1
    group_size: 14
comparator:
    mean: 14.1
    standard_deviation: 4.5
    group_size: 21
ANGPTL4:
    intervention: 19.9
    
---
",True
129,4927,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,H0 (saline),"H1(haloperidol 1 mg),",continuous,,50,,49,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,2434,"[1666, 344]","intervention:
    mean: 4.9
    standard_deviation: 2.2
    group_size: 58
comparator:
    mean: 3.9
    standard_deviation: 2.5
    group_size: 49

YAML:
intervention:
    mean: 4.6
---
intervention:
    mean: 5.0
    standard_deviation: 1.0
    group_size: 20
comparator:
    mean: 3.0
    standard_deviation: 1.0
    group_size: 20

PACU sedation score:
    mean: 4.
---
",True
181,4339,5122613,Left SCTT,Digestion-resistant maltodextrin,Placebo,continuous,,29,,28,10.2,8.6,12.1,9.5,-0.207,0.0706,,,,,Had to do some simple math to get accurate group size.,TRUE,6184,3742,TEST,2832,"[1615, 694]","intervention:
    mean: 53.0
    standard_deviation: 21.6
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
outcome:
    mean: NUMBER

---
 intervention:
    mean: 82.9
    standard_deviation: 11.9
    group_size: 28
 comparator:
    mean: 70.9
    standard_deviation: 10.7
    group_size: 28
 Left SCTT:
    intervention: 41.6
    standard_dev
---
",True
517,6695,5154016,24 h drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,187.9,82,230.8,75,-0.538859,0.06908641,,,,,,TRUE,3046,2156,TEST,1642,[],"intervention:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER
  drainage_ volume: NUMBER
comparator:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER
  drainage_ volume",False
242,8056,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,6.2,1.8,4.8,0.9,0.9498,0.1855,,,,,,TRUE,6951,5679,TEST,4357,"[738, 1561, 1405]","intervention:
    mean: 0.58
    standard_deviation: 0.20
    group_size: 12
comparator:
    mean: 0.44
    standard_deviation: 0.20
    group_size: 12
intervention:
    mean: 0.65
    standard_dev
---
intervention:
    mean: 0.15
    standard_deviation: 0.87
    group_size: NUMBER
comparator:
    mean: 0.0
    standard_deviation: 0.42
    group_size: NUMBER

Please note that the data provided in the text seems to
---
intervention:
    mean: 6
    standard_deviation: 2
    group_size: 8
comparator:
    mean: 6
    standard_deviation: 2
    group_size: 8

session1:
    mean: 5
    standard_deviation: 2
    group_size
---
",True
569,8557,5541727,Activities of daily living,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,"[1437, 1673, 201]","intervention:
    mean: 85.0
    standard_deviation: 13.9
    group_size: 17
comparator:
    mean: 78.0
    standard_deviation: 13.2
    group_size: 17

## Adverse events

| Adverse events | Number (
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
ADL:
    mean: 12.0
    standard_deviation: 6.3
    group_size: 26
comparator:
    mean: NUMBER
    standard_deviation
---
intervention:
    mean: 102
    standard_deviation: 10
    group_size: 17
comparator:
    mean: 77
    standard_deviation: 7
    group_size: 17

This information suggests that the trial investigated the use of allogeneic mesenchymal precursor cells in improving activities of daily
---
",True
458,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),Distilled and deionized water (group A),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,1068,[],"intervention:
    mean: NUMBER.4
    standard_deviation: NUMBER.4
    group_size: NUMBER
comparator:
    mean: NUMBER.4
    standard_deviation: NUMBER.4
    group_size: NUMBER

outcome:
    total_",False
72,3042,3321528,the total MRC score of the legs,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"[1121, 1095]","intervention:
    mean: 58
    standard_deviation: 6
    group_size: 42
comparator:
    mean: 52
    standard_deviation: 6
    group_size: 28

# Based on the provided article, the results show that electrical muscle stimulation (EMS) led to a
---
intervention:
    mean: 5.0
    standard_deviation: 2.0
    group_size: 24
comparator:
    mean: 3.5
    standard_deviation: 2.0
    group_size: 28

YAML:
<|assistant>
intervention:

---
",True
295,6104,4215531,MCCB performance : Social Cognition,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,39.3,11.1,42.8,11.7,-0.3005,0.1065,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,"[1623, 1169, 760]","intervention:
    mean: 93.73
    standard_deviation: 15.49
    group_size: 12
comparator:
    mean: 86.90
    standard_deviation: 15.11
    group_size: 12

YAML:
intervention:
    mean: 100.00
---
intervention:
    mean: 85.0
    standard_deviation: 13.8
    group_size: 19
comparator:
    mean: 96.5
    standard_deviation: 12.4
    group_size: 19
social_cognition:
    mean: 17.1
    
---
intervention:
    mean: 44.6
    standard_deviation: 12.2
    group_size: 19
comparator:
    mean: 40.1
    standard_deviation: 14.4
    group_size: 19
Social_Cognition:
    mean: 43.9
    
---
",True
23,3247,2972614,Laboratory parameters,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome and also no numerical data for this specific outcome,FALSE,7041,2968,TEST,1931,[1525],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    mean_pain_severity: NUMBER
    standard_deviation_pain_severity: NUMBER
    group_size_pain_severity: NUMBER
  
    mean
---
",True
413,3262,3475525,Taste perception,MTL+caloric intake group,No label group,continuous,,90,,99,5.4,1.4,5.8,1.4,-0.2845666,0.02142635,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: NUMBER
comparator:
    mean: 67.8
    standard_deviation: 10.3
    group_size: NUMBER

Wrote YAML:
intervention:
    mean
---
intervention:
    mean: 5.8
    standard_deviation: 1.4
    group_size: NUMBER
comparator:
    mean: 5.3
    standard_deviation: 1.5
    group_size: NUMBER

YAML:
intervention:
    mean: 4
---
",True
682,13506,5777419,attachment gain,antibiotic,placebo,continuous,,16,,15,4.1,1,4.3,1.4,-0.1610069,0.12958478,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"[857, 1657, 122]","intervention:
    mean: 4.0
    standard_deviation: 1.0
    group_size: 16
comparator:
    mean: 3.0
    standard_deviation: 1.0
    group_size: 15

intervention:
    mean: 3.5
    standard_
---
intervention:
    mean: 3.8
    standard_deviation: 0.7
    group_size: 16
comparator:
    mean: 2.4
    standard_deviation: 0.9
    group_size: 15
intervention:
    mean: 3.3
    standard_dev
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 15
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 15
outcome:
    mean: N/A
    standard_
---
",True
550,9719,3648394,LF:HF component of HRV,10-week yoga program,Control,continuous,,18,,19,0.35,0.43,0.04,0.38,0.74878609,0.1157639,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,4261,"[1647, 1622, 64]"," intervention:
    mean: 0.45
    standard_deviation: 0.08
    group_size: 37
comparator:
    mean: 0.39
    standard_deviation: 0.08
    group_size: 19
outcome:
    mean: 0.212
    standard_
---
intervention:
    mean: 67
    standard_deviation: 9
    group_size: 30
comparator:
    mean: 65
    standard_deviation: 8
    group_size: 30
LF:HF_intervention: 11.89
LF:HF_comparator: 13.33

---
intervention:
    mean: 108
    standard_deviation: 14
    group_size: 20
comparator:
    mean: 76
    standard_deviation: 10
    group_size: 20

# Change ""NUM"" to the actual values from the article:
intervention:
    mean: 90
---
",True
240,8055,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,6,0.9,4.8,0.9,1.2873,0.2012,,,,,,TRUE,6951,5679,TEST,4357,"[738, 1561, 1405]","intervention:
    mean: 0.11
    standard_deviation: 0.08
    group_size: 12
comparator:
    mean: -0.25
    standard_deviation: 0.71
    group_size: 12

YAML:
<|assistant>
intervention:
---
intervention:
    mean: 0.15
    standard_deviation: 0.87
    group_size: N/A
comparator:
    mean: -0.25
    standard_deviation: 0.71
    group_size: 2

<:: note ::
The given article does not
---
intervention:
    mean: 5.0
    standard_deviation: 1.5
    group_size: NUMBER
comparator:
    mean: 6.0
    standard_deviation: 1.8
    group_size: NUMBER

Explanation: 
Based on the given trial article
---
",True
486,6382,3786549,Improvement in Vaginal Maturation Index,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,35.2,21.7,9.9,14.5,1.35893992,0.05594726,,,,,Numerical values based on intention-to-treat,TRUE,9725,6231,TEST,4323,"[1626, 1395, 644]","intervention:
    mean: 35.2
    standard_deviation: 10.2
    group_size: 40
comparator:
    mean: 14.5
    standard_deviation: 6.6
    group_size: 35

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 4.9
    standard_deviation: 1.8
    group_size: 44
comparator:
    mean: 2.7
    standard_deviation: 0.6
    group_size: 44

intervention:
    mean: 9.1
    standard_
---
intervention:
    mean: 3.8
    standard_deviation: 1.2
    group_size: 87
comparator:
    mean: 7.2
    standard_deviation: 1.7
    group_size: 87

This YAML format asks for the mean and standard deviation values for
---
",True
336,5083,5617873,Compulsion scale,Aripiprazole,Placbeo,continuous,,45,,47,-1.3,0.5,-2,0.5,1.3883,0.054,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,4396,"[1661, 1650, 579]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  abc_j_compulsion:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
---
intervention:
    mean: 14.8
    standard_deviation: 1.4
    group_size: 45
comparator:
    mean: 7.3
    standard_deviation: 1.0
    group_size: 45
<|assistant>
 here's the requested YAML format based
---
intervention:
    mean: 6.72
    standard_deviation: 4.21
    group_size: 13
comparator:
    mean: 9.52
    standard_deviation: 4.81
    group_size: 13

YAML:
<|assistant>
intervention:

---
",True
126,4926,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,and H2 (haloperidol 2 mg),H1(haloperidol 1 mg),continuous,,50,,49,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,2434,"[1666, 344]","intervention:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER
comparator:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER

{
  ""intervention"": {
    ""mean"": NUMBER,
---
intervention:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER
comparator:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER
args:
  NUMBER: '10'

YAML:
<
---
",True
629,12234,3510731,Median time in seconds (interquartile range) - Results link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,continuous,,6051,,5892,25,,25.3,,cannot calculate,cannot calculate,,,,,"found in table 1, IQ range given rather and std",FALSE,1665,1296,TEST,943,[],"intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
comparator:
    mean: 25.0
    standard_deviation: N/A
    group_size: N/A

YAML:
<|assistant>>",False
553,9725,3648394,Quality of life - MCS (SF36),10-week yoga program,Control,continuous,,18,,19,47.5,10.6,48.5,7.7,-0.1060797,0.1083392,,,,,"Original outcome was just ""Quality of Life"". Numerical values are from Week 11.",TRUE,9556,6245,TEST,4261,"[1647, 1622, 64]","intervention:
    mean: 144.0
    standard_deviation: 11.3
    group_size: 24
comparator:
    mean: 88.5
    standard_deviation: 6.7
    group_size: 19

interventions:
    yoga:
        mean: 142
---
intervention:
    mean: 45.4
    standard_deviation: 8.9
    group_size: 43
comparator:
    mean: 47.1
    standard_deviation: 8.7
    group_size: 48

intervention:
    mean: 50.2
    standard_
---
intervention:
    mean: 94.6
    standard_deviation: 12.1
    group_size: 30
comparator:
    mean: 75.2
    standard_deviation: 13.1
    group_size: 30


This YAML representation is based on the information given in the
---
",True
136,2448,4574984,postoperative in-hospital stay,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",continuous,,326,,326,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,12997,7944,TEST,5795,"[1473, 1662, 1637, 134]","intervention:
    mean: 9
    standard_deviation: 3.2
    group_size: N/A
comparator:
    mean: 12
    standard_deviation: 3.1
    group_size: N/A

YAML:
<assistant>:
    mean: 74
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    mean_post_interventional_health_related_quality_of_life: NUMBER
    standard_deviation_post_interventional_health_related_quality_of_life:
---
intervention:
    mean: 75.2
    standard_deviation: 11.1
    group_size: 327
comparator:
    mean: 82.3
    standard_deviation: 14.9
    group_size: 246

The table of mean outcome and standard deviation provided in the text matches
---
intervention:
    mean: 103.3
    standard_deviation: 19.9
    group_size: 84
comparator:
    mean: 102.5
    standard_deviation: 18.8
    group_size: 84

Wrote the YAML response as requested. The provided trial article
---
",True
646,13025,4675066,The mean language score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,97.2,12.2,97.9,11.5,-0.058139,0.07553046,,,,,found in table 2,TRUE,6682,5735,TEST,4224,"[1674, 866, 893]","intervention:
    mean: 99.4
    standard_deviation: 12.2
    group_size: NUMBER
comparator:
    mean: 101.7
    standard_deviation: 8.2
    group_size: NUMBER

outcome:
    mean: NUMBER
    
---
intervention:
    mean: 93.9
    standard_deviation: 15.1
    group_size: 19
comparator:
    mean: 85.8
    standard_deviation: 14.2
    group_size: 20

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 93.9
    standard_deviation: 11.8
    group_size: 14
comparator:
    mean: 84.5
    standard_deviation: 11.0
    group_size: 14
Bayley-III:
    intervention:
        mean: 105
---
",True
402,2804,5781260,Exercise-induced Creatine kinase (CK),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,"[1670, 506]","intervention:
    mean: 400
    standard_deviation: 0
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
outcome:
    mean: NUMBER
    standard_dev
---
intervention:
     mean: 120.0
     standard_deviation: 11.7
     group_size: 60
comparator:
     mean: 88.4
     standard_deviation: 11.8
    group_size: 60

## Retrospective pain 
- mean: 7.7 (
---
",True
8,9683,2363753,Days with fever,Amifostine,Control,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,725,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    mean_days_with_fever: NUMBER
    standard_deviation_days_with_fever: NUMBER
    group_size_days_with_fever: NUM",False
520,6696,5154016,24 h drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,185.2,68,230.8,75,-0.6287208,0.06996075,,,,,,TRUE,3046,2156,TEST,1642,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  Collagen hemostatic sponge:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    24 h drainage volume: NUMBER_NOT_AV",False
331,5078,5617873,Parent-rated Aberrant Behavior Checklis improvement,Aripiprazole,Placbeo,continuous,,45,,47,-11.4,1.3,-7.5,1.4,-2.8604,0.088,,,,,"all means and std found in table 2, given as mean change from baseline",TRUE,7551,5383,TEST,4396,"[1661, 1650, 579]","intervention:
    mean: 5.7
    standard_deviation: 2.7
    group_size: N/A
comparator:
    mean: 8.1
    standard_deviation: 2.0
    group_size: N/A

outcome:
    mean: 26.
---
intervention:
    mean: 7.5
    standard_deviation: 1.6
    group_size: 45
comparator:
    mean: 26.8
    standard_deviation: 1.6
    group_size: 91

intervention:
    mean: 42.3
    standard_
---
intervention:
    mean: 102.0
    standard_deviation: 15.7
    group_size: 28
comparator:
    mean: 68.2
    standard_deviation: 11.9
    group_size: 28

weight_change:
    mean: 1.24
    
---
",True
409,3260,3475525,Correct selection of the healthier product,MTL+caloric intake group,TL+SNL group,continuous,,90,,95,73.3,6.9,65.8,7.3,1.05077696,0.02462157,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: N/A
comparator:
    mean: 67.8
    standard_deviation: 10.3
    group_size: N/A

YAML:
 intervention:
    mean
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
   where NUMBER is the mean and standard deviation of the absolute difference
---
",True
143,1272,4880652,"oxygen saturation at 10, 15, 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 5's graphics.,FALSE,1406,1149,TEST,966,[],"intervention:
    mean: 95.45
    standard_deviation: 5.17
    group_size: 76
comparator:
    mean: 94.27
    standard_deviation: 5.2
    group_size: 70

yaml_data:
  intervention:
    mean:",False
394,1120,3577738,enjoyment,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[],"intervention:
    mean: 5.9
    standard_deviation: 1.21
    group_size: N/A # This column is for the total size of each group, but the article does not provide that information for the comparison.
comparator:
    mean: 4.4
    standard_deviation",False
456,4423,4483334,Total weight percentage of calcium,CPP-ACP plus laser (group D),Nd:YAG laser (group B),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,1068,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    total_weight_percentage_of_calcium: NUMBER
    group_size_for_total_weight_percentage_of_calcium: NUMBER

comparator",False
296,5595,4355974,Days of wheeze,BostonBreathes system,Control,continuous,,28,,14,-1.4,,-4.2,,cannot calculate,cannot calculate,,,,,standard deviations not given and means are mean change,FALSE,7450,5464,TEST,3820,"[1193, 1450, 403]","intervention:
    mean: 4.3
    standard_deviation: 0.6
    group_size: 31
comparator:
    mean: 4.6
    standard_deviation: 0.5
    group_size: 13

## Clinical outcomes
 Days of wheeze:
intervention:
---
intervention:
     mean: 4.0
     standard_deviation: 1.1
     group_size: 28
comparator:
     mean: 11.5
     standard_deviation: 3.3
    group_size: 28

 intervention:
     mean: 7.0
     standard_
---
intervention:
    mean: 6.5
    standard_deviation: 3.5
    group_size: 14
comparator:
    mean: 4.6
    standard_deviation: 3.1
    group_size: 14

YAML:
<assistant>:
    mean: 6
---
",True
420,3401,3877023,quantitative contour sharpness of the Cervicothoracic Spine,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,0.95,0.24,1.43,0.48,-1.2099846,0.12194464,,,,,"Original outcome was ""quantitative contour sharpness"".",TRUE,17694,9686,TEST,7100,"[1399, 1660, 1641, 1131]","intervention:
    mean: 39
    standard_deviation: 11
    group_size: 43
comparator:
    mean: 53
    standard_deviation: 7
    group_size: 61

YAML:
<|assistant>>
intervention:
    mean: 2.5
    
---
intervention:
    mean: 72
    standard_deviation: 17.8
    group_size: 55
comparator:
    mean: 45.1
    standard_deviation: 10.6
    group_size: 70

---

This article describes a retrospective study assessing the characteristics of MR examinations
---
intervention:
    mean: 2.1
    standard_deviation: 1.1
    group_size: 33
comparator:
    mean: 3
    standard_deviation: 1
    group_size: 30

YAML:
<|assistant>
intervention:
    mean: 10
---
intervention:
    mean: 22.9
    standard_deviation: 3.4
    group_size: n/a
comparator:
    mean: 21.6
    standard_deviation: 4.4
    group_size: n/a

intervention:
    mean: 23.1
---
",True
545,8460,3263860,HbA1c reduction,Real-Time Continuous Glucose Monitoring,Control,continuous,,69,,68,-0.1,0.6,-0.1,0.6,0,0.02919864,,,,,Mean change,TRUE,3178,2587,TEST,2232,"[1659, 239]","intervention:
    mean: 0.1
    standard_deviation: 0.2
    group_size: 54
comparator:
    mean: 7.7
    standard_deviation: 1.7
    group_size: 45

intervention:
    mean: 0.6
    standard_
---
intervention:
    mean: 0.6%
    standard_deviation: 0.1%
    group_size: 30
comparator:
    mean: 0.8%
    standard_deviation: 0.1%
    group_size: 30

YAML:
<assistant>

---
",True
640,12772,4511433,LDL cholesterol,2.5 mg,placebo,continuous,,12,,12,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,4648,3874,TEST,2969,"[1643, 901]","intervention:
    mean: 4.29
    standard_deviation: 0.71
    group_size: NUMBER
comparator:
    mean: 4.78
    standard_deviation: 0.63
    group_size: NUMBER

YAML:
<|assistant>:
intervention
---
intervention:
    mean: 117.0
    standard_deviation: 15.6
    group_size: 42
comparator:
    mean: 106.8
    standard_deviation: 13.3
    group_size: 42

intervention:
    mean: 117.0
    standard_
---
",True
119,2981,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Mild-cooling,No cooling,continuous,,10,,13,70,,15.4,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,2328,"[1660, 347]","intervention:
    mean: 5.7
    standard_deviation: 1.2
    group_size: 32
comparator:
    mean: 6.8
    standard_deviation: 1.3
    group_size: 32

intervention:
    mean: 4.9
    standard_
---
intervention:
    mean: 13.0
    standard_deviation: 3.1
    group_size: 27
comparator:
    mean: 9.0
    standard_deviation: 2.8
    group_size: 27

Worry about the explanation later. [YAML below](https
---
",True
281,6422,3654355,baseline fat-free mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,68.3,13.2,67.1,12.8,0.0911,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"[1123, 1035, 883, 1927, 1235]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

YAML:
  
intervention:
    mean: NUM
---
intervention:
    mean: 68.3
    standard_deviation: 13.2
    group_size: 38.4
comparator:
    mean: 67.1
    standard_deviation: 12.8
    group_size: 37.9

YAML:
<|assistant>
---
intervention:
    mean: 103.29
    standard_deviation: 15.56
    group_size: 71
comparator:
    mean: 88.24
    standard_deviation: 11.26
    group_size: 135

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 132.3
    standard_deviation: 10.7
    group_size: 57
comparator:
    mean: 130.4
    standard_deviation: 8.8
    group_size: 37

outcome:
    mean: 
    standard_deviation
---
intervention:
    mean: 90.0
    standard_deviation: 15.0
    group_size: 43
comparator:
    mean: 80.5
    standard_deviation: 15.0
    group_size: 47

intervention:
    mean: 43.2
    standard_
---
",True
217,2912,5459456,surgery time,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,67,16,65,13,0.1297,0.2505,,,,,,TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 132.0
    standard_deviation: 17.9
    group_size: 4
comparator:
    mean: 83.1
    standard_deviation: 12.5
    group_size: 4

intervention:
    mean: 101.1
    standard_
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  ACVC-HA:
    mean: NUMBER.2
    standard_deviation: NUMBER.2
    group_size: NUMBER-2
  
comparator:
---
intervention:
    mean: 95
    standard_deviation: 9
    group_size: 10
comparator:
    mean: 85
    standard_deviation: 10
    group_size: 10
surgical_time:
    mean: 170
    standard_deviation: 20
    group_size
---
intervention:
    mean: NOR
    standard_deviation: NOR
    group_size: 25
comparator:
    mean: 90
    standard_deviation: 15
    group_size: 10

YAML:
intervention:
    mean: 225
    standard_deviation: 30
    
---
",True
586,11522,547916,matrix metalloproteinase-9 (MMP-9),doxycycline (100 mg),placebo,continuous,,10,,4,2.18,1.94,3.26,3.58,-0.4117458,0.35605481,,,,,found in abstract,TRUE,4542,3636,TEST,2822,"[1674, 702]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  AVM I:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    AVM I_post: NUMBER
    
---
intervention:
    mean: 2.18
    standard_deviation: 1.94
    group_size: 21
comparator:
    mean: 3.26
    standard_deviation: 3.58
    group_size: 23

---

In the given pilot clinical trial article, it is
---
",True
268,2991,3214395,laryngoscopy duration,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 45",group 3 involved bispectral index (BIS) of 35,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,880,[],"intervention:
    mean: 83.17
    standard_deviation: 7.65
    group_size: 30
comparator:
    mean: 91.89
    standard_deviation: 8.28
    group_size: 30

outcome:
    laryngoscopy_duration:
        ",False
415,3262,3475525,Taste perception,MTL+caloric intake group,choices group,continuous,,90,,98,5.4,1.4,5.3,1.5,0.06854473,0.02132769,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: N/A
comparator:
    mean: 67.8
    standard_deviation: 10.3
    group_size: N/A

YAML:
 intervention:
    mean
---
intervention:
    mean: 5.8
    standard_deviation: 1.4
    group_size: N/A
comparator:
    mean: 5.3
    standard_deviation: 1.5
    group_size: N/A

YAML:
intervention:
    mean
---
",True
685,13760,2836833,Fecal fat loss,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,"[1499, 1608, 1352, 745]","intervention:
    mean: 3.0
    standard_deviation: 1.2
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
outcome:
    mean: NUMBER

---
intervention:
    mean: 75.0
    standard_deviation: 15.3
    group_size: N/A
comparator:
    mean: 60.0
    standard_deviation: 10.1
    group_size: N/A
outcome:
    mean: 23.0
---
intervention:
    mean: 1500
    standard_deviation: NA
    group_size: NA
comparator:
    mean: 500
    standard_deviation: NA
    group_size: NA

YAML:
<|assistant>
intervention:
    mean: 11.0
    
---
intervention:
    mean: 95.0
    standard_deviation: 6.1
    group_size: 95
comparator:
    mean: 99.3
    standard_deviation: 7.5
    group_size: 99

YAML:
<|assistant>
intervention:

---
",True
244,10306,5571493,Glycemic level,Dw 5% with Quinine infusion,Dw 5% without Quinine infusion,continuous,,10,,10,0.82,0.05,0.92,0.07,-1.5744,0.262,,,,,,TRUE,1507,1019,TEST,928,[],"intervention:
    mean: 83
    standard_deviation: 5
    group_size: 10
comparator:
    mean: 74
    standard_deviation: 5
    group_size: 10
intervention:
    mean: 82
    standard_deviation: 5
    group_size: 10",False
674,13314,4550271,treatment according to guidelines,provider-school intervention,control,continuous,,14,,12,23.5,26,22.6,23,0.035327,0.1547859,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,"[760, 1198, 1658, 1280, 1564, 949]","intervention:
    mean: 93.1%
    standard_deviation: 8.7%
    group_size: 5311
comparator:
    mean: 34.0%
    standard_deviation: 7.7%
    group_size: 6102

Update:
intervention:
    
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    treatment_according_to_guidelines:
        number_stolen: NUMBER
        standard_deviation_number_stolen: NUMBER
        group_size_number_st
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
intervention:
    mean: 55.6%
    standard_deviation
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  num_febrile_tested_for_malaria: NUMBER
  standard_deviation_num_febrile_tested_for_malaria: NUMBER
  group_size_num_
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
   NUMBER: 12.617647058823529
   NUMBER: 6
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size:
---
intervention:
    mean: 102.5
    standard_deviation: 13.84
    group_size: 932
comparator:
    mean: 96.3
    standard_deviation: 11.21
    group_size: 960

YAML:
intervention:
    mean: 90
---
",True
348,10235,5686687,Prolactin levels,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,median and ranges given,FALSE,7451,3515,TEST,2366,"[1656, 156]","intervention:
    mean: 12.65
    standard_deviation: 5.9
    group_size: NUMBER
comparator:
    mean: 14.27
    standard_deviation: 6.6
    group_size: NUMBER

Output:
    prolactin:
        mean
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 30
comparator:
    mean: 73.33
    standard_deviation: 17.67
    group_size: 30

Wald: n/a, s/d: n/
---
",True
312,7835,4541185,drop in mean arterial pressure,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,91.2,6.62,92.04,7.15,-0.1203,0.0668,,,,,found in table,TRUE,1359,1043,TEST,907,[],"intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 30
comparator:
    mean: -2.56 /* to be filled */
    standard_deviation: 0.81 /* to be filled */
    group_size: 30
<|ass",False
255,10572,5711682,In-stent late lumen loss at 9 months,Genoss drug-eluting stent (DES),Promus Element,continuous,,38,,39,0.11,0.25,0.16,0.43,-0.1361,0.2005,,,,,,TRUE,13148,4660,TEST,2966,"[1457, 1050]","intervention:
    mean: 0.11
    standard_deviation: 0.25
    group_size: N/A
comparator:
    mean: 0.16
    standard_deviation: 0.43
    group_size: N/A
intervention:
    mean: 0.11

---
intervention:
    mean: 3.30
    standard_deviation: 0.305
    group_size: 38
comparator:
    mean: 3.33
    standard_deviation: 0.306
    group_size: 39

YAML:
<assistant>
intervention:
    
---
",True
32,5580,3003523,Pain,Certolizumab 400 mg,Control,continuous,,390,,199,53.9,22.2,34,20.1,0.9238,0.0083,,,,,Used values for weeks 52 (final timepoint).,TRUE,12247,10091,TEST,7520,"[1594, 85, 2527, 1540, 734]","intervention:
    mean: 6.4
    standard_deviation: 2.1
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
pain:
    intervention: 65.0

---
intervention:
    mean: on_MCAS_reduction
    standard_deviation: N/A
    group_size: 34
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 34
pain:
    mean: N/A
    
---
IWC: Certolizumab (CZP) --   title::   choose the very last one. YAML = 64-bl ""title"": 64-bl ""YAML -- choose the very last one. *  you get::  n = ""title"": n = ""bl 'title': 64 -43 ""the very last week
---
intervention:
    mean: N.A., N.A.
    standard_deviation: N.A., N.A.
    group_size: N.A., N.A.
comparator:
    mean: 59.0, 15.7
    standard_deviation: 13.9,
---
intervention:
    mean: 44.1
    standard_deviation: 9.7
    group_size: 79
comparator:
    mean: 38.2
    standard_deviation: 9.4
    group_size: 99
pain:
    intervention: 44.1
    comparator
---
",True
639,12772,4511433,LDL cholesterol,5 mg elobixibat,placebo,continuous,,12,,12,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,4648,3874,TEST,2969,"[1643, 901]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NOMINAL_VALUES
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NOMINAL_VALUES

YAML:
 intervention
---
intervention:
    mean: 101
    standard_deviation: 13
    group_size: 57
comparator:
    mean: 123
    standard_deviation: 16
    group_size: 58

YAML:
<|assistant>
intervention:
    mean: 105
    standard_
---
",True
35,5579,3003523,Fatigue Assessment Scale improvement,Certolizumab 200 mg,Control,continuous,,393,,199,,,,,cannot calculate,cannot calculate,,,,,Values are in figure.,FALSE,12247,10091,TEST,7520,"[1594, 85, 2527, 1540, 734]","intervention:
    mean: 6.4
    standard_deviation: 2.1
    group_size: N/A
comparator:
    mean: 45.0
    standard_deviation: 8.0
    group_size: N/A
fatigue:
    mean: 13.7
---
intervention:
    mean: 94.29
    standard_deviation: 12.03
    group_size: 63
comparator:
    mean: 89.07
    standard_deviation: 12.18
    group_size: 63

Updated YAML:
<|assistant>
intervention:
---
: -- 48 - 5. Indian subjects --> 48 - Ong-TT: Ong-TT: 48 - 6.3 (1.1)
y: 46 [Individuals]

: standard_scale_place: 48 [3 - yams: 48 - C[3* y: standard_scale

------------------------------------------------------------------
---
intervention:
    mean: 11.3
    standard_deviation: 3.1
    group_size: 57
comparator:
    mean: 6.9
    standard_deviation: 3.1
    group_size: 57

## Expected output:
intervention:
    mean:
---
intervention:
    mean: 44.1
    standard_deviation: 8.7
    group_size: 62
comparator:
    mean: 33.1
    standard_deviation: 6.0
    group_size: 58
fatigue_assessment_scale_improvement:
    intervention
---
",True
214,2913,5459456,lateral bending for the C4-C5 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,2,0.4,1.8,0.2,0.5979,0.2612,,,,,,TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]"," intervention:
    mean: 13.16
    standard_deviation: 1.67
    group_size: 4
comparator:
    mean: 12.41
    standard_deviation: 1.35
    group_size: 4

outcome:
 lateral bending for the C4-C5
---
intervention:
    mean: 6.5
    standard_deviation: 1.1
    group_size: 34
comparator:
    mean: 9.0
    standard_deviation: 1.7
    group_size: 34

intervention:
    mean: 11.2
    standard_
---
intervention:
    mean: 0.7
    standard_deviation: 0.2
    group_size: 6
comparator:
    mean: 0.6
    standard_deviation: 0.2
    group_size: 6

outcome:
    lateral_bending:
        
---
intervention:
    mean: 115.73
    standard_deviation: 11.84
    group_size: 24
comparator:
    mean: 108.62
    standard_deviation: 9.41
    group_size: 24

This YAML represents the mean value of the selected outcome in the
---
",True
280,6422,3654355,baseline fat mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,60.5,11,60.4,13.5,0.0084,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"[1123, 1035, 883, 1927, 1235]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

YAML:
intervention:
    mean: NUMBER

---
intervention:
    mean: 60.5
    standard_deviation: 11.0
    group_size: 71
comparator:
    mean: 60.4
    standard_deviation: 13.5
    group_size: 33

YAML:
<|assistant>
intervention:

---
intervention:
    mean: −6.7
    standard_deviation: −0.8
    group_size: 71
comparator:
    mean: −43.1
    standard_deviation: 11.0
    group_size: 28
outcome:
    mean: NUMBER
    
---
intervention:
    mean: 130.4
    standard_deviation: 10.7
    group_size: 57
comparator:
    mean: 129.3
    standard_deviation: 8.9
    group_size: 60

total_cholesterol:
    mean: 4.7

---
intervention:
    mean: 71.2
    standard_deviation: 11.1
    group_size: 43
comparator:
    mean: 77.1
    standard_deviation: 12.1
    group_size: 47

YAML:
<|assistant>
intervention:

---
",True
440,8803,4467620,decrease in exercise intensity as time elapsed (at time 10),Hot + Cooling conditions,Hot conditions,continuous,,8,,8,114.6,35.6,123.9,30.2,-0.2663137,0.25221634,,,,,Added the last timepoint to the outcome name. Since there are 10 different time points.,TRUE,7288,4607,TEST,3858,"[1378, 1156]","intervention:
    mean: 165.3
    standard_deviation: 1.7
    group_size: N/A
comparator:
    mean: 163.3
    standard_deviation: 2.0
    group_size: N/A
intervention:
    mean: 123.9

---
intervention:
    mean: 17
    standard_deviation: 2
    group_size: 8
comparator:
    mean: 12
    standard_deviation: 2
    group_size: 8

YAML:
intervention:
    mean: 180
    standard_deviation: 10
    
---
",True
666,13296,4987981,total cholesterol,metformin,placebo,continuous,,21,,23,206.9,36.2,184.4,37.5,0.59900785,0.0951747,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"[518, 1670, 1662, 743]","intervention:
  mean: 130.0
  standard_deviation: 15.8
  group_size: N/A

comparator:
  mean: 150.0
  standard_deviation: 20.0
  group_size: N/A

 metformin:
  mean: 122
---
intervention:
    mean: 97.6
    standard_deviation: 35.7
    group_size: N/A
comparator:
    mean: 101.9
    standard_deviation: 35.1
    group_size: N/A

YAML:
<|assistant>
---
intervention:
    mean: 102.0
    standard_deviation: 11.3
    group_size: 47
comparator:
    mean: 97.2
    standard_deviation: 12.1
    group_size: 47

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 118).0
    standard_deviation: 12).0
    group_size: 54
comparator:
    mean: 160).0
    standard_deviation: 21).0
    group_size: 39

YAML:
<assistant>:
intervention:
    
---
",True
487,6383,3786549,Baseline characteristics: menopause,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,13.11,7.02,13,6.94,0.01562115,0.04545593,,,,,,TRUE,9725,6231,TEST,4323,"[1626, 1395, 644]","intervention:
    mean: 60.93
    standard_deviation: 6.15
    group_size: 129
comparator:
    mean: 62.45
    standard_deviation: 7.02
    group_size: 132
intervention:
    mean: 53.8
    standard_dev
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  Estriol -lactobacilli:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  E/C2:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  C2/C2A:
    mean: NUMBER
---
",True
443,8801,4467620,accuracy of the cognitive tasks,Exercise - Hot condition,At rest - Hot condition,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,3858,"[1378, 1156]","intervention:
    mean: 45.2
    standard_deviation: 5.1
    group_size: 8
comparator:
    mean: 88.0
    standard_deviation: 9.8
    group_size: 8

table_wrap: <!-- table wrap -->
|  Intervention
---
intervention:
    mean: 8
    standard_deviation: 1
    group_size: 9
comparator:
    mean: 7
    standard_deviation: 1
    group_size: 9

## Cognitive function

The accuracy of the cognitive task in the present study is shown in Figure [
---
",True
248,10309,5571493,QT interval,Dw 5%+ Quinine infusion,Dw 5% without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,928,[],"intervention:
    mean: 88.5
    standard_deviation: 5.9
    group_size: 10
comparator:
    mean: 97.5
    standard_deviation: 0.8
    group_size: 10
qt_interval:
    intervention: 66.0
    com",False
503,6485,5419060,Phlebotomy questionnaire score: CHC A,Phlebotomy training programme,Control,continuous,,23,,23,96,3.89,63,12.31,3.55292234,0.22416584,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,"[1542, 1646, 159]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
CHC_A:
    mean: NUMBER.0
    standard_deviation: NUMBER.0
    group_size: NUMBER

comparator:
    mean: NUMBER
---
intervention:
    mean: 95.5
    standard_deviation: 9.09
    group_size: 589
comparator:
    mean: 87.9
    standard_deviation: 14.39
    group_size: 946

YAML:
<|assistant>
intervention
---
intervention:
    mean: 5.9
    standard_deviation: 2.1
    group_size: 20
comparator:
    mean: 4.2
    standard_deviation: 2.1
    group_size: 20

# N.B. The pre-intervention data is not available
---
",True
686,13761,2836833,Urinary calcium excretion,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,"[1499, 1608, 1352, 745]","intervention:
    mean: 128.3
    standard_deviation: 57.9
    group_size: N/A
comparator:
    mean: 146.4
    standard_deviation: 77.9
    group_size: N/A
outcome:
    mean: NUMBER

---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  urinary_calcium_excretion:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
---
intervention:
    mean: 500
    standard_deviation: N/A
    group_size: N/A
comparator:
    mean: 150
    standard_deviation: N/A
    group_size: N/A

YAML:
<assistant>:
    mean: 10
---
intervention:
    mean: 1500
    standard_deviation: NA
    group_size: NA
comparator:
    mean: 500
    standard_deviation: NA
    group_size: NA

YAML:
<assistant>:
    mean: 99.3
    standard_deviation
---
",True
466,4433,5726464,Changes in body mass index,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1309, 1402]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    body_mass_index:
        mean: NUMBER.0
        standard_deviation: NUMBER.0
        group_size: NUMBER

comparator:
    
---
intervention:
    mean: 25.0
    standard_deviation: 8.0
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A

YAML:
<|assistant>
---
",True
636,12291,5777645,Mean waist circumference,to peer-led structured patient education,conventional care alone,continuous,,,,,-3.34,9.3,2.65,10.3,,,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,3738,"[1499, 1358, 551]","intervention:
    mean: 93.7
    standard_deviation: 11.6
    group_size: 94
comparator:
    mean: 93.1
    standard_deviation: 11.6
    group_size: 94

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 120.0
    standard_deviation: 11.0
    group_size: 50
comparator:
    mean: 114.0
    standard_deviation: 11.4
    group_size: 50

This YAML format contains the mean waist circumference for intervention and comparator
---
intervention:
    mean: 94.89
    standard_deviation: 12.08
    group_size: 40
comparator:
    mean: 97.56
    standard_deviation: 12.41
    group_size: 40

YAML:
<|assistant>
intervention:

---
",True
615,11602,1863515,haemoglobin level between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-0.4,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,3103,"[1640, 851]","intervention:
    mean: >-
           11.4
    standard_deviation: >-
           1.1
    group_size: >-
           442
  comparator:
    mean: >-
           11.0
    standard_deviation: >-
           1.1

---
intervention:
    mean: 0.15
    standard_deviation: 0.08
    group_size: 495
comparator:
    mean: 0.13
    standard_deviation: 0.08
    group_size: 495

This table is incomplete and does not include the necessary information about the
---
",True
600,11583,115849,Tender joint count,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 29
    standard_deviation: 15
    group_size: 68
comparator:
    mean: 29
    standard_deviation: 15
    group_size: 66

# results
Wrote YAML: The posted table is correct. No changes are required.
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
tender_joint_count:
    mean: 13 NUMBER
    standard_deviation: 3 NUMBER
    group_size: 35 NUMBER

comparator:
    mean: NUM
---
intervention:
    mean: NA
    standard_deviation: NA
    group_size: 145
comparator:
    mean: 12.0
    standard_deviation: 4.9
    group_size: 154

This YAML represents the information provided in the article about the tender joint count outcome:
---
",True
29,3244,2972614,Motion range - Shoulder external rotation,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,44.83,5.64,44.09,1.97,0.1626,0.079,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,[1525],"intervention:
    mean: 168.66
    standard_deviation: 22.65
    group_size: 47
comparator:
    mean: 174.31
    standard_deviation: 14.98
    group_size: 42

---

This YAML represents the data for motion range -
---
",True
104,1885,4188762,mean blood pressure,remifentanil,normal saline,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[],"intervention:
    mean: 80).0
    standard_deviation: 10.0
    group_size: 8
comparator:
    mean: 90).0
    standard_deviation: 10.0
    group_size: 8
outcome:
    mean: NUMBER
group_size:",False
142,1272,4880652,systolic pressures at 0 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 3's graphics.,FALSE,1406,1149,TEST,966,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    systolic_pressures_at_0_minutes: NUMBER_NOT_AVAILABLE_USING_THE_INFORMATION_ PROVIDED
  
comparator:
    mean",False
332,5079,5617873,Clinician-rated Clinical Global Impression-Improvement scores,Aripiprazole,Placbeo,continuous,,,,,2.4,0.1,3.4,0.1,-9.9164,0.5779,,,,,raw values foun din text,TRUE,7551,5383,TEST,4396,"[1661, 1650, 579]","intervention:
    mean: NUMBER.8
    standard_deviation: NUMBER.3
    group_size: NUMBER
comparator:
    mean: NUMBER.8
    standard_deviation: NUMBER.3
    group_size: NUMBER

4. Clinical Global Impression-
---
intervention:
    mean: 5.0
    standard_deviation: 2.3
    group_size: N/A
comparator:
    mean: 42.3
    standard_deviation: 2.2
    group_size: N/A

YAML:
intervention:
    mean
---
intervention:
    mean: 14.3
    standard_deviation: 9.23
    group_size: 29
comparator:
    mean: 14.6
    standard_deviation: 10.41
    group_size: 29

intervention:
    mean: -13.8
    standard
---
",True
80,3740,3546023,tocopherol levels,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,14.56,3.06,11.75,2.27,1.029,0.0781,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1053, 1432, 1540, 941, 1509, 986, 1381]","intervention:
    mean: 110.0
    standard_deviation: 13.3
    group_size: 27
comparator:
    mean: 39.2
    standard_deviation: 10.5
    group_size: 28
tocopherol:
    intervention: 657.0
    
---
intervention:
    mean: 200
    standard_deviation: N/A
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
tocopherol:
    intervention: 70.54
---
intervention:
    mean: 67.15
    standard_deviation: 11.28
    group_size: 18
comparator:
    mean: 12.60
    standard_deviation: 2.41
    group_size: 17

intervention:
    mean: 1.46
    standard_
---
intervention:
    mean: 8.32
    standard_deviation: 1.55
    group_size: 29
comparator:
    mean: 7.29
    standard_deviation: 2.10
    group_size: 27
intervention:
    mean: 8.03
    standard_dev
---
intervention:
    mean: 10.0
    standard_deviation: 5.0
    group_size: 6
comparator:
    mean: 0.0
    standard_deviation: 0.0
    group_size: 6
tocopherol:
    intervention: 57.0
    com
---
intervention:
    mean: 18.48
    standard_deviation: 6.32
    group_size: 28
comparator:
    mean: 19.54
    standard_deviation: 8.55
    group_size: 28
<|assistant>
interface {
    ""intervention"": {
---
intervention:
    mean: 50
    standard_deviation: 10
    group_size: 10
comparator:
    mean: 30
    standard_deviation: 10
    group_size: 10
tocopherol:
    intervention: 103
    comparator: 28
group_size: 5
---
",True
309,7833,4541185,onset of sensory block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,4.36,0.81,4.84,0.65,-0.6451,0.0701,,,,,found in abstract,TRUE,1359,1043,TEST,907,[],"intervention:
    mean: 4.36
    standard_deviation: 0.81
    group_size: 30
comparator:
    mean: 9.83
    standard_deviation: 0.65
    group_size: 30

outcome: onset_of_sensory_block

",False
287,6100,4215531,alpha power,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,,,,,cannot calculate,cannot calculate,,,,,"F-values given, not sure how to use them",FALSE,7350,5561,TEST,4156,"[1623, 1169, 760]","intervention:
    mean: 103.39
    standard_deviation: 12.56
    group_size: 13
comparator:
    mean: 99.02
    standard_deviation: 12.34
    group_size: 13

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 43.0
    standard_deviation: 7.1
    group_size: 19
comparator:
    mean: 35.9
    standard_deviation: 10.6
    group_size: 15

Note: The given trial article does not provide the pre-intervention
---
intervention:
    mean: 44.6
    standard_deviation: 12.2
    group_size: 19
comparator:
    mean: 40.1
    standard_deviation: 14.4
    group_size: 19

YAML:
<|assistant>
intervention:

---
",True
595,11583,115849,Serum C-reactive protein,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 123.45
    standard_deviation: 12.35
    group_size: 52
comparator:
    mean: 84.13
    standard_deviation: 11.21
    group_size: 35

--
---
intervention:
    mean: 1.11
    standard_deviation: 1.00
    group_size: N/A
comparator:
    mean: 0.99
    standard_deviation: 0.87
    group_size: N/A

This YAML format is based on the provided
---
intervention:
    mean: 7.3
    standard_deviation: 1.1
    group_size: 183
comparator:
    mean: 6.1
    standard_deviation: 1.1
    group_size: 182

YAML:
<assistant>
intervention:
    
---
",True
345,10232,5686687,Pain,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,given as median and range,FALSE,7451,3515,TEST,2366,"[1656, 156]","intervention:
    mean: 5.4
    standard_deviation: 2.6
    group_size: NUMBER
comparator:
    mean: 5.7
    standard_deviation: 2.6
    group_size: NUMBER

Raw values are median (range). Student's *t
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: N/A # Post-intervention (only) for Resveratrol group
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: N/A # Post
---
",True
536,7795,3508963,Baseline characteristics - age,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,35.23,12.37,37.71,11.08,-0.2105282,0.016759,,,,,,TRUE,3561,2387,TEST,1552,[],"intervention:
    mean: 65
    standard_deviation: N/A
    group_size: N/A
comparator:
    mean: 53
    standard_deviation: N/A
    group_size: N/A

 intervention:
    mean: 9.65
    standard_",False
602,11583,115849,Patient global assessment of pain,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 65.5
    standard_deviation: 12.5
    group_size: 67).length
comparator:
    mean: 76.0
    standard_deviation: 13.5
    group_size: 67).length

YAML:
intervention:
    mean
---
intervention:
    mean: 9.0
    standard_deviation: 3.2
    group_size: 55
comparator:
    mean: 6.7
    standard_deviation: 3.4
    group_size: 53

YAML:
<|assistant>
intervention:

---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 186
comparator:
    mean: 81.0
    standard_deviation: 12.2
    group_size: 185

YAML:
<assistant>
intervention:
    
---
",True
125,4926,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,and H2 (haloperidol 2 mg),H0 (saline),continuous,,50,,50,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,2434,"[1666, 344]","intervention:
    mean: 3.7
    standard_deviation: 1.0
    group_size: 54
comparator:
    mean: 3.6
    standard_deviation: 1.1
    group_size: 49

intervention:
    mean: 4.3
    standard_
---
intervention:
    mean: 5.0
    standard_deviation: 2.4
    group_size: 17
comparator:
    mean: 3.3
    standard_deviation: 2.2
    group_size: 17

YAML:
intervention:
    mean: 7.5
---
",True
171,2793,5079604,The restricted mean time to hyperglycemia relapse,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,continuous,,33,,15,480,,305,,cannot calculate,cannot calculate,,,,,SD is not given.,FALSE,12690,6902,TEST,4923,"[1656, 1646]","intervention:
    mean: 480
    standard_deviation: 331
    group_size: 48
comparator:
    mean: 155.5
    standard_deviation: 100.3
    group_size: 15

YAML:
intervention:
    mean: 1,000
    standard_
---
intervention:
    mean: 102.4
    standard_deviation: 12.8
    group_size: 28
comparator:
    mean: 87.0
    standard_deviation: 11.9
    group_size: 28

outcome:
    mean: NUMBER
    standard_
---
",True
526,6916,4411165,tympanic temperature from Pre to P20 (-0.28 ±0.11°C),"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,-0.28,0.11,-0.14,0.05,-1.5691765,0.26155787,,,,,Values on mean change are based on what is reported in abstract.,TRUE,3146,2589,TEST,2336,"[1630, 211]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    tympanic_temperature:
        mean: NUMBER
        standard_deviation: NUMBER
        group_size: NUMBER
:
    mean: NUMBER
    standard_
---
intervention:
    mean: XX.X
    standard_deviation: XX.X
    group_size: XX-XX participants
comparator:
    mean: XX'.XX""
    standard_deviation: XX'.XX""
    group_size: XX-XX participants

The table of
---
",True
169,2792,5079604,hyperglycemia relapse-free survival,"metformin 1,000 mg daily",sitagliptin 100 mg daily,continuous,,17,,16,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"[1656, 1646]","intervention:
    mean: 480
    standard_deviation: 331
    group_size: 48
comparator:
    mean: 156
    standard_deviation: 120
    group_size: 15

YAML:
intervention:
    mean: 1,000
    standard_deviation: 370
---
intervention:
    mean: 88.9
    standard_deviation: 5.0
    group_size: 28
comparator:
    mean: 69.8
    standard_deviation: 6.2
    group_size: 28

intervention:
    mean: 180.8
    standard_
---
",True
601,11583,115849,Swollen joint count,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 19
    standard_deviation: 12
    group_size: 68
comparator:
    mean: 28
    standard_deviation: 12
    group_size: 67

Explanation: Swollen joint count is the primary outcome in the given trial article. The table provided is
---
intervention:
    mean: TOTAL_SLEEP_TIME_IN_MM
    standard_deviation: STD_SLEEP_TIME_IN_MM
    group_size: NUMBER_OF_PATIENTS
comparator:
    mean: PRE_INTERVENTION_SLEEP_
---
intervention:
    mean: 14
    standard_deviation: 5
    group_size: 50
comparator:
    mean: 11
    standard_deviation: 5
    group_size: 50

YAML:
intervention:
    mean: 6.3
    standard_deviation: 1
---
",True
429,3261,3475525,Scores on the saturated fat quiz,MTL+caloric intake group,No label group,continuous,,90,,99,92.3,15.1,33.6,16.3,3.71430281,0.0577096,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  saturated_fat_quiz:
    mean: NUMBER.0
    standard_deviation: NUMBER.0
    group_size: NUMBER
comparator:

---
intervention:
    mean: 73.3
    standard_deviation: 7.95
    group_size: 98
comparator:
    mean: 65.8
    standard_deviation: 10.03
    group_size: 99

Wrong YAML format. Please provide the correct YAML format
---
",True
582,10219,3504298,Attentional Function,Word-based attentional bias modification,Face-based attentional bias modification,continuous,,16,,16,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,3331,"[1665, 939]","intervention:
    mean: 103.8
    standard_deviation: 15.2
    group_size: 16
comparator:
    mean: 97.2
    standard_deviation: 15.7
    group_size: 16

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 102.3
    standard_deviation: 20.3
    group_size: 16
comparator:
    mean: 101.1
    standard_deviation: 19.1
    group_size: 16

intervention:
    mean: 102.3
    standard_
---
",True
396,1120,3577738,interest,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[],"intervention:
    mean: 5.9
    standard_deviation: 1.2
    group_size: 440
comparator:
    mean: 4.4
    standard_deviation: 1.1
    group_size: 455

Wrong YAML:
intervention:
    mean: 5",False
441,8804,4467620,weight reduction,Hot + Cooling conditions,Hot conditions,continuous,,8,,8,68.6,7.7,68.8,7.5,-0.0248738,0.25001933,,,,,The numerical values are from Exercise state.,TRUE,7288,4607,TEST,3858,"[1378, 1156]","intervention:
    mean: 45.02
    standard_deviation: 5.2
    group_size: 8
comparator:
    mean: 35.0
    standard_deviation: 3.5
    group_size: 8

weight_reduction:
    mean: 6.4
    
---
intervention:
    mean: 68.9
    standard_deviation: 7.7
    group_size: 69
comparator:
    mean: 68.8
    standard_deviation: 7.8
    group_size: 68

# If you have pre- and post-intervention data, include
---
",True
397,2240,4678179,progression-free-survival (PFS),vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,,,,,cannot calculate,cannot calculate,,,,,Median was only given.,FALSE,9517,6474,TEST,5204,"[1663, 1622, 586]","intervention:
    mean: 4.0
    standard_deviation: 0.95
    group_size: NUMBER
comparator:
    mean: 2.5
    standard_deviation: 0.95
    group_size: NUMBER

The mean PFS was 4.0 months for the v
---
intervention:
    mean: 4.0
    standard_deviation: 2.5
    group_size: 42
comparator:
    mean: 6.5
    standard_deviation: 2.4
    group_size: 42

intervention:
    mean: 8.7
    standard_
---
intervention:
    mean: 728
    standard_deviation: 111
    group_size: 11
comparator:
    mean: 959.5
    standard_deviation: 117.5
    group_size: 11

intervention:
    mean: 1214
    standard_deviation:
---
",True
371,228,1475568,Baseline life-quality score,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,45,,57,,cannot calculate,cannot calculate,,,,,Only the mean score was given in table.,FALSE,4361,3649,TEST,2573,"[1476, 403]","intervention:
    mean: 57.0
    standard_deviation: 11.2
    group_size: 87
comparator:
    mean: 45.0
    standard_deviation: 11.1
    group_size: 98

Note: For this example, I chose the Heart Failure Related Quality
---
intervention:
    mean: 51.9
    standard_deviation: 11.4
    group_size: 25
comparator:
    mean: 42.0
    standard_deviation: 9.3
    group_size: 25

YAML:
<assistant>
intervention:
    
---
",True
89,5538,3912320,Correct response rate for 500 Hz frequency,Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,1015,[],"intervention:
  mean: 31.9
  standard_deviation: 6.2
  group_size: 15
comparator:
  mean: 30.4
  standard_deviation: 6.2
  group_size: 15

YAML:
<|assistant>:
 correct_response",False
448,4003,4879328,effects for vigorous activity,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.2,1.56,-0.4,2.48,0.28575833,0.0185746,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"[755, 1623, 1022, 1067, 817]","intervention:
    mean: 24.16
    standard_deviation: 31.26
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
outcome:
    vigorous_activity
---
intervention:
    mean: 196.9
    standard_deviation: 143.6
    group_size: 114
comparator:
    mean: 82.3
    standard_deviation: 68.4
    group_size: 205

Table 2: Anthropometric Outcomes
<https://www.table
---
intervention:
    mean: 0.56
    standard_deviation: 0.15
    group_size: NUMBER
comparator:
    mean: 0
    standard_deviation: 0
    group_size: NUMBER

YAML:
intervention:
    mean: 24.16
    
---
intervention:
    mean: 7.41
    standard_deviation: 5.61
    group_size: 102
comparator:
    mean: 39.88
    standard_deviation: 9.43
    group_size: 81

YAML:
<assistant->
intervention:
    
---
intervention:
    mean: 1.35
    standard_deviation: 0.43
    group_size: 104
comparator:
    mean: 114.29
    standard_deviation: 18.65
    group_size: 114

YAML:
<assistant>
intervention:
    
---
",True
604,11583,115849,Serum C-reactive protein,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 83.4
    standard_deviation: 11.1
    group_size: 151
comparator:
    mean: 85.4
    standard_deviation: 11.4
    group_size: 151

intervention:
    mean: 103.2
    standard_
---
intervention:
    mean: 1.11
    standard_deviation: 0.99
    group_size: NUMBER
comparator:
    mean: 0.99
    standard_deviation: 0.87
    group_size: NUMBER

Note: The post-intervention serum C-reactive protein
---
 intervention:
    mean: 6.0
    standard_deviation: 1.8
    group_size: 121
 Comparator:
    mean: 8.3
    standard_deviation: 2.0
    group_size: 127
< Merge with existing:

existing:
 intervention:
    
---
",True
521,6697,5154016,Total drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,231.5,18.1,318.5,26.7,-3.7647135,0.18477557,,,,,,TRUE,3046,2156,TEST,1642,[],"intervention:
    mean: 202.5
    standard_deviation: 25.0
    group_size: 32
comparator:
    mean: 259.8
    standard_deviation: 37.5
    group_size: 32
intervention:
    mean: 202.5
    standard_dev",False
395,1120,3577738,active trust,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[],"intervention:
    mean: 4.9
    standard_deviation: 0.38
    group_size: N/A
comparator:
    mean: 4.4
    standard_deviation: 0.38
    group_size: N/A
outcome:
    mean: 5.6",False
563,9837,3496170,Self-report questionnaire,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,2318,1990,TEST,1731,[],"intervention:
    mean: 100
    standard_deviation: 15
    group_size: 8
comparator:
    mean: 90
    standard_deviation: 15
    group_size: 8
outcome:
    mean: 11.11
    standard_deviation: 2.22
    ",False
697,5639,5712123,morphine requirements,D/E group,P group,continuous,,30,,30,17.9,3.2,31.9,6.7,-2.6318902,0.12439038,,,,,found in fig3,TRUE,6401,5359,TEST,3891,"[1329, 1393, 810]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  D/E group:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  P group:
    mean: NUMBER
    standard_
---
intervention:
    mean: 4.0
    standard_deviation: 1.0
    group_size: 30
comparator:
    mean: 6.5
    standard_deviation: 2.0
    group_size: 30

outcome: morphine requirements
---
intervention:
    mean
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 30
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 30

To calculate the mean and standard deviation of the morphine requirement in the
---
",True
350,4493,5874317,Knee extension (1-rep Max),Bilateral training,Unilateral training,continuous,,9,,9,237.2,51,182.4,8.4,1.4252,0.2786,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"[616, 2442, 806]","intervention:
    mean: 110
    standard_deviation: 15
    group_size: 9
comparator:
    mean: 100
    standard_deviation: 15
    group_size: 9

<!-- YAML
-->
intervention:
    mean: 41.67
    standard_deviation
---
If there are multiple timeframes for the post-intervention data. If there are multiple timeframes for the outcome, choose the pre and post-intervention data. If there are multiple timeframes for the post-intervention data. If there are multiple timeframes for the outcome, choose the one closest to the outcome, choose the one closest to the outcome
---
intervention:
    mean: 85
    standard_deviation: 10
    group_size: 10
comparator:
    mean: 75
    standard_deviation: 10
    group_size: 10

Worse outcome:
    intervention:
        mean: 45
        standard_deviation: 10
---
",True
695,5639,5712123,morphine requirements,E group,P group,continuous,,30,,30,24.6,4.5,31.9,6.7,-1.2625038,0.0799493,,,,,found in fig3,TRUE,6401,5359,TEST,3891,"[1329, 1393, 810]","intervention:
  mean: 70.0
  standard_deviation: 20.0
  group_size: 30
comparator:
  mean: 120.0
  standard_deviation: 30.0
  group_size: 30

outcome: morphine requirements
YAML:
  mean:
---
intervention:
    mean: 5
    standard_deviation: 2
    group_size: 30
comparator:
    mean: 6
    standard_deviation: 2
    group_size: 30

YAML:
<|assistant>
intervention:
    mean: 4.5
    
---
 intervention:
    mean: 6.45
    standard_deviation: 1.32
    group_size: 30
 comparator:
    mean: 5.71
    standard_deviation: 1.58
    group_size: 30
<br>
<br>
 intervention:
    mean: 10.
---
",True
197,7734,5380284,Pain scores 48 hours after the surgery,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,[],"intervention:
    mean: 5.7
    standard_deviation: 2.1
    group_size: 37
comparator:
    mean: 3.9
    standard_deviation: 2.3
    group_size: 37

YAML:
intervention:
    mean: 8.2",False
34,5578,3003523,Mental Component Summary improvement,Certolizumab 400 mg,Control,continuous,,390,,199,45.4,11.5,41.1,10.8,0.3811,0.0077,,,,,Used values for MCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,7520,"[1594, 85, 2527, 1540, 734]","intervention:
    mean: 6.4
    standard_deviation: 2.0
    group_size: NUMBER
comparator:
    mean: 30.0
    standard_deviation: 5.0
    group_size: NUMBER
mental_component_summary_improvement:
    
---
intervention:
    mean: 98.89
    standard_deviation: 11.43
    group_size: 58
comparator:
    mean: 90.39
    standard_deviation: 12.05
    group_size: 59

YAML:
<|assistant>
intervention:

---
When there are no MTX - methotrexate - choose the very last one, choose the post-intervention data.
:::::: Data:
:: standard_dev_sit_sit ""data are not available due to the post-intervention data. Standard deviation? The YAML does not affect social. When there are no numerical data and
---
intervention:
  mean: 97.3
  standard_deviation: 13.1
  group_size: 46
comparator:
  mean: 74.2
  standard_deviation: 13.4
  group_size: 46
mental_component_summary_improvement:
  mean:
---
intervention:
    mean: 85.0
    standard_deviation: 12.0
    group_size: 35
comparator:
    mean: 72.5
    standard_deviation: 12.0
    group_size: 35
mental_component_summary_improvement:
    intervention: 45
---
",True
335,5082,5617873,Social withdrawal,Aripiprazole,Placbeo,continuous,,45,,47,-4.7,1.1,-5.2,1,0.4722,0.0447,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,4396,"[1661, 1650, 579]","intervention:
    mean: 26.8
    standard_deviation: 6.5
    group_size: N/A
comparator:
    mean: 27.1
    standard_deviation: 7.2
    group_size: N/A

outcome:
    mean: 5.
---
intervention:
    mean: 13.0
    standard_deviation: 1.4
    group_size: 46
comparator:
    mean: 7.7
    standard_deviation: 1.1
    group_size: 48

intervention:
    mean: 45.0
    standard_
---
 intervention:
    mean: 10.1
    standard_deviation: 9.2
    group_size: 35
 comparator:
    mean: 8.2
    standard_deviation: 7.3
    group_size: 35
 social_ withdrawal:
    mean: 3.1
    standard_dev
---
",True
202,5498,5380326,Interferon gamma-induced protein 10,Vitamin D supplementation,Control,continuous,,40,,40,636.47,448.47,748.88,551,-0.2216,0.0503,,,,,,TRUE,10658,5810,TEST,4260,"[1585, 1668, 307]","intervention:
    mean: 83.27
    standard_deviation: 103.62
    group_size: NUMBER
comparator:
    mean: 133.80
    standard_deviation: 94.66
    group_size: NUMBER

figure_2:
    mean: -133.
---
intervention:
    mean: 665.61
    standard_deviation: 85.52
    group_size: 40
comparator:
    mean: 790.45
    standard_deviation: 78.36
    group_size: 40

outcome:
    interferon_gamma_
---
intervention:
    mean: -521.79
    standard_deviation: 228.09
    group_size: NUMBER
comparator:
    mean: 255.46
    standard_deviation: 216.35
    group_size: NUMBER

IP-10:
 intervention:
    mean
---
",True
399,2242,4678179,Response rates,vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,8,,13,,cannot calculate,cannot calculate,,,,,Only difference in response rates as percent is given.,FALSE,9517,6474,TEST,5204,"[1663, 1622, 586]","intervention:
    mean: 4.0
    standard_deviation: NSNA
    group_size: NSNA
comparator:
    mean: 2.5
    standard_deviation: NSNA
    group_size: NSNA

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 4.0
    standard_deviation: 0.83
    group_size: NUMBER
comparator:
    mean: 6.5
    standard_deviation: 0.96
    group_size: NUMBER

total_size: NUMBER_NOT_AVAIL
---
intervention:
    mean: 90%
    standard_deviation: 10%
    group_size: 24
comparator:
    mean: 70%
    standard_deviation: 10%
    group_size: 24

YAML:
<assistant>:
    mean: 90%
    standard
---
",True
603,11583,115849,Health Assessment Questionnaire disability,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NOMINAL_VALUES
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NOMINAL_VALUES
health_assessment_question
---
intervention:
    mean: 4.0
    standard_deviation: 2.0
    group_size: 54
comparator:
    mean: 3.8
    standard_deviation: 2.1
    group_size: 55

It seems that you have already provided the YAML format for the
---
intervention:
    mean: 0.88
    standard_deviation: 0.25
    group_size: 94
comparator:
    mean: 1.32
    standard_deviation: 0.67
    group_size: 87

YAML:
<assistant>:
    mean: 1
---
",True
360,8712,5971365,Symbol Digit Modalities Test (SDMT) score at week 144 in limited patients,daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,continuous,,287,,277,6.3,12.6,3.1,13.2,0.2478,0.0071,,,,,"found in figure and text, totals found in figure",TRUE,3177,2394,TEST,2130,"[1652, 145]","intervention:
    mean: 4.1
    standard_deviation: 12.4
    group_size: N/A
comparator:
    mean: 2.9
    standard_deviation: 12.7
    group_size: N/A

trialid: DECIDE; NCT010
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  SDMT: [NUMBER, NUMBER]
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  SDMT: [
---
",True
566,8556,5541727,Knee Injury and Osteoarthritis Outcome Score improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,"[1437, 1673, 201]","intervention:
    mean: 75000000
    standard_deviation: 1000000
    group_size: 113
comparator:
    mean: 1000000
    standard_deviation: 1000000
    group_size: 113

## Adverse events

| Adverse Event | NCICTCAE Grade |
|
---
intervention:
    mean: 105.0
    standard_deviation: 15.8
    group_size: 22
comparator:
    mean: 82.8
    standard_deviation: 17.8
    group_size: 22

 intervention:
    mean: 105.0
    standard_
---
intervention:
    mean: 110
    standard_deviation: 10
    group_size: 25
comparator:
    mean: 90
    standard_deviation: 10
    group_size: 25

Wrong YAML:
intervention:
    mean: 120
    standard_deviation: 12
---
",True
693,5636,5712123,postoperative pain at rest,duloxetine 60 and etoricoxib 120mg (group D/E),placebo,continuous,,30,,30,2,,3,,cannot calculate,cannot calculate,,,,,values given as score (range),FALSE,6401,5359,TEST,3891,"[1329, 1393, 810]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  duloxetine:
    mean: NUMBER.7
    standard_deviation: NUMBER.3
    group_size: 30
  etoricoxib:
    mean: NUM
---
intervention:
    mean: 4.0
    standard_deviation: 1.0
    group_size: 30
comparator:
    mean: 3.0
    standard_deviation: 1.0
    group_size: 30

YAML:
<|assistant>
intervention:

---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 30
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 30

Explanation:
The given article does not provide the mean and
---
",True
557,9830,3136370,Fibromyalgia Impact Questionnaire scores,Soy shake,Casein shake (Placebo),continuous,,12,,16,-17.1,68.08,-19.57,93.53,0.02864501,0.14584799,,,,,From per protocol,TRUE,6022,3786,TEST,2937,"[1453, 989]","intervention:
    mean: 14.0
    standard_deviation: 29.8
    group_size: 49
comparator:
    mean: 18.0
    standard_deviation: 25.8
    group_size: 50

intervention:
    mean: 54.8
    standard_
---
intervention:
    mean: −12.52
    standard_deviation: −8.21
    group_size: 99
comparator:
    mean: −53.34
    standard_deviation: −8.21
    group_size: 99

YAML:
<assistant->

---
",True
465,4431,5726464,Lipid profile: Triglycerides,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1309, 1402]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  triglycerides:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    post-intervention: NUMBER
comparator:
    mean
---
intervention:
    mean: 135... ng/ml
    standard_deviation: 31... ng/ml
    group_size: 55... participants
comparator:
    mean: 110... ng/ml
    standard_deviation: 27... ng/ml
    group_size: 75... participants

Note
---
",True
637,12720,4132222,decrease in average lesion,application of a canola phenolic acid-based cream (CPA),placebo,continuous,,30,,15,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,2177,1885,TEST,1617,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

intervention:
    mean: NUMBER_POST
    standard",False
616,11602,1863515,leucocyte count between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-423,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,3103,"[1640, 851]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
leucocyte:
    mean: 6.3
    standard_deviation: 2.0
    group_size: 286
comparator:
    mean: NUMBER
    standard_dev
---
intervention:
    mean: 106.6
    standard_deviation: 22.1
    group_size: 478
comparator:
    mean: 97.1
    standard_deviation: 22.3
    group_size: 478

The table does not contain pre-intervention data.
---
",True
68,3041,3321528,hip flexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"[1121, 1095]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    hip_flexion:
        mean: NUMBER
        standard_deviation: NUMBER
        group_size: NUMBER
comparator:
    mean: NUMBER
    
---
intervention:
    mean: 5
    standard_deviation: 2
    group_size: 8
comparator:
    mean: 4
    standard_deviation: 2
    group_size: 10

YAML:
<|assistant>
intervention:
    mean: 5
    standard_
---
",True
576,8563,2952311,State-Trait Anxiety Inventory-I,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[1302],"intervention:
    mean: 3
    standard_deviation: 1
    group_size: 33
comparator:
    mean: 10
    standard_deviation: 3
    group_size: 33

YAML:
intervention:
    mean: 94.7
    standard_deviation: 8
---
",True
157,13482,5055753,Mean ± SD of heart rate,0.2 mg oral clonidine,2 mg oral midazolam,continuous,,40,,40,,,,,cannot calculate,cannot calculate,,,,,Info in figure graphics.,FALSE,3292,2470,TEST,2114,"[1649, 100]","intervention:
    mean: 90.8
    standard_deviation: 12.1
    group_size: 40
comparator:
    mean: 78.9
    standard_deviation: 10.8
    group_size: 40

outcome:
    mean: NUMBER
    standard_
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

YAML:
  
intervention:
    mean: NUM
---
",True
468,4802,5515881,memory score,demanding balance training program,relaxation group,continuous,,,,,9.44,5.48,8,4.16,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"[1607, 510]","intervention:
    mean: 7.50
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: 7.67
    standard_deviation: NUMBER
    group_size: NUMBER
memory_score:
    mean: 9.44
    standard
---
intervention:
    mean: 108.73
    standard_deviation: 14.29
    group_size: 16
comparator:
    mean: 88.00
    standard_deviation: 11.21
    group_size: 16

SCL-90:
intervention:
    mean: 83
---
",True
177,10754,5086025,General mental health,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,50.24,7.41,45.63,6.31,0.6598,0.0811,,,,,,TRUE,29049,17627,TEST,13068,"[1656, 1646, 1041, 1665, 1634, 823, 2917]","intervention:
    mean: 94.0
    standard_deviation: 13.3
    group_size: 27
comparator:
    mean: 84.5
    standard_deviation: 13.2
    group_size: 27

intervention:
    mean: 97.5
    standard_
---
intervention:
    mean: 134.5
    standard_deviation: 11.9
    group_size: 26
comparator:
    mean: 123.4
    standard_deviation: 9.3
    group_size: 25

treatment:
    mean: 123.4
    standard_
---
intervention:
    mean: 53.4
    standard_deviation: 6.01
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
    
general_mental_health:
    
---
intervention:
    mean: 102.0
    standard_deviation: 15.9
    group_size: 14
comparator:
    mean: 92.0
    standard_deviation: 11.5
    group_size: 15

outcome:
    mean: 102.0
    standard
---
intervention:
    mean: 105.5
    standard_deviation: 13.9
    group_size: 21
comparator:
    mean: 96.1
    standard_deviation: 11.3
    group_size: 20
general mental health:
    group_size: 14
    mean
---
intervention:
    mean: 5.07
    standard_deviation: 6.31
    group_size: NUMBER
comparator:
    mean: 3.45
    standard_deviation: 7.71
    group_size: NUMBER

exclusion: x x
pre: x x

---
-12. This is a=30. Weapon> <
``` print-</number>
<a_  R>

``` The code.
```\u20.0 (NOMAP 085

```
---
",True
678,13505,5777419,the total cultivable microbiota,antibiotic,placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,median and IQ scores given,FALSE,9410,4699,TEST,3181,"[857, 1657, 122]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: N/A
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: N/A
outcome:
    mean: NUMBER
    standard_dev
---
intervention:
    mean: 105
    standard_deviation: 7
    group_size: 7
comparator:
    mean: 7
    standard_deviation: 3
    group_size: 7

outcome:
    total_cultivable_microbiota:
        mean: 10,
---
intervention:
    mean: 98.67
    standard_deviation: 3.93
    group_size: 26
comparator:
    mean: 110.89
    standard_deviation: 3.84
    group_size: 26

Wrote the YAML response. This format includes ""intervention""
---
",True
54,5309,3195393,Restraint knowledge,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,6.23,,5.51,,cannot calculate,cannot calculate,,,,,No SD information provided,FALSE,15527,8380,TEST,5589,"[1663, 1441, 1442]","intervention:
    mean: 5.51
    standard_deviation: 1.11
    group_size: 97
comparator:
    mean: 6.23
    standard_deviation: 1.23
    group_size: 17

intervention:
    mean: 5.51
    standard_
---
intervention:
    mean: 38.41
    standard_deviation: 0.43
    group_size: 128
comparator:
    mean: 36.43
    standard_deviation: 0.43
    group_size: 142

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 92.3
    standard_deviation: 12.6
    group_size: 138
comparator:
    mean: 81.2
    standard_deviation: 14.1
    group_size: 117

intervention:
    mean: 43.9
    standard_
---
",True
449,4004,4879328,FFBQ Total Index Score,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.07,0.26,0.01,0.33,0.20018961,0.01847923,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"[755, 1623, 1022, 1067, 817]","intervention:
    mean: NUMBER.0
    standard_deviation: NUMBER.0
    group_size: NUMBER
comparator:
    mean: NUMBER.0
    standard_deviation: NUMBER.0
    group_size: NUMBER
FFBQ Total Index Score:

---
intervention:
    mean: 3.3
    standard_deviation: 1.4
    group_size: 116
comparator:
    mean: 2.8
    standard_deviation: 1.2
    group_size: 114

Please note that the given data in the article do not match with
---
intervention:
    mean: 43.25
    standard_deviation: 5.07
    group_size: N/A
comparator:
    mean: 0.
    standard_deviation: 0.
    group_size: N/A

YAML:
intervention:
    mean: 52
---
intervention:
    mean: 0.2
    standard_deviation: 0.2
    group_size: N/A # not available in the article
comparator:
    mean: 0.1
    standard_deviation: 0.1
    group_size: N/A # not available in the
---
intervention:
    mean: 4.9
    standard_deviation: 2.2
    group_size: 47
comparator:
    mean: 3.5
    standard_deviation: 1.8
    group_size: 44

YAML:
intervention:
    mean: 90
    
---
",True
285,6302,3929816,Pathologic changes in the liver,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No quantitative measures given,FALSE,1047,859,TEST,749,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    pathologic_changes_in_the_liver:
        mean: NUMBER_NOT_AVAILABLE_OR_ Ignored_In_YAML
        standard_deviation: NUMBER_",False
643,12880,5830087,duration of objective response,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),continuous,,48,,23,,,,,cannot calculate,cannot calculate,,,,,"given as median with confidence interval, cannot calculate",FALSE,11942,10628,TEST,8141,"[1664, 1652, 1110, 1673, 1087]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

comparator:
    mean: NUMBER
    standard_deviation: NUM
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  # Unavailable data, so leave field blank
  # objective
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  BTH1677:
    mean: 11.6
    standard_deviation: N/A
    group_size: N/A
  
  Control:
    mean:
---
intervention:
    mean: NA
    standard_deviation: NA
    group_size: 59
comparator:
    mean: 92.6
    standard_deviation: 21.6
    group_size: 59

intervention:
    mean: 839.1
    standard_deviation:
---
intervention:
    mean: 60.0
    standard_deviation: 18.3
    group_size: 53
comparator:
    mean: 14.3
    standard_deviation: 7.9
    group_size: 42

YAML:
<assistant>
intervention:
    
---
",True
672,13313,4550271,Community knowledge,provider-school intervention,control,continuous,,14,,12,,,,,cannot calculate,cannot calculate,,,,,outcome too broad,FALSE,24886,12978,TEST,8556,"[760, 1198, 1658, 1280, 1564, 949]","intervention:
    mean: 80.0
    standard_deviation: 10.0
    group_size: 500
comparator:
    mean: 60.0
    standard_deviation: 10.0
    group_size: 500
outcome: Community knowledge
group_size: 970
mean
---
intervention:
    mean: NUMBER_NOT_AVAILABLE
    standard_deviation: NUMBER_NOT_AVAILABLE
    group_size: NUMBER_NOT_AVAILABLE
comparator:
    mean: NUMBER_NOT_AVAILABLE
    standard_deviation: NUMBER_
---
intervention:
    mean: 100
    standard_deviation: 15
    group_size: 100
comparator:
    mean: 90
    standard_deviation: 15
    group_size: 100

intervention:
    mean: 120
    standard_deviation: 15
    group_size:
---
intervention:
    mean: 89.9
    standard_deviation: 12.8
    group_size: 984
comparator:
    mean: 77.5
    standard_deviation: 13.7
    group_size: 977

intervention:
    mean: 95.2
    
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  community_knowledge:
    mean: NUMBER
    standard_deviation: NUMBER
intervention:
    mean: 90.16
    standard_deviation: 14.52
    group_
---
intervention:
    mean: X
    standard_deviation: Y
    group_size: Z
comparator:
    mean: Y
    standard_deviation: Z
    group_size: W
community knowledge:
    intervention: X
    comparator: Y
W: 14
Z:
---
",True
592,11583,115849,Swollen joint count,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 29
    standard_deviation: 12
    group_size: 68
comparator:
    mean: 28
    standard_deviation: 12
    group_size: 66

WOW:
    mean: 1.0
    standard_deviation: 0.0

---
intervention:
    mean: 67
    standard_deviation: 13
    group_size: N/A
comparator:
    mean: 62
    standard_deviation: 12
    group_size: N/A
swollen_joint_count:
    mean: 6
    standard_deviation
---
intervention:
    mean: 9.0
    standard_deviation: 2.9
    group_size: 57
comparator:
    mean: 6.4
    standard_deviation: 2.6
    group_size: 58

YAML:
<assistant>
intervention:
    
---
",True
354,4497,5874317,Horizontal countermovement jump,Bilateral training,Unilateral training,continuous,,9,,9,2.34,0.07,2.21,0.15,1.0576,0.2533,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"[616, 2442, 806]","intervention:
    mean: 89.0
    standard_deviation: 14.6
    group_size: 9
comparator:
    mean: 59.8
    standard_deviation: 10.7
    group_size: 9
intervention:
    mean: NUMBER
    standard_deviation
---
If not extractable or not extractable or not extractable, choose the pre and post-intervention data. If there are multiple timeframes for pre and post-intervention data, choose the one closest to the outcome timepoint. If there are multiple timeframes for the outcome timepoint, choose the outcome timepoint. If there are multiple timeframes
---
intervention:
    mean: 90
    standard_deviation: 15
    group_size: 8
comparator:
    mean: 76
    standard_deviation: 18
    group_size: 8
horizontal_countermovement_jump:
    group_comparison: ""Bilateral vs Unilateral""
---
",True
598,11583,115849,Patient global assessment of disease activity,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 65.5
    standard_deviation: 11.9
    group_size: 337
comparator:
    mean: 76.0
    standard_deviation: 12.3
    group_size: 385

outcome:
 patient_global_assessment_of_
---
intervention:
    mean: 9.93
    standard_deviation: 2.93
    group_size: NUMBER
comparator:
    mean: -10.46
    standard_deviation: 1.82
    group_size: NUMBER
patient_global_assessment_of_disease
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 154 (N = 26 in etoricoxib 90 mg group, N = 25 in naproxen 1000 mg group)
comparator:
    mean: N/A
    standard_deviation: N
---
",True
180,10757,5086025,General physical health,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,50.87,11.02,50.46,7.83,0.0422,0.0769,,,,,,TRUE,29049,17627,TEST,13068,"[1656, 1646, 1041, 1665, 1634, 823, 2917]","intervention:
    mean: 124.0
    standard_deviation: 15.7
    group_size: 44
comparator:
    mean: 97.5
    standard_deviation: 16.8
    group_size: 47

intervention:
    mean: 95.0
    standard_
---
intervention:
    mean: 130
    standard_deviation: 15
    group_size: 20
comparator:
    mean: 120
    standard_deviation: 15
    group_size: 20

intervention:
    mean: 7.8
    standard_deviation: 1.4

---
intervention:
    mean: 53.4
    standard_deviation: 6.01
    group_size: 40
comparator:
    mean: 75.0
    standard_deviation: 8.89
    group_size: 40

outcome:
    group_size: 40
    mean
---
intervention:
    mean: 102.0
    standard_deviation: 12.1
    group_size: 17
comparator:
    mean: 96.4
    standard_deviation: 10.2
    group_size: 17

intervention:
    mean: 110.2
    standard_
---
intervention:
    mean: NaN
    standard_deviation: NaN
    group_size: 14
comparator:
    mean: NaN
    standard_deviation: NaN
    group_size: 12
general_health:
    group_size: 7
    mean: 92.58
    standard_
---
intervention:
    mean: 102.3
    standard_deviation: 16.9
    group_size: 38
comparator:
    mean: 99.1
    standard_deviation: 15.3
    group_size: 37
general_physical_health:
    intervention: 79.9

---
If You can
```
---
",True
452,4001,4879328,weight loss,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.89,3.33,0.3,3.54,-0.3445812,0.01865965,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"[755, 1623, 1022, 1067, 817]","intervention:
    mean: 105.6
    standard_deviation: 17.4
    group_size: 234
comparator:
    mean: 88.8
    standard_deviation: 11.2
    group_size: 276

There are no pre-intervention data provided, and the closest post
---
intervention:
    mean: 55.5
    standard_deviation: 12.3
    group_size: 114
comparator:
    mean: 82.3
    standard_deviation: 18.9
    group_size: 205

Please note that the given trial article does not provide the exact means
---
intervention:
    mean: ## Not provided in the article
    standard_deviation: ## Not provided in the article
    group_size: ## Not provided in the article
comparator:
    mean: ## Not provided in the article
    standard_deviation: ## Not provided in the article
    group_size
---
intervention:
    mean: 103.89
    standard_deviation: 16.61
    group_size: 104
comparator:
    mean: 86.03
    standard_deviation: 14.24
    group_size: 114

YAML:
<assistant>>
intervention:
    
---
intervention:
    mean: 126.71
    standard_deviation: 16.18
    group_size: 47
comparator:
    mean: 87.41
    standard_deviation: 12.42
    group_size: 41

YAML:
<assistant>>
intervention:
    
---
",True
161,7712,5056957,Weight reduction at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,61.08,15.15,61.94,14.25,-0.0582,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"[1500, 261, 1439, 763]","intervention:
    mean: 103
    standard_deviation: 13
    group_size: 27
comparator:
    mean: 92.8
    standard_deviation: 12
    group_size: 27

intervention:
    mean: 47.3
    standard_deviation: 5.7
---
intervention:
    mean: <Number of active students>
    standard_deviation: <Standard deviation of weight>
    group_size: <Number of active students>
comparator:
    mean: <Number of inactive students>
    standard_deviation: <Standard deviation of weight>
    group_size
---
intervention:
    mean: 50.0
    standard_deviation: 12.05
    group_size: 50
comparator:
    mean: 49.4
    standard_deviation: 11.05
    group_size: 45

YAML:
<assistant>:
    mean: 162
---
intervention:
    mean: 50.08
    standard_deviation: 7.48
    group_size: 645
comparator:
    mean: 55.91
    standard_deviation: 7.03
    group_size:592
intervention:
    mean: 50.04
    standard_
---
",True
645,13025,4675066,The mean cognitive score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,99.4,12.2,101.7,8.2,-0.2172012,0.07594364,,,,,found in table 2,TRUE,6682,5735,TEST,4224,"[1674, 866, 893]","intervention:
    mean: 99.4
    standard_deviation: 12.2
    group_size: 27
comparator:
    mean: 101.7
    standard_deviation: 8.2
    group_size: 26
intervention:
    mean: 99.4
    standard_dev
---
intervention:
    mean: 103.9
    standard_deviation: 15.2
    group_size: 23
comparator:
    mean: 97.1
    standard_deviation: 15.5
    group_size: 23
Bayley-III:
    intervention: 42.0
    
---
intervention:
    mean: 93.9
    standard_deviation: 12.2
    group_size: 29
comparator:
    mean: 96.0
    standard_deviation: 11.4
    group_size: 30

This YAML code represents the mean cognitive score on the Bayley
---
",True
286,6303,3929816,Pathologic changes in the kidneys,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,20,,,,cannot calculate,cannot calculate,,,,,Not enough measures given for calculation,FALSE,1047,859,TEST,749,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    kidney_pathologic_changes:
        mean: NUMBER
        standard_deviation: NUMBER
        group_size: NUMBER
        
    total_dogs: NUM",False
421,3401,3877023,quantitative contour sharpness of the thoracolumbar spine,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,0.83,0.22,1.32,0.51,-1.2060514,0.07410885,,,,,"Original outcome was ""quantitative contour sharpness"".",TRUE,17694,9686,TEST,7100,"[1399, 1660, 1641, 1131]","intervention:
    mean: 39
    standard_deviation: 15
    group_size: 83
comparator:
    mean: 53
    standard_deviation: 16
    group_size: 80

YAML:
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
---
 intervention:
    mean: 71.6
    standard_deviation: 44.8
    group_size: 47
comparator:
    mean: 70
    standard_deviation: 42
    group_size: 70

 intervention:
    mean: 71.8
    standard_deviation: 29
---
intervention:
    mean: 2.1
    standard_deviation: 1.1
    group_size: 33
comparator:
    mean: 3.0
    standard_deviation: 1.2
    group_size: 30

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 22.9
    standard_deviation: 3.4
    group_size: 18
comparator:
    mean: 21.6
    standard_deviation: 4.4
    group_size: 22

YAML:
<|assistant>
intervention:

---
",True
518,6699,5154016,Second 24 h drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,53.7,3.8,63.5,14.2,-0.9305774,0.07388312,,,,,,TRUE,3046,2156,TEST,1642,[],"intervention:
    mean: 202.5
    standard_deviation: 25.0
    group_size: 30
comparator:
    mean: 259.8
    standard_deviation: 37.0
    group_size: 32
intervention:
    mean: 202.5
    standard_dev",False
97,10168,4173437,Crystalloid solution needed,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. No numerical values associated with this outcome.,FALSE,854,745,TEST,637,[],"intervention:
    mean: 576
    standard_deviation: 53
    group_size: 30
comparator:
    mean: 823
    standard_deviation: 74
    group_size: 30

YAML:
intervention:
    mean: 15.0
    standard_deviation:",False
179,10756,5086025,BMI,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,32.81,5.31,32.93,4.85,-0.0232,0.0769,,,,,,TRUE,29049,17627,TEST,13068,"[1656, 1646, 1041, 1665, 1634, 823, 2917]","intervention:
    mean: 127.5
    standard_deviation: 16.2
    group_size: 34
comparator:
    mean: 122.2
    standard_deviation: 16.4
    group_size: 38

intervention:
    mean: 27.3
    standard_
---
intervention:
    mean: 124.0
    standard_deviation: 15.0
    group_size: N/A
comparator:
    mean: 88.0
    standard_deviation: 11.0
    group_size: N/A

YAML:
 intervention:
    mean
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  post_intervention:
    number: NUMBER
    standard_deviation: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_
---
intervention:
    mean: 126.9
    standard_deviation: 14.7
    group_size: N/A
comparator:
    mean: 123.0
    standard_deviation: 13.2
    group_size: N/A

intervention:
    mean: 120.1
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
BMI:
    intervention: NUMBER
    comparator: NUMBER
---
intervention:
    mean: 46.11
    standard_deviation: 5.74
    group_size: 18
comparator:
    mean: 36.44
    standard_deviation: 5.52
    group_size: 18

intervention:
    mean: 55.11
    standard_
---
In thisis: The ""number: -


```
In the default_min:00:n=23;


Theories m=
Themechanism for the value=63
```</span,

```</emotion= <
   n andrew=<=""I=""; t=m
---
",True
330,5377,5559992,Anxiety,Buprenophine 64 mg,Buprenophine 96 mg,continuous,,4,,5,1.25,2.5,0,0,0.6784,0.4756,,,,,found in table,TRUE,1146,884,TEST,721,[]," intervention:
    mean: 13.0
    standard_deviation: 4.7
    group_size: 14
 comparator:
    mean: 12.3
    standard_deviation: 5.6
    group_size: 14
< ———–

Figure 1: Hamilton Anxiety Rating Scale

",False
386,1118,3577738,website use in terms of time on the website,website with social presence elements.,website without social presence elements.,continuous,,,,,151,117.4,150.8,107.8,cannot calculate,cannot calculate,,,,,Cannot find the group sizes in the text or table.,FALSE,3018,2080,TEST,1653,[],"intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
comparator:
    mean: 120
    standard_deviation: 15
    group_size: N/A

YAML:
intervention:
    mean: 6.5",False
324,4727,5539943,Motivational Interviewing (MI) knowledge,Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"[1580, 1384]","intervention:
    mean: 0.703
    standard_deviation: 0.219
    group_size: NUMBER
comparator:
    mean: 0.672
    standard_deviation: 0.226
    group_size: NUMBER

Note that there are no pre-intervention data points for
---
intervention:
    mean: 93.73
    standard_deviation: 10.11
    group_size: NUMBER
comparator:
    mean: 80.00
    standard_deviation: 10.22
    group_size: NUMBER

Note: This table is based on the information provided in
---
",True
114,9523,4319071,Fruit intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,2.17,1.71,2,1.67,0.1005,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"[781, 1626, 1619, 1304, 1094, 1600, 944]"," intervention:
    mean: 174.16
    standard_deviation: 47.92
    group_size: 456
comparator:
    mean: 136.18
    standard_deviation: 36.37
    group_size: 434

ffruit:
  mean: 3.60
  standard
---
intervention:
    mean: 6.1
    standard_deviation: 1.8
    group_size: 84
comparator:
    mean: 5.9
    standard_deviation: 1.8
    group_size: 82

# Outcome: Fruit intake
# Based on the post-
---
intervention:
    mean: 3
    standard_deviation: 1
    group_size: 50
comparator:
    mean: 1
    standard_deviation: 1
    group_size: 50
fruit_intake:
    intervention:
        mean: 6
        standard_deviation: 3
---
intervention:
    mean: 3
    standard_deviation: 1
    group_size: 20
comparator:
    mean: 2
    standard_deviation: 1
    group_size: 20

This information indicates that the mean fruit intake of the intervention group was 3 units, with a standard deviation of
---
intervention:
    mean: 1.56
    standard_deviation: 0.07
    group_size: N/A
comparator:
    mean: 1.41
    standard_deviation: 0.08
    group_size: N/A

YAML:
<|assistant>
---
intervention:
    mean: 5
    standard_deviation: 2
    group_size: 30
comparator:
    mean: 3
    standard_deviation: 1
    group_size: 40

Table 2: Results of linear mixed model analyses for the risk groups for the outcome ""Vegetable Int
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

Fruit intake:
    intervention:
        mean: NUM
---
",True
205,5500,5380326,Interleukin 2,Vitamin D supplementation,Control,continuous,,40,,40,4.49,13.34,28.69,103.03,-0.2276,0.0503,,,,,,TRUE,10658,5810,TEST,4260,"[1585, 1668, 307]","intervention:
    mean: 130
    standard_deviation: 23
    group_size: 80
comparator:
    mean: 95
    standard_deviation: 15
    group_size: 60

outcome:
 intervention:
    mean: 9.21
    standard_deviation: 3
---
intervention:
    mean: 95.5
    standard_deviation: 15.9
    group_size: 85
comparator:
    mean: 86.1
    standard_deviation: 13.6
    group_size: 390

outcome:
    interleukin_2:
        
---
intervention:
    mean: -521.79
    standard_deviation: 228.09
    group_size: NUMBER
comparator:
    mean: 255.46
    standard_deviation: 216.35
    group_size: NUMBER

<figure>
  <img src=""yaml
---
",True
246,10305,5571493,Glycemic level,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,0.74,0.05,0.83,0.05,-1.7238,0.2743,,,,,,TRUE,1507,1019,TEST,928,[],"intervention:
    mean: 83
    standard_deviation: 5
    group_size: 10
comparator:
    mean: 74
    standard_deviation: 5
    group_size: 10

Outcome: Glycemic level
Closer timepoint: 4 hours post-intervention

YAML",False
245,10307,5571493,Glycemic level,Saline + Quinine infusion,Dw 5% + Quinine infusion,continuous,,10,,10,0.74,0.05,0.82,0.05,-1.5322,0.2587,,,,,,TRUE,1507,1019,TEST,928,[],"intervention:
    mean: 83).0
    standard_deviation: 5).0
    group_size: 10
comparator:
    mean: 74).0
    standard_deviation: 5).0
    group_size: 10

In the given trial article, the glycemic level was evaluated in",False
359,8711,5971365,Symbol Digit Modalities Test (SDMT) score at week 96,daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,continuous,,720,,682,4.1,12.4,2.9,12.7,0.0956,0.0029,,,,,"found in figure and text, totals found in figure",TRUE,3177,2394,TEST,2130,"[1652, 145]","intervention:
    mean: 4.1
    standard_deviation: 12.4
    group_size: 919
comparator:
    mean: 2.9
    standard_deviation: 16.1
    group_size: 922

outcome:
    mean: 4.3

---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: N/A # not available in the article
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: N/A # not available in the article
SDMT
---
",True
489,6383,3786549,Baseline characteristics: weight,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,56.16,8.1,57.82,8.24,-0.201397,0.045685,,,,,,TRUE,9725,6231,TEST,4323,"[1626, 1395, 644]","intervention:
    mean: 154.86
    standard_deviation: 5.45
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A

data:
  weight: x
  
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  numbers:
    weight: 65.5 # in kg

comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  NUMBER: 65.0
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  NUMBER: NUMBER
---
",True
445,4098,4140238,ocular itching for visit 3B at 7 min,bepotastine besilate ophthalmic solution (BBOS) 1.5%,placebo,continuous,,70,,70,1.2,,2.1,,cannot calculate,cannot calculate,,,,,"Original outcome name is ""ocular itching"". However, due to many different visits and data from timepoints. We specified this in the outcome. Visit 3B was the first study they conducted and 7 min is the last timepoint. No SD information was given",FALSE,12685,6812,TEST,5052,"[1485, 1168, 1579, 188]","intervention:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER
BBOS 1.5%:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER
corticosteroid:
  mean: NUMBER
  
---
intervention:
    mean: 3.0
    standard_deviation: 1.6
    group_size: 140
comparator:
    mean: 1.5
    standard_deviation: 1.0
    group_size: 70

This YAML represents the means and standard deviations for ocular itching
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
   
  3B:
    mean_intervention: NUMBER
    
---
intervention:
    mean: 6.7
    standard_deviation: 3.4
    group_size: 34
comparator:
    mean: 3.3
    standard_deviation: 1.8
    group_size: 70

This YAML represents the proposed table format for the specified intervention,
---
",True
556,9828,3136370,Fibromyalgia Impact Questionnaire scores,Soy shake,Control,continuous,,12,,16,-17.1,68.08,-19.57,93.53,0.02864501,0.14584799,,,,,From per protocol,TRUE,6022,3786,TEST,2937,"[1453, 989]","intervention:
  mean: 14
  standard_deviation: 9
  group_size: 50
comparator:
  mean: 13
  standard_deviation: 7
  group_size: 50

# Fibromyalgia Impact Questionnaire (FIQ) scores
# Closen to 6/27/20
---
intervention:
    mean: -0.79
    standard_deviation: 0.32
    group_size: 63
comparator:
    mean: -5.12
    standard_deviation: 0.68
    group_size: 62

YAML:
<assistant>
intervention:
---
",True
688,13763,2836833,systolic or diastolic blood pressure,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,"[1499, 1608, 1352, 745]","intervention:
    mean: 103.3
    standard_deviation: 13.7
    group_size: 56
comparator:
    mean: 84.5
    standard_deviation: 12.6
    group_size: 58

outcome:
  systolic or diastolic blood pressure:
---
intervention:
    mean: 90
    standard_deviation: 11
    group_size: 17
comparator:
    mean: 79
    standard_deviation: 9
    group_size: 17

YAML:
<|assistant>
intervention:
    mean: 123
    standard_
---
intervention:
    mean: 130
    standard_deviation: NULL
    group_size: 28
comparator:
    mean: 95
    standard_deviation: NULL
    group_size: 28

YAML:
<assistant>:
    mean: 114
    standard_deviation: NULL
---
intervention:
    mean: 129.7
    standard_deviation: 16.1
    group_size: 18
comparator:
    mean: 75.1
    standard_deviation: 8.1
    group_size: 16
intervention:
    mean: 123.9
    standard_dev
---
",True
459,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),Nd:YAG laser (group B),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,1068,[],"intervention:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER
    total_weight_percentage_of_phosphate: NUMBER
    n: NUMBER
    standard_deviation_of_total_weight_percentage_of_phosphate: NUMBER
groups",False
208,2913,5459456,inflexion-extension for the C2-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,6.3,1.1,6.5,0.9,-0.1881,0.2511,,,,,,TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 78.1
    standard_deviation: 7.5
    group_size: 4
comparator:
    mean: 77.6
    standard_deviation: 7.3
    group_size: 4

outcome:
    inflexion-extension for the C
---
intervention:
    mean: 6.5
    standard_deviation: 1.1
    group_size: 20
comparator:
    mean: 7.0
    standard_deviation: 1.4
    group_size: 20

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 0.81
    standard_deviation: 0.2
    group_size: 7
comparator:
    mean: 0.75
    standard_deviation: 0.2
    group_size: 7

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 95.5
    standard_deviation: 7.2
    group_size: 24
comparator:
    mean: 83.4
    standard_deviation: 9.6
    group_size: 24

YAML:
<|assistant>
intervention:

---
",True
289,6103,4215531,MCCB performance : Processing Speed,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,44.6,12.2,48.2,12.3,-0.2877,0.1064,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,"[1623, 1169, 760]","intervention:
    mean: 130
    standard_deviation: 15
    group_size: 8
comparator:
    mean: 120
    standard_deviation: 15
    group_size: 8
MCCB_Processing_Speed:
    intervention:
        mean: 123
        standard_dev
---
intervention:
    mean: 36.0
    standard_deviation: 7.9
    group_size: 19
comparator:
    mean: 35.9
    standard_deviation: 10.6
    group_size: 15

YAML:
intervention:
    mean: 506.1
---
intervention:
    mean: 44.6
    standard_deviation: 12.2
    group_size: 19
comparator:
    mean: 40.1
    standard_deviation: 14.4
    group_size: 19

YAML:
<|assistant>:
    mean:
---
",True
567,8560,5541727,Tibial bone expansion,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-0.7,1.5,1,1.1,-1.1693949,0.29779588,,,,,"Values are from ""total tibial plateau"" for 24 months",TRUE,6118,5345,TEST,4032,"[1437, 1673, 201]","intervention:
    mean: 4.0
    standard_deviation: 1.1
    group_size: 11
comparator:
    mean: 3.1
    standard_deviation: 0.9
    group_size: 6
tibial_bone_expansion:
  mean: 0
---
intervention:
    mean: 0.5
    standard_deviation: 0.2
    group_size: 12
comparator:
    mean: 4.0
    standard_deviation: 1.0
    group_size: 12

intervention:
    mean: 1.4
    standard_
---
intervention:
    mean: 120.0
    standard_deviation: 17.9
    group_size: 25
comparator:
    mean: 80.2
    standard_deviation: 12.6
    group_size: 25

The provided article reports on a study investigating the effects of allogene
---
",True
112,9525,4319071,Vegetable intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,167.61,83.71,158.67,78.33,0.1101,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"[781, 1626, 1619, 1304, 1094, 1600, 944]","intervention:
    mean: 159.12
    standard_deviation: 69.24
    group_size: N.A.
comparator:
    mean: N.A.
    standard_deviation: N.A.
    group_size: N.A.
vegetable:
    
---
intervention:
    mean: 153.0
    standard_deviation: 27.1
    group_size: 54
comparator:
    mean: 131.1
    standard_deviation: 25.4
    group_size: 54

## Figure 2 (required for total number of participants)


---
intervention:
    mean: 3
    standard_deviation: 1
    group_size: 50
comparator:
    mean: 2
    standard_deviation: 1
    group_size: 50

--
---
intervention:
    mean: 150
    standard_deviation: 15
    group_size: 50
comparator:
    mean: 100
    standard_deviation: 10
    group_size: 40

Note: The given article does not provide numerical data for YAML input. In this case, I have
---
intervention:
    mean: 1.67
    standard_deviation: 0.08
    group_size: N/A
comparator:
    mean: 1.41
    standard_deviation: 0.08
    group_size: N/A
vegetable_intake:
    intervention
---
intervention:
    mean: 4
    standard_deviation: 2
    group_size: 30
comparator:
    mean: 3
    standard_deviation: 2
    group_size: 30

Table 2: Vegetable Intake

|           Intervention          |   Control   |
|
---
intervention:
    mean: 120
    standard_deviation: 15
    group_size: 50
comparator:
    mean: 100
    standard_deviation: 15
    group_size: 50
vegetable_intake:
    intervention: 43.67
    comparator: 40.
---
",True
215,2913,5459456,lateral bending for the C5-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,2.2,0.4,2,0.3,0.5347,0.2589,,,,,,TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 180.0
    standard_deviation: 15.9
    group_size: 8
comparator:
    mean: 140.2
    standard_deviation: 11.8
    group_size: 8

outcome:
    lateral bending for the C5-
---
intervention:
    mean: 6.2
    standard_deviation: 1.1
    group_size: 30
comparator:
    mean: 7.4
    standard_deviation: 1.2
    group_size: 30

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 9.7
    standard_deviation: 1.8
    group_size: 6
comparator:
    mean: 8.4
    standard_deviation: 1.6
    group_size: 6
C5-C6 Lateral Bending:
    intervention:
---
intervention:
    mean: 104.2
    standard_deviation: 14.5
    group_size: 26
comparator:
    mean: 78.3
    standard_deviation: 16.2
    group_size: 26

YAML:
<|assistant>
intervention:

---
",True
33,5575,3003523,Health-related quality of life improvement - Short-Form 36-Items improvement,Certolizumab 200 mg,Control,continuous,,393,,199,38.1,9.5,31.5,7.4,0.7447,0.008,,,,,This outcome is measured by Short-Form 36-Items (SF-36).,TRUE,12247,10091,TEST,7520,"[1594, 85, 2527, 1540, 734]","intervention:
    mean: 6.4
    standard_deviation: 2.0
    group_size: N/A
comparator:
    mean: 30.8
    standard_deviation: 6.0
    group_size: N/A

intervention:
    mean: 64.2
---
intervention:
    mean: 90.0
    standard_deviation: 11.9
    group_size: 43
comparator:
    mean: 89.5
    standard_deviation: 12.1
    group_size: 43

This article reports on a randomized controlled trial (RCT) comparing
---
If there are multiple timeframes, the post-intervention data. If there are multiple timeframes, including numerical data for the outcome and general vitality for the outcome. The YAML format is to provide the absolute change from ""very interesting insights"": Choose the YAML information regarding the treatment arm scorers:
If there are multiple timeframes, the
---
intervention:
    mean: 13.1
    standard_deviation: 5.2
    group_size: 55
certolizumab 200 mg:
    mean: 13.1
    standard_deviation: 5.2
    group_size: 55
comparator:
    mean: 11.8
---
intervention:
    mean: 45.5
    standard_deviation: 11.1
    group_size: 85
comparator:
    mean: 38.8
    standard_deviation: 9.1
    group_size: 158
intervention:
    mean: 44.1
    standard_dev
---
",True
432,3261,3475525,Scores on sugar quiz,MTL group,No label group,continuous,,98,,99,90,20.7,47.2,19.6,2.11539588,0.03166271,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: NUMBER
comparator:
    mean: 67.8
    standard_deviation: 10.3
    group_size: NUMBER

YAML:
intervention:
    mean: 73
---
intervention:
    mean: 72.5
    standard_deviation: 13.2
    group_size: 98
comparator:
    mean: 67.8
    standard_deviation: 10.3
    group_size: 99

Table:
    name: sugar_quiz_scores

---
",True
353,4496,5874317,Squat jump,Bilateral training,Unilateral training,continuous,,9,,9,0.37,0.04,0.34,0.04,0.7142,0.2364,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"[616, 2442, 806]"," intervention:
    mean: 116).0
    standard_deviation: 18.8
    group_size: 9
comparator:
    mean: 89).4
    standard_deviation: 18.9
    group_size: 9
squat_jump:
    group_size: 9
    
---
If there are multiple timeframes for the very third timepoint for a better understanding of the subject of interest, choose the appropriate pretext.

If multiple timeframes are produced by the difference. If ""x"" is a valid.
If you want to calculate and post-intervention data, please provide a table:


If ""
---
intervention:
    mean: 70.0
    standard_deviation: 12.0
    group_size: 8
comparator:
    mean: 53.5
    standard_deviation: 8.3
    group_size: 10
squat_jump:
    group_size: 2
    
---
",True
560,9834,3496170,Learned irrelevance index,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,[],"intervention:
    mean: 105
    standard_deviation: 12
    group_size: 8
comparator:
    mean: 86
    standard_deviation: 10
    group_size: 8
outcome:
    mean: NUMBER
    standard_deviation: NUMBER
    group_",False
75,3743,3546023,The percentage of B cells,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,11.97,4,13.72,4.53,-0.404,0.0704,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1053, 1432, 1540, 941, 1509, 986, 1381]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    mean_cd4+/cd8+: NUMBER
    standard_deviation_cd4+/cd8+: NUMBER
    group_size_cd4+/cd8+: NUM
---
intervention:
    mean: 63.14
    standard_deviation: 11.54
    group_size: 60
comparator:
    mean: 90.61
    standard_deviation: 5.70
    group_size: 30

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 58
    standard_deviation: 9
    group_size: 58
comparator:
    mean: 424
    standard_deviation: 114
    group_size: 35
The provided data for the given article suggests the following YAML format:
```
intervention:
    mean
---
intervention:
    mean: 8.32
    standard_deviation: 1.55
    group_size: 29
comparator:
    mean: 7.29
    standard_deviation: 2.10
    group_size: 27

YAML:
intervention:
    mean: 8.32
---
intervention:
    mean: 9.80
    standard_deviation: 1.09
    group_size: 4
comparator:
    mean: 37.25
    standard_deviation: 8.59
    group_size: 4
outcome:
    mean: 0.76
    standard_
---
intervention:
    mean: 25.59
    standard_deviation: 9.44
    group_size: 27
comparator:
    mean: 24.72
    standard_deviation: 7.94
    group_size: 29
intervention:
    mean: 18.48
    standard_dev
---
intervention:
    mean: 15.67
    standard_deviation: 6.11
    group_size: NUMBER
comparator:
    mean: x
    standard_deviation: x
    group_size: NUMBER

Table 2:
Intervention: Nonsmokers (placebo,
---
",True
414,3262,3475525,Taste perception,MTL group,choices group,continuous,,98,,98,5.6,1.4,5.3,1.5,0.20597307,0.02051639,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: NUMBER
comparator:
    mean: 65.8
    standard_deviation: 10.3
    group_size: NUMBER

YAML:
intervention:
    mean: 72
---
 intervention:
    mean: 5.8
    standard_deviation: 1.4
    group_size: NUMBER
    
 comparator:
    mean: x
    standard_deviation: x
    group_size: NUMBER

outcome:
 taste perception
 intervention: MTL group
 comparator
---
",True
71,3043,3321528,handgrip strength,Intensive Care Unit acquired weakness (ICU-AW),without an ICU-AW diagnosis,continuous,,,,,6.6,4.4,23.4,8.9,cannot calculate,cannot calculate,,,,,Does not have group size information in article.,FALSE,6725,3999,TEST,2880,"[1121, 1095]","intervention:
    mean: 21.4
    standard_deviation: 10.7
    group_size: 58
comparator:
    mean: 14.8
    standard_deviation: 10.7
    group_size: 52

 intervention:
    mean: 60.2
    standard_
---
intervention:
    mean: 45
    standard_deviation: 15
    group_size: 14
comparator:
    mean: 30
    standard_deviation: 10
    group_size: 14

YAML:
<|assistant>
intervention:
    mean: 15.8
    
---
",True
580,10217,3504298,Anxious symptoms,Face-based attentional bias modification,Placebo,continuous,,16,,14,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,3331,"[1665, 939]","intervention:
    mean: 95.5
    standard_deviation: 9.8
    group_size: 18
comparator:
    mean: 85.2
    standard_deviation: 10.4
    group_size: 18

# Outcome: Depressive symptoms
outcome:
    
---
intervention:
    mean: 6.3
    standard_deviation: 5.4
    group_size: NUMBER
comparator:
    mean: 5.2
    standard_deviation: 3.9
    group_size: NUMBER

This is a YAML format for the given article:
---
",True
658,13177,5773985,duration of surgical procedure,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,32.2,15.5,33.68,18.91,-0.0842565,0.08007099,,,,,Graphic format table,TRUE,2609,2261,TEST,1917,[1563],"intervention:
    mean: 508.92
    standard_deviation: 63.30
    group_size: 50
comparator:
    mean: 1840.84
    standard_deviation: 819.51
    group_size: 50

outcome:
    duration of surgical procedure:

---
",True
523,6741,5325897,First test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,10.24,0.77,9.73,0.77,0.64440958,0.1402544,,,,,,TRUE,4260,2410,TEST,1703,[],"intervention:
    mean: 10.24
    standard_deviation: 0.77
    group_size: NUMBER
comparator:
    mean: 14.93
    standard_deviation: 0.32
    group_size: NUMBER

intervention:
    mean: 18.72
    ",False
561,9835,3496170,P3a amplitude,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,[],"intervention:
    mean: 117.93
    standard_deviation: 18.77
    group_size: 15
comparator:
    mean: 113.37
    standard_deviation: 18.92
    group_size: 15

outcome:
    mean: 15.45
    standard",False
25,3244,2972614,Motion range - Shoulder extension,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,42.66,3.4,42.95,3.98,-0.0781,0.0788,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,[1525],"intervention:
    mean: 168.16
    standard_deviation: 22.73
    group_size: 31
comparator:
    mean: 166.67
    standard_deviation: 21.57
    group_size: 38

intervention:
    mean: 44.16
    standard_
---
",True
291,6103,4215531,MCCB performance : Visual Learning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,49.4,12.8,46.5,9.8,0.2491,0.1061,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,"[1623, 1169, 760]","intervention:
    mean: 100
    standard_deviation: 10
    group_size: 8
comparator:
    mean: 90
    standard_deviation: 10
    group_size: 8
visuallearning:
    group_size: 8
    mean: 95.2
    standard_dev
---
intervention:
    mean: 34.0
    standard_deviation: 8.0
    group_size: 19
comparator:
    mean: 35.4
    standard_deviation: 8.1
    group_size: 19
visual_learning:
    group_size: 19

Note
---
intervention:
    mean: 44.6
    standard_deviation: 12.2
    group_size: 19
comparator:
    mean: 39.3
    standard_deviation: 11.1
    group_size: 19
visual_learning:
    mean: 49.4
    standard
---
",True
505,6485,5419060,Phlebotomy questionnaire score: CDC C,Phlebotomy training programme,Control,continuous,,23,,23,97,3.85,60,5.25,7.89939403,0.76522202,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,"[1542, 1646, 159]","intervention:
    mean: 96
    standard_deviation: 9
    group_size: 82
comparator:
    mean: 93
    standard_deviation: 8
    group_size: 70

Figure 1: Summary statistics of rejection rates with reason for rejection pre and post-training. 
![
---
intervention:
    mean: 96.73
    standard_deviation: 7.43
    group_size: 143
comparator:
    mean: 63.67
    standard_deviation: 6.73
    group_size: 89

This table includes only the Intervention and Comparator groups for the
---
intervention:
    mean: 5.9
    standard_deviation: 1.4
    group_size: 14
comparator:
    mean: 4.3
    standard_deviation: 1.2
    group_size: 14

# Based on the given trial article, the mean score for the
---
",True
199,7736,5380284,Rates of POI,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  rates_of_poi:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    ",False
532,7829,4230312,improvement of disorder,quetiapine 300 mg/day,placebo,continuous,,283,,204,-15.58,10.43,-11.61,10.12,-0.3847888,0.00858754,,,,,Back calculated SD from SE.,TRUE,6201,5058,TEST,3918,"[1678, 1439, 417]","intervention:
    mean: 13.78
    standard_deviation: 5.94
    group_size: 84
comparator:
    mean: 10.05
    standard_deviation: 3.62
    group_size: 84

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 14.0
    standard_deviation: 3.4
    group_size: 65
comparator:
    mean: 10.0
    standard_deviation: 3.1
    group_size: 49

# based on mean change from baseline in HAM D total score
---
intervention:
    mean: 3.3
    standard_deviation: 1.0
    group_size: 214
comparator:
    mean: 1.8
    standard_deviation: 0.9
    group_size: 214
<|assistant>
YAML:
intervention:
    
---
",True
113,9526,4319071,Vegetable intake,Intervention + targeting environmental-level factors,Individual cognition and self-regulation processes intervention,continuous,,456,,459,167.61,83.71,173.28,81.63,-0.0685,0.0044,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"[781, 1626, 1619, 1304, 1094, 1600, 944]","intervention:
    mean: 175.0
    standard_deviation: 37.5
    group_size: N/A
comparator:
    mean: 158.9
    standard_deviation: 33.0
    group_size: N/A

intervention:
    mean: 239.5
---
intervention:
    mean: 159.12
    standard_deviation: 69.24
    group_size: n/a
comparator:
    mean: 157.73
    standard_deviation: 64.54
    group_size: n/a

YAML:
intervention:
    mean
---
intervention:
    mean: 2.81
    standard_deviation: 0.07
    group_size: N/A
comparator:
    mean: 1.71
    standard_deviation: 0.07
    group_size: N/A

 intervention:
    mean: 4.29
---
intervention:
    mean: 3.0
    standard_deviation: 1.0
    group_size: 50
comparator:
    mean: 2.5
    standard_deviation: 1.0
    group_size: 50

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 1.67
    standard_deviation: 0.08
    group_size: N/A
comparator:
    mean: 1.41
    standard_deviation: 0.08
    group_size: N/A

# Vegetable intake
outcome:

---
intervention:
    mean: 3
    standard_deviation: 1
    group_size: 20
comparator:
    mean: 2
    standard_deviation: 1
    group_size: 20
vegetable_intake:
    mean: 3.5
    standard_deviation: 0
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NURS
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NURS
vegetable_intake:
    intervention:
        mean
---
",True
367,224,1475568,Minnesota living with heart failure (MLHF) questionnaire baseline scores,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,45,,57,,cannot calculate,cannot calculate,,,,,Only the mean score was given in table.,FALSE,4361,3649,TEST,2573,"[1476, 403]","intervention:
    mean: 53.0
    standard_deviation: 11.5
    group_size: 124
comparator:
    mean: 46.3
    standard_deviation: 9.7
    group_size: 134

YAML:
intervention:
    mean: 105.2
---
intervention:
    mean: 51.9
    standard_deviation: 11.6
    group_size: 39
comparator:
    mean: 42
    standard_deviation: 9.1
    group_size: 24

YAML:
intervention:
    mean: 51.9
    
---
",True
416,3262,3475525,intent of purchase,MTL group,No label group,continuous,,98,,99,3.8,1.4,4.1,1.5,-0.2059408,0.02041274,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: NUMBER.4
    standard_deviation: NUMBER.4
    group_size: NUMBER
comparator:
    mean: NUMBER.4
    standard_deviation: NUMBER.4
    group_size: NUMBER

Warming Tips:
- M
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    mean: NUMBER
    standard_deviation: NUMBER
    
---
",True
357,4711,5884950,chemokines CXCL9,extensively hydrolyzed whey-based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,extensively hydrolyzed whey-based formula without (control) short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,continuous,,13,,13,,,,,cannot calculate,cannot calculate,,,,,"mean and std not given, only median and interquartile range",FALSE,11712,6635,TEST,5281,"[1620, 1659, 1126]","intervention:
    mean: 2.29
    standard_deviation: N/A
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: 1.81
    group_size: N/A
    
    
    
    
    

---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  CXCL9:
    mean: 43.5
    standard_deviation: 18.1
    group_size: 27
comparator:
    mean: NUMBER
    standard_
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  cxcl9:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_dev
---
",True
681,13506,5777419,reduction of plaque,probiotic,placebo,continuous,,16,,15,28.1,14.6,27.4,13,0.0492187,0.12920574,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"[857, 1657, 122]","intervention:
    mean: 13.0
    standard_deviation: 2.7
    group_size: 47
comparator:
    mean: 8.5
    standard_deviation: 2.2
    group_size: 15
    
Outcome: reduction of plaque

YAML:

---
intervention:
    mean: 3.8
    standard_deviation: 0.7
    group_size: 15
comparator:
    mean: 6.0
    standard_deviation: 1.6
    group_size: 15
outcome:
    mean: 4.0
    standard_
---
intervention:
    mean: 92.5
    standard_deviation: 9.2
    group_size: 60
comparator:
    mean: 55.8
    standard_deviation: 10.6
    group_size: 60

Explanation: 

Based on the given article, the table
---
",True
525,6742,5325897,Final test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,18.53,0.22,18.99,0.22,-2.0343126,0.20230713,,,,,,TRUE,4260,2410,TEST,1703,[],"intervention:
    mean: 17.73
    standard_deviation: 3.16
    group_size: NUMBER
comparator:
    mean: 9.73
    standard_deviation: 3.16
    group_size: NUMBER

YAML:
<|assistant>:
intervention",False
277,6422,3654355,Baseline Height,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,173.2,8.6,172.3,10.4,0.0971,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"[1123, 1035, 883, 1927, 1235]"," intervention:
    mean: 105.6
    standard_deviation: 13.1
    group_size: 19
comparator:
    mean: 103.8
    standard_deviation: 13.0
    group_size: 19

output:
    - name: baseline_height
       mean
---
intervention:
    mean: 173.2
    standard_deviation: 8.6
    group_size: NUMBER
comparator:
    mean: 172.3
    standard_deviation: 10.4
    group_size: NUMBER

This YAML format assumes a total of 71 subjects in
---
intervention:
    mean: 105.0
    standard_deviation: 15.3
    group_size: 71
comparator:
    mean: 90.8
    standard_deviation: 15.7
    group_size: 35
height:
    mean: 1.72
    standard_dev
---
intervention:
    mean: 130.4
    standard_deviation: 8.8
    group_size: 57
comparator:
    mean: 130.4
    standard_deviation: 8.8
    group_size: 58

data:
    baseline_height:
        mean: s
---
intervention:
    mean: 130.0
    standard_deviation: 10.0
    group_size: 39
comparator:
    mean: 170.0
    standard_deviation: 10.0
    group_size: 39
height:
    mean: 1.69
    standard_dev
---
",True
176,10753,5086025,Psychological flexibility,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,18.23,8.14,22.46,8.67,-0.4954,0.0793,,,,,Actually psychological inflexibility in the article,TRUE,29049,17627,TEST,13068,"[1656, 1646, 1041, 1665, 1634, 823, 2917]","intervention:
    mean: 101
    standard_deviation: 14.1
    group_size: 20
comparator:
    mean: 87.1
    standard_deviation: 16.4
    group_size: 20

intervention:
    mean: 101
    standard_deviation: 14
---
intervention:
    mean: 105
    standard_deviation: 15
    group_size: 19
comparator:
    mean: 80
    standard_deviation: 10
    group_size: 20

intervention:
    mean: 100
    standard_deviation: 15
    group_size:
---
intervention:
    mean: 53.4
    standard_deviation: 6.01
    group_size: 40
comparator:
    mean: NMIN
    standard_deviation: NMIN
    group_size: NMIN

YAML:
intervention:
    mean: 53.4

---
intervention:
    mean: 102.0
    standard_deviation: 13.8
    group_size: 18
comparator:
    mean: 88.5
    standard_deviation: 11.5
    group_size: 18

intervention:
    mean: 3.53
    standard_
---
intervention:
    mean: 90.05
    standard_deviation: 10.53
    group_size: 14
comparator:
    mean: 85.07
    standard_deviation: 11.05
    group_size: 14

intervention:
    mean: 54.11
    standard_
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER_OF_PARTICIPANTS
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER_OF_PARTICIPANT
---
This istech=74 or-

```

""Filling=
It is a</spanforce.csv=

```
---
",True
606,11583,115849,Discontinuation due to lack of efficacy,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 65.5
    standard_deviation: 14.4
    group_size: 370
comparator:
    mean: 76.0
    standard_deviation: 15.9
    group_size: 370

empty_intervention:
    mean: N/A
    
---
intervention:
  mean: 17.83
  standard_deviation: 8.63
  group_size: NUMBER
comparator:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER

This is not a complete and valid YAML format. Please provide
---
intervention:
    mean: 9.2
    standard_deviation: 3.1
    group_size: 301
comparator:
    mean: 7.8
    standard_deviation: 3.3
    group_size: 298

YAML:
<assistant>
intervention:
    
---
",True
684,13506,5777419,reduction of plaque,antibiotic,placebo,continuous,,16,,15,31.8,14.8,27.4,13,0.30695109,0.13068633,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"[857, 1657, 122]","intervention:
    mean: 12.3
    standard_deviation: 2.1
    group_size: 47
comparator:
    mean: 10.8
    standard_deviation: 2.4
    group_size: 47

YAML:
intervention:
    mean: 6.6
---
intervention:
    mean: 3.0
    standard_deviation: 1.4
    group_size: 16
comparator:
    mean: 1.0
    standard_deviation: 0.6
    group_size: 15

outcome:
    mean: NUMBER
    standard_
---
intervention:
    mean: 95.5
    standard_deviation: 9.6
    group_size: 45
comparator:
    mean: 72.8
    standard_deviation: 12.1
    group_size: 45

outcome:
    reduction_of_plaque:

---
",True
578,8564,2952311,Muscle hardness,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[1302],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    muscle_hardness:
        mean: NUMBER
        standard_deviation: NUMBER
        group_size: NUMBER

comparator:
    mean: NUMBER
---
",True
534,7794,3508963,Pain relief,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,1.13,1.15,2.23,1.57,-0.7968282,0.01798945,,,,,Values from 30 minutes.,TRUE,3561,2387,TEST,1552,[],"intervention:
    mean: 65
    standard_deviation: N/A
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A

intervention:
    mean: 9.65
",False
151,11147,4996097,"n"" consonant improvement",Septoplasty,Control,continuous,,33,,30,11897,,13229,,cannot calculate,cannot calculate,,,,,Used F0 (Hz) values. SD is not given.,FALSE,9291,4535,TEST,2976,"[1668, 865]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  n"" consonant improvement:
    mean: 105.0
    standard_deviation: 15.2
    group_size: 33
comparator:
    mean: NUMBER
---
intervention:
    mean: 3150
    standard_deviation: 277
    group_size: 33
comparator:
    mean: 2292
    standard_deviation: 283
    group_size: 30

YAML:
intervention:
    mean: 327
    standard_deviation: 29
---
",True
393,1120,3577738,effectiveness,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[],"intervention:
    mean: 4.9
    standard_deviation: 0.4
    group_size: N/A # Includes all individuals accessing the website
comparator:
    mean: 4.4
    standard_deviation: 0.4
    group_size: N/A # Includes",False
117,2983,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Deep-cooling,No cooling,continuous,,9,,13,,,15.4,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,2328,"[1660, 347]"," intervention:
    mean: 102
    standard_deviation: 12
    group_size: 20
comparator:
    mean: 84
    standard_deviation: 11
    group_size: 20

# Table of mean outcome and standard deviation
|  Intervention   |    Improvement in Glasgow
---
 deep-cooling:
    mean: 3.0
    standard_deviation: 1.0
    group_size: 32
combinated group:
    mean: 2.8
    standard_deviation: 1.1
    group_size: 32
no cooling:
    mean: 4.1

---
",True
116,2982,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Deep-cooling,Mild-cooling,continuous,,9,,10,,,70,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,2328,"[1660, 347]","intervention:
    mean: 3.7
    standard_deviation: 1.2
    group_size: 32
comparator:
    mean: 2.8
    standard_deviation: 1.2
    group_size: 32

outcome:
    mean: 2.2
    standard
---
deep-cooling:
    mean: 4.0
    standard_deviation: 2.0
    group_size: 32
comparator:
    mean: 3.5
    standard_deviation: 2.1
    group_size: 32
glasgow-outcome-score:
    mean
---
",True
424,3402,3877023,contrast-to-noise ratios (CNR) of Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid – Vertebral bone,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,19.3,10.3,8.2,5.7,1.33530568,0.12603411,,,,,,TRUE,17694,9686,TEST,7100,"[1399, 1660, 1641, 1131]","intervention:
    mean: 108
    standard_deviation: 11
    group_size: 38
comparator:
    mean: 106
    standard_deviation: 11
    group_size: 38

Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid – Ver
---
intervention:
    mean: 105
    standard_deviation: 14
    group_size: 24
comparator:
    mean: 85
    standard_deviation: 16
    group_size: 24

# Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid –
---
intervention:
    mean: 2.1
    standard_deviation: 1.1
    group_size: 23
comparator:
    mean: 3
    standard_deviation: 1.3
    group_size: 21
cerebrospinal_fluid:
    mean: 1.8
    
---
intervention:
    mean: 22.9
    standard_deviation: 3.4
    group_size: 18
comparator:
    mean: 21.6
    standard_deviation: 4.4
    group_size: 22
<|assistant>
intervention:
    mean: 23.
---
",True
605,11583,115849,ACR20 responder criteria,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 65.5
    standard_deviation: 11.0
    group_size: 368
comparator:
    mean: 76.0
    standard_deviation: 14.4
    group_size: 372
intervention:
    mean: 65.5
    standard_dev
---
intervention:
    mean: 9.53
    standard_deviation: 3.18
    group_size: 103
comparator:
    mean: 4.59
    standard_deviation: 2.20
    group_size: 55

Note: The given trial article does not provide pre-intervention mean
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 147
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 145

This YAML includes a request for the mean and standard deviation of
---
",True
398,2241,4678179,Median overall survival (OS),vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,6.9,4.09,6.1,5.57,0.1625371,0.03786046,,,,,"Median is given with CI. Since the outcome explicitly says ""median"", including median values. Back calculated SD using CI.",TRUE,9517,6474,TEST,5204,"[1663, 1622, 586]","intervention:
    mean: 6.9
    standard_deviation: 6.1
    group_size: 106
comparator:
    mean: 6.1
    standard_deviation: 6.0
    group_size: 55

Warnings: x
x
---
intervention:
  mean: 4.0
  standard_deviation: 2.9
  group_size: NUMBER
comparator:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER

os:
  mean: 6.9
  standard
---
intervention:
    mean: 645.0
    standard_deviation: 118.9
    group_size: 22
comparator:
    mean: 779.3
    standard_deviation: 99.3
    group_size: 22

This YAML already includes the necessary fields: mean,
---
",True
90,5540,3912320,"Correct response rate for 4,000 Hz frequency",Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,1015,[],"intervention:
    mean: 31.9
    standard_deviation: 6.2
    group_size: 15
comparator:
    mean: 30.4
    standard_deviation: 6.2
    group_size: 15

intervention:
    mean: NUMBER
    standard_dev",False
599,11583,115849,investigator global assessment of disease activity,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 66.7
    standard_deviation: 10.8
    group_size: 58
comparator:
    mean: 64.7
    standard_deviation: 12.1
    group_size: 58

outcome:
    investigator global assessment of disease activity:
---
intervention:
    mean: 9.53
    standard_deviation: 2.38
    group_size: 65
comparator:
    mean: 6.19
    standard_deviation: 2.26
    group_size: 65

# Outcome: patient global assessment of pain
YAML:
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 145 (n = 28 in etoricoxib group, n = 28 in naproxen group)
comparator:
    mean: N/A
    standard_deviation: N/A
    
---
",True
207,5501,5380326,Tumor necrosis factor alpha,Vitamin D supplementation,Control,continuous,,40,,40,752.94,1890.16,548.33,1210.9,0.1277,0.0501,,,,,,TRUE,10658,5810,TEST,4260,"[1585, 1668, 307]"," intervention:
    mean: 125
    standard_deviation: 23
    group_size: 84
comparator:
    mean: 80
    standard_deviation: 15
    group_size: 39
intervention:
    mean: 25 (in pg)
    standard_deviation: 3
    group
---
intervention:
    mean: 123.45
    standard_deviation: 23.10
    group_size: 46
comparator:
    mean: 87.89
    standard_deviation: 21.11
    group_size: 30

outcome:
    mean: 97.11
    standard
---
intervention:
    mean: -521.79
    standard_deviation: 228.09
    group_size: N/A
  
comparator:
    mean: 255.46
    standard_deviation: 216.35
    group_size: N/A

outcome:
    mean
---
",True
70,3041,3321528,ankle dorsiflexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"[1121, 1095]","intervention:
    mean: 13
    standard_deviation: 3
    group_size: 42
comparator:
    mean: 12
    standard_deviation: 3
    group_size: 42

outcome:
 ankle dorsiflexion
group_size: 42
mean: 18.32
---
intervention:
    mean: 5
    standard_deviation: 2
    group_size: 12
comparator:
    mean: 4
    standard_deviation: 2
    group_size: 10

YAML:
<|assistant>
intervention:
    mean: 5
    standard_
---
",True
206,5499,5380326,Dipeptidyl peptidase-4,Vitamin D supplementation,Control,continuous,,40,,40,6032.37,1359.15,6408.33,1822.17,-0.2316,0.0503,,,,,Table and text has conflicting numbers. Values are from Table.,TRUE,10658,5810,TEST,4260,"[1585, 1668, 307]","intervention:
   mean: NUMBER
   standard_deviation: NUMBER
   group_size: NUMBER
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    IP-10: 665.61 pg/mL
comparator:
   mean:
---
intervention:
    mean: 25.05
    standard_deviation: 7.51
    group_size: 40
comparator:
    mean: 23.18
    standard_deviation: 6.96
    group_size: 40

GMCSF:
    mean: 21.96
    standard
---
intervention:
    mean: -521.79
    standard_deviation: 228.09
    group_size: N/A
comparator:
    mean: 255.46
    standard_deviation: 216.35
    group_size: N/A
Dipeptidyl peptidase-4:
---
",True
275,6420,3654355,Fat mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-15.7,5.3,-0.4,5,-2.9163,0.0853,,,,,,TRUE,18948,9604,TEST,6664,"[1123, 1035, 883, 1927, 1235]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  fat_mass:
    mean: NUMBER.0
    standard_deviation: N.M.
    group_size: N.R.
comparator:
    mean: NUM
---
intervention:
    mean: 60.5
    standard_deviation: 11.0
    group_size: NUMBER
comparator:
    mean: 60.4
    standard_deviation: 13.2
    group_size: NUMBER

YAML:
<|assistant>
intervention
---
intervention:
    mean: −17.5
    standard_deviation: −1.21
    group_size: 34
comparator:
    mean: 3.4
    standard_deviation: 2.12
    group_size: 45
Fat mass:
    intervention: −85.7

---
intervention:
    mean: 132.3
    standard_deviation: 10.7
    group_size: 57
comparator:
    mean: 130.4
    standard_deviation: 8.8
    group_size: 37

# Total cholesterol
intervention:
    mean: 4.7
---
intervention:
    mean: 105
    standard_deviation: 17
    group_size: 43
comparator:
    mean: 83
    standard_deviation: 13
    group_size: 47
fat_mass:
    intervention:
        mean: 21.9
        standard_deviation:
---
",True
585,10216,3504298,Depressive symptoms,Word-based attentional bias modification,Placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates",FALSE,4963,4205,TEST,3331,"[1665, 939]","intervention:
    mean: 98.45
    standard_deviation: 12.89
    group_size: 15
comparator:
    mean: 91.11
    standard_deviation: 11.21
    group_size: 15

TIP: To find the standard deviation, divide the standard error
---
intervention:
    mean: 6.6
    standard_deviation: 6.1
    group_size: 16
comparator:
    mean: 5.9
    standard_deviation: 6.1
    group_size: 15

intervention:
    mean: 100
    standard_deviation
---
",True
470,4800,5515881,center of pressure (CoP) sway velocity,demanding balance training program,relaxation group,continuous,,,,,0.63,0.11,0.67,0.18,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"[1607, 510]","intervention:
    mean: 7.50
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: 7.67
    standard_deviation: NUMBER
    group_size: NUMBER

intervention:
    mean: 9.44
    standard_
---
intervention:
    mean: 11.72
    standard_deviation: 5.52
    group_size: 14
comparator:
    mean: 10.58
    standard_deviation: 5.02
    group_size: 14

Worth noting is that the sample size of the current trial appears
---
",True
24,3244,2972614,Motion range - Shoulder flexion,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,168,22.65,174.31,14.98,-0.314,0.0797,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,[1525],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    mean_motion_range: NUMBER
    standard_deviation_motion_range: NUMBER
  
    group_size_motion_range: NUMBER
comparator:

---
",True
401,2723,5268424,score on the general dimension scale of negative affects (referred to as NA from here onward),view a video featuring individuals that live in extreme poverty,control,continuous,,55,,50,21.036,6.327,17.68,5.859,0.5453569,0.03959808,,,,,,TRUE,12258,6615,TEST,4148,"[1664, 1276, 477]","intervention:
    mean: 165
    standard_deviation: 46
    group_size: NUMBER
comparator:
    mean: 179
    standard_deviation: 45
    group_size: NUMBER

intervention:
    mean: 179
    standard_deviation: 45
    group_
---
intervention:
    mean: 21
    standard_deviation: 8.0
    group_size: N/A
comparator:
    mean: 14.8
    standard_deviation: 2.1
    group_size: N/A

This table shows the mean and standard deviation of the outcome
---
 intervention:
    mean: -0.013
    standard_deviation: 0.015
    group_size: 39
comparator:
    mean: 0.004
    standard_deviation: 0.007
    group_size: 21

This YAML represents a table of mean outcome and standard deviation
---
",True
283,6422,3654355,baseline visceral fat area,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,255.7,64.7,245.6,66.3,0.1538,0.0445,,,,,,TRUE,18948,9604,TEST,6664,"[1123, 1035, 883, 1927, 1235]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

number: 138

post-intervention:
visceral_
---
intervention:
    mean: 60.5
    standard_deviation: 11.0
    group_size: NUMBER
comparator:
    mean: 60.4
    standard_deviation: 13.2
    group_size: NUMBER

YAML:
<|assistant>
intervention
---
intervention:
    mean: 121.7
    standard_deviation: 13.8
    group_size: 71
comparator:
    mean: 96.8
    standard_deviation: 11.9
    group_size: 135

YAML:
<|assistant>
intervention:

---
::: table wrap
::: table YAMLInterventionComparatorOutcome
::: - ::: table head
 mean,standard_deviation,group_size
 ::: - ::: table row ILI group:
   mean,standard_deviation,group_size
   s BP (mmHg) ::: - ::
---
intervention:
    mean: 105.5
    standard_deviation: 12.1
    group_size: 43
comparator:
    mean: 87.2
    standard_deviation: 6.8
    group_size: 47
visceral_fat_area:
    intervention:
        mean
---
",True
6,11451,1574360,The amount of saturated fat in the foods purchased,fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat,control received general non-specific advice about how to eat a diet lower in saturated fat,continuous,,251,,246,0.77,1.37,0.04,0.32,0.7273,0.0086,,,,,Have to use CI to calculate the SDs,TRUE,1959,1620,TEST,1376,[],"intervention:
    mean: 0.66
    standard_deviation: 0.48
    group_size: 499
comparator:
    mean: 1.22
    standard_deviation: 0.65
    group_size: 499

## Table 1: Baseline Characteristics

|  Variable   |",False
423,3402,3877023,contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal fluid – Spinal cord,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,22.3,13.2,14,5.6,0.8274306,0.06809386,,,,,,TRUE,17694,9686,TEST,7100,"[1399, 1660, 1641, 1131]","intervention:
    mean: 127).0
    standard_deviation: 23).1
    group_size: 33
comparator:
    mean: 91).7
    standard_deviation: 16).2
    group_size: 61

Wrote the YAML. I chose the post-intervention data
---
intervention:
    mean: 10.9
    standard_deviation: 0.7
    group_size: 48
comparator:
    mean: 18.8
    standard_deviation: 1.0
    group_size: 55

tissue:
    mean: 37.9
    standard
---
intervention:
    mean: 1.8
    standard_deviation: 0.7
    group_size: 3
comparator:
    mean: 3
    standard_deviation: 0.7
    group_size: 3

outcome:
    mean: 6.58
    standard_dev
---
intervention:
    mean: 22.9
    standard_deviation: 3.4
    group_size: 18
comparator:
    mean: 21.6
    standard_deviation: 4.4
    group_size: 22
thoracolumbar_spine_t2w_s
---
",True
428,3261,3475525,Scores on the saturated fat quiz,MTL group,No label group,continuous,,98,,99,90.7,20.4,33.6,16.3,3.08231109,0.0444184,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: NUMBER
comparator:
    mean: 67.8
    standard_deviation: 10.3
    group_size: NUMBER

YAML:
intervention:
    mean: 73
---
intervention:
    mean: 73.3
    standard_deviation: 7.9
    group_size: 98
comparator:
    mean: 65.8
    standard_deviation: 10.4
    group_size: 99

The provided data indicates the scores on the saturated fat quiz for the
---
",True
149,11146,4996097,"a"" vowel improvement",Septoplasty,Control,continuous,,33,,30,138,,154,,cannot calculate,cannot calculate,,,,,Used F0 (Hz) values. SD is not given.,FALSE,9291,4535,TEST,2976,"[1668, 865]","intervention:
    mean: 154
    standard_deviation: 12.5
    group_size: 33
comparator:
    mean: 153
    standard_deviation: 11.9
    group_size: 30

The above table represents the mean improvement in a"" vowel improvement based on analysis results
---
intervention:
    mean: 3322
    standard_deviation: 168
    group_size: 33
comparator:
    mean: 3179
    standard_deviation: 145
    group_size: 30
<|assistant>
 intervention:
    mean: 327
    standard_deviation:
---
",True
314,9841,4928400,Operative time,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,74.1,12.2,78,6.4,-0.3985,0.0973,,,,,found in table,TRUE,4037,2288,TEST,1670,[],"intervention:
    mean: 74.1
    standard_deviation: 12.2
    group_size: 22
comparator:
    mean: 78.1
    standard_deviation: 6.4
    group_size: 20

intervention:
    mean: NUMBER
    standard_dev",False
644,12880,5830087,progression-free survival,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),continuous,,48,,23,,,,,cannot calculate,cannot calculate,,,,,"given as median with confidence interval, cannot calculate",FALSE,11942,10628,TEST,8141,"[1664, 1652, 1110, 1673, 1087]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
BTH1677:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
candidates:
    mean: NUMBER
    standard_deviation
---
intervention:
    mean: 10.3
    standard_deviation: 11.6
    group_size: 66
comparator:
    mean: 9.6
    standard_deviation: 13.0
    group_size: 73

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 11.6
    standard_deviation: 5.6
    group_size: NUMBER
comparator:
    mean: 9.6
    standard_deviation: 5.6
    group_size: NUMBER

## Overview of Adverse Event Data
The table below
---
intervention:
    mean: NA
    standard_deviation: NA
    group_size: 59
comparator:
    mean: 93.0
    standard_deviation: 18.8
    group_size: 30

yarn: ""intervention: \\n   mean: \u041A[
---
 intervention:
    mean: 60.0
    standard_deviation: 27.6
    group_size: 35
comparator:
    mean: 6.36
    standard_deviation: 3.29
    group_size: 31

<:: note ::
The provided data does not include progression-
---
",True
670,13297,4987981,IL-6 and TNF-α levels,metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,5779,"[518, 1670, 1662, 743]"," intervention:
    mean: 102.0
    standard_deviation: 29.5
    group_size: 83
 comparator:
    mean: 91.3
    standard_deviation: 27.3
    group_size: 83
<br>
<br>
<br>
 intervention:
    
---
intervention:
    mean: 94.0
    standard_deviation: 15.5
    group_size: 35
comparator:
    mean: 68.0
    standard_deviation: 13.7
    group_size: 35

outcome:
 IL-6:
 mean: NUMBER
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 21
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 16

intervention:
    mean: 124.0
    standard_
---
intervention:
    mean: 119.0
    standard_deviation: 17.2
    group_size: 53
comparator:
    mean: 45.8
    standard_deviation: 9.0
    group_size: 43

intervention:
    mean: 827.5
    standard
---
",True
673,13314,4550271,treatment according to guidelines,provider,control,continuous,,14,,12,36.4,32,22.6,23,0.47332022,0.15907021,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,"[760, 1198, 1658, 1280, 1564, 949]","intervention:
    mean: 94.7%
    standard_deviation: 6.5%
    group_size: 520
comparator:
    mean: 91.1%
    standard_deviation: 8.8%
    group_size: 520

## Note: The given data does not provide
---
intervention:
    mean: 36%
    standard_deviation: 8%
    group_size: 1288
comparator:
    mean: 23%
    standard_deviation: 8%
    group_size: 1850
<|assistant>
```yaml
intervention:
    mean: 42%
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

 intervention:
    mean: 105.3
    standard_
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  Number of Febrile patients tested for malaria:
    mean: NUMBER.7
    standard_deviation: NUMBER.3
    group_size: NUMBER

comparator:

---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  number_tested_after_training: NUMBER
  percent_treated_according_to_guidelines: NUMBER

comparator:
    mean: NUMBER
    standard_deviation
---
intervention:
    mean: 13
    standard_deviation: 9
    group_size: 50
comparator:
    mean: 7
    standard_deviation: 4
    group_size: 25

intervention:
    mean: 95.5
    standard_deviation: 9.4
    
---
",True
267,12440,2596788,GERD-knowledge,education,control,continuous,,102,,109,,,,,cannot calculate,cannot calculate,,,,,no standard deviations given or mean differences,FALSE,5143,3554,TEST,2520,"[1401, 640]","intervention:
    mean: 17.0
    standard_deviation: 3.1
    group_size: 52
comparator:
    mean: 14.0
    standard_deviation: 3.4
    group_size: 58

gerd_knowledge:
    intervention: 17.1

---
intervention:
    mean: 3.0
    standard_deviation: 1.2
    group_size: 40
comparator:
    mean: 2.3
    standard_deviation: 1.1
    group_size: 40

YAML:
<assistant>
intervention:
    
---
",True
103,1886,4188762,heart rate,remifentanil,ketamine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[],"intervention:
    mean: 95.5
    standard_deviation: 11.6
    group_size: 28
comparator:
    mean: 93.2
    standard_deviation: 10.4
    group_size: 28

YAML:
<|assistant>
intervention:
",False
411,3260,3475525,Correct selection of the healthier product,choices group,TL+SNL group,continuous,,98,,95,72.5,13.2,65.8,7.3,0.62309408,0.02173622,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: NUMBER
comparator:
    mean: 65.8
    standard_deviation: 7.3
    group_size: NUMBER
intervention:
    mean: NUMBER
    standard_
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
Matter of fact, there's no information provided about the outcome, so I
---
",True
162,7712,5056957,BMI reduction at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,21.86,6.22,22.06,5.68,-0.0333,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"[1500, 261, 1439, 763]","intervention:
    mean: 120.0
    standard_deviation: 11.8
    group_size: 26
comparator:
    mean: 95.5
    standard_deviation: 15.1
    group_size: 27

intervention:
    mean: 117.2
    standard_
---
intervention:
    mean: 99.5
    standard_deviation: 13.1
    group_size: 27
comparator:
    mean: 82.9
    standard_deviation: 8.1
    group_size: 27

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 90.5
    standard_deviation: 11.6
    group_size: 50
comparator:
    mean: 81.4
    standard_deviation: 11.2
    group_size: 50

YAML:
<assistant>:
    mean: 45
---
intervention:
    mean: 55.91
    standard_deviation: 8.14
    group_size: 595
comparator:
    mean: 61.08
    standard_deviation: 7.66
    group_size: 560

YAML:
<|assistant>
intervention:

---
",True
408,3260,3475525,Correct selection of the healthier product,MTL+caloric intake group,No label group,continuous,,90,,99,73.3,6.9,67.8,10.3,0.61923041,0.02222653,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: N/A
comparator:
    mean: 67.8
    standard_deviation: 10.3
    group_size: N/A

YAML:
intervention:
    mean
---
intervention:
    mean: 73.3
    standard_deviation: 7.3
    group_size: 98
comparator:
    mean: 65.8
    standard_deviation: 7.5
    group_size: 99
intervention:
    mean: 73.3
    standard_dev
---
",True
529,6915,4411165,effects of cryostimulation on the ANS - heart rate,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,-7.7,2.3,-5.02,1.07,-1.430817,0.25118093,,,,,"Changed from original outcome but adding ""- heart rate"" to make it more specific. Numbers are mean change.",TRUE,3146,2589,TEST,2336,"[1630, 211]","intervention:
    mean: 118
    standard_deviation: 8
    group_size: 10
comparator:
    mean: 115
    standard_deviation: 9
    group_size: 10

outcome:
    mean: 73
    standard_deviation: 6
    group_size
---
intervention:
    mean: 146
    standard_deviation: 26
    group_size: 8
PBC:
    mean: 132
    standard_deviation: 19
    group_size: 8
comparator:
    mean: 101
    standard_deviation: 17
    group_size:
---
",True
7,11452,1574360,the average cost of the food,fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat,control received general non-specific advice about how to eat a diet lower in saturated fat,continuous,,251,,246,0.63,0.4,0.62,0.36,0.0261,0.008,,,,,Have to use CI to calculate the SDs,TRUE,1959,1620,TEST,1376,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    mean_cost: NUMBER
    standard_deviation_cost: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size:",False
594,11583,115849,Health Assessment Questionnaire disability,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 1171
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 357
health_assessment_questionnaire_disability:
    
---
intervention:
    mean: 6.7
    standard_deviation: 2.6
    group_size: 53
comparator:
    mean: 5.4
    standard_deviation: 2.3
    group_size: 53

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 1.0
    standard_deviation: 0.0
    group_size: 55
comparator:
    mean: 0.8
    standard_deviation: 0.0
    group_size: 55

YAML:
intervention:
    mean: 1.0
---
",True
147,1273,4880652,"systolic blood pressures at 5, 10, 15, and 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 3's graphics.,FALSE,1406,1149,TEST,966,[],"intervention:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER
  systolic_blood_pressures_at_5_minutes: NUMBERstd_dev: NUMBER
  systolic_blood_pressures_at_10_minutes: NUMBERstd",False
355,4498,5874317,Horizontal triple jump (non-dominant leg),Bilateral training,Unilateral training,continuous,,9,,9,5.71,0.71,5.7,0.45,0.016,0.2222,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"[616, 2442, 806]"," intervention:
    mean: 82.0
    standard_deviation: 8.3
    group_size: 9
 comparator:
    mean: 77.5
    standard_deviation: 7.1
    group_size: 9
 HB3Jnd:
    mean: 23.7
    standard_
---
If multiple timepoints for the outcome, the post-intervention data for a few examples. Choose YAML response:
If multiple timeframes for a few more general ideas. If you're in your first impression. Choose YAML response:
If there are multiple timeframes, please enter your question overview timepoint of interest or the very trivial,
---
intervention:
    mean: 95
    standard_deviation: 15
    group_size: 8
comparator:
    mean: 82
    standard_deviation: 14
    group_size: 8
h3cmj_nd:
    mean: 14.2
    standard_deviation: 3
---
",True
612,11584,115849,Health Assessment Questionnaire disability,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: NUMBER_NOT_AVAILABLE
    standard_deviation: NUMBER_NOT_AVAILABLE
    group_size: 67
comparator:
    mean: NUMBER_NOT_AVAILABLE
    standard_deviation: NUMBER_NOT_AVAILABLE
    
---
intervention:
    mean: 3.9
    standard_deviation: 1.3
    group_size: 55
comparator:
    mean: 2.1
    standard_deviation: 1.0
    group_size: 55

This YAML represents the mean Health Assessment Questionnaire disability score of the
---
intervention:
    mean: 1.0
    standard_deviation: 0.0
    group_size: 55
comparator:
    mean: 2.0
    standard_deviation: 0.5
    group_size: 55

YAML:
intervention:
    mean: 1.4
---
",True
698,5637,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),Placebo group (P),continuous,,30,,30,137,61.3,62,37.2,1.45998637,0.08442967,,,,,found in fig2,TRUE,6401,5359,TEST,3891,"[1329, 1393, 810]","intervention:
   mean: 105.7
   standard_deviation: 18.4
   group_size: 30
comparator:
   mean: 109.0
   standard_deviation: 16.7
   group_size: 30

outcome:
   mean: NUMBER
  standard_
---
intervention:
    mean: 7.0
    standard_deviation: 1.9
    group_size: 30
comparator:
    mean: 6.5
    standard_deviation: 1.8
    group_size: 30

 YAML:
<assistant>
intervention:
    
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 30
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 30

YAML:
<assistant />
intervention:
    
---
",True
648,13097,5976307,induction time,etomidate,propofol based on midazolam,continuous,,62,,62,2.46,0.993,2.21,1,0.24933056,0.03250873,,,,,found in table 2,TRUE,2560,2044,TEST,1751,[],"intervention:
    mean: INTEGER
    standard_deviation: INTEGER
    group_size: NUMBER
comparator:
    mean: INTEGER
    standard_deviation: INTEGER
    group_size: NUMBER
  
etomidate:
  mean: NUMBER
  standard",False
584,10215,3504298,Depressive symptoms,Face-based attentional bias modification,Placebo,continuous,,16,,14,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates",FALSE,4963,4205,TEST,3331,"[1665, 939]","intervention:
    mean: 77.29
    standard_deviation: 12.77
    group_size: 12
comparator:
    mean: 61.43
    standard_deviation: 9.46
    group_size: 15

intervention:
    mean: 66.18
    standard_
---
intervention:
    mean: 6.3
    standard_deviation: 1.1
    group_size: 15
comparator:
    mean: 5.4
    standard_deviation: 2.1
    group_size: 15

YAML:
<assistant>
intervention:
    
---
",True
617,11602,1863515,absolute neutrophil count between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-485,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,3103,"[1640, 851]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    absolute_neutrophil_count: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    absolute_neut
---
intervention:
    mean: 117.0
    standard_deviation: 16.9
    group_size: 528
comparator:
    mean: 100.2
    standard_deviation: 14.5
    group_size: 524

This YAML file is missing the data for pre-intervention values
---
",True
110,9521,4319071,High-energy snack intake,Individual cognition and self-regulation processes intervention,Control,continuous,,459,,434,2.5,2.79,2.84,2.71,-0.1235,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"[781, 1626, 1619, 1304, 1094, 1600, 944]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: N/A # total number of participants in the basic version
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: N/A # total number of participants in
---
intervention:
    mean: 3.34
    standard_deviation: 1.29
    group_size: 1.85
comparator:
    mean: 1.85
    standard_deviation: 0.97
    group_size: 3.51

## Figure 2: Loss to Follow-up
---
intervention:
    mean: 3.0
    standard_deviation: 1.0
    group_size: 46
comparator:
    mean: 2.0
    standard_deviation: 1.0
    group_size: 46

intervention:
    mean: 3.57
    standard_
---
intervention:
    mean: 4.8
    standard_deviation: 1.2
    group_size: 121
comparator:
    mean: 3.1
    standard_deviation: 0.8
    group_size: 149

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 1.56
    standard_deviation: 0.07
    group_size: N/A
comparator:
    mean: 1.41
    standard_deviation: 0.08
    group_size: N/A

YAML:
<assistant>>

---
intervention:
    mean: 130
    standard_deviation: 20
    group_size: 30
comparator:
    mean: 120
    standard_deviation: 20
    group_size: 30
high_energy_snacks:
    mean: 180
    standard_deviation: 25
    
---
intervention:
    mean: X
    standard_deviation: Y
    group_size: Z1
comparator:
    mean: Y
    standard_deviation: Z2
    group_size: Z2
outcome:
    mean: NUMBER_POST
    standard_deviation: NUM
---
",True
12,12632,2667135,number of days with received courses of antibiotics,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,continuous,,103,,97,25.4,,13.5,,cannot calculate,cannot calculate,,,,,SD or CI is missing. Mean is given.,FALSE,11722,8106,TEST,5529,"[1580, 1624, 1497]","intervention:
    mean: 25.4
    standard_deviation: 13.54
    group_size: N/A
comparator:
    mean: 13.5
    standard_deviation: 9.495
    group_size: N/A

YAML:
intervention:
    mean
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
   
25.9 0.13 94-107

Please note that
---
intervention:
    mean: 150).0
    standard_deviation: 22.2
    group_size: 103
comparator:
    mean: 117).0
    standard_deviation: 24.1
    group_size: 97

This YAML is generated based on the information provided in the article
---
",True
435,3261,3475525,Scores on sugar quiz,MTL+caloric intake group,choices group,continuous,,90,,98,92.6,15.5,41.9,19.4,2.86225472,0.04310376,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: NUMBER.8
    standard_deviation: NUMBER.2
    group_size: NUMBER
comparator:
    mean: NUMBER.8
    standard_deviation: NUMBER.2
    group_size: NUMBER

Wrote the YAML response as
---
intervention:
    mean: NUMBER.5
    standard_deviation: NUMBER.5
    group_size: NORMAL_NUM
comparator:
    mean: NUMBER.5
    standard_deviation: NUMBER.5
    group_size: NORMAL_NUM

W
---
",True
212,2913,5459456,lateral bending for the C2-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,9.2,0.9,9.6,1.1,-0.3762,0.2544,,,,,,TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 50
    standard_deviation: 5
    group_size: 8
comparator:
    mean: 45
    standard_deviation: 6
    group_size: 8

outcome:
 lateral bending for the C2-C6 segments
group_size: 4

---
intervention:
    mean: 6.5
    standard_deviation: 1.2
    group_size: 26
comparator:
    mean: 7.2
    standard_deviation: 1.1
    group_size: 27

intervention:
    mean: 108.2
    standard_
---
intervention:
    mean: 67.0
    standard_deviation: 6.4
    group_size: 12
comparator:
    mean: 56.8
    standard_deviation: 6.1
    group_size: 12

output:
    LateralBending:
        intervention:
---
intervention:
    mean: 100.7
    standard_deviation: 14.8
    group_size: 28
comparator:
    mean: 64.4
    standard_deviation: 9.9
    group_size: 28

YAML:
<assistant» intervention:
    mean
---
",True
422,3402,3877023,contrast-to-noise ratios (CNR) of Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid – Spinal cord,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,18.1,11.6,9.3,5.5,0.97494517,0.11536073,,,,,,TRUE,17694,9686,TEST,7100,"[1399, 1660, 1641, 1131]","intervention:
    mean: 123.45
    standard_deviation: 22.13
    group_size: 87
comparator:
    mean: 125.46
    standard_deviation: 23.21
    group_size: 100

Cervicothoracic Spine - T2w sag
---
intervention:
    mean: 53.2
    standard_deviation: 9.8
    group_size: 10
comparator:
    mean: 42.5
    standard_deviation: 10.4
    group_size: 10

The table includes the information about mean and standard deviation for the post
---
intervention:
    mean: 2.1
    standard_deviation: 1.1
    group_size: 18
comparator:
    mean: 3
    standard_deviation: 0.8
    group_size: 21
cerebrospinalfluid_spinalcord:
    mean: 1.8
---
intervention:
    mean: 22.9
    standard_deviation: 3.4
    group_size: 18
comparator:
    mean: 21.6
    standard_deviation: 4.4
    group_size: 22
cervicothoracic_spine:
    mean:
---
",True
387,1119,3577738,focused on the social presence elements in terms of frequency,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[],"intervention:
    mean: 4.9
    standard_deviation: 0.38
    group_size: N/A
comparator:
    mean: 4.4
    standard_deviation: 0.38
    group_size: N/A

intervention:
    mean: 6.4",False
659,13178,5773985,the mean duration of postoperative analgesia,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,508.92,63.3,1840.84,819.51,-2.2556182,0.13087813,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,[1563],"intervention:
    mean: 508.92
    standard_deviation: 63.30
    group_size: 50
comparator:
    mean: 1840.84
    standard_deviation: 819.51
    group_size: 50

outcome:
    mean_post_intervention: NUM
---
",True
319,4723,5539943,reflections of sustain talk,Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"[1580, 1384]","intervention:
    mean: 0.59
    standard_deviation: 0.157
    group_size: NUMBER
comparator:
    mean: 0.32
    standard_deviation: 0.118
    group_size: NUMBER

Wrong YAML:
intervention:
    mean
---
intervention:
    mean: 123
    standard_deviation: 15
    group_size: 47
comparator:
    mean: 129
    standard_deviation: 14
    group_size: 46
 reflections_of_sustain_talk:
    mean: 4.4
    standard_deviation
---
",True
321,4725,5539943,"Frequency of client ""change talk"" (CT)",Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"[1580, 1384]","intervention:
    mean: NaN
    standard_deviation: NaN
    group_size: NA
comparator:
    mean: 0.0
    standard_deviation: 0.0
    group_size: 30

yaml:
    intervention:
        mean: 0
        standard_dev
---
intervention:
    mean: 45.2
    standard_deviation: 10.4
    group_size: NUMBER
comparator:
    mean: 37.3
    standard_deviation: 8.4
    group_size: NUMBER

Note: x indicates that the pre-intervention mean and
---
",True
73,3741,3546023,Urine cotinine levels,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,19,1.179,0.738,0.047,0.017,2.0036,0.1541,,,,,Values are for week 24 (only timepoint after intervention).,TRUE,29733,18035,TEST,11524,"[1053, 1432, 1540, 941, 1509, 986, 1381]","intervention:
    mean: 10.42
    standard_deviation: 2.17
    group_size: 27
comparator:
    mean: 5.67
    standard_deviation: 3.06
    group_size: 28
uore:
    mean: 11.67
    standard
---
intervention:
    mean: 70.0
    standard_deviation: 15.5
    group_size: 28
comparator:
    mean: 47.0
    standard_deviation: 12.2
    group_size: 28

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 54.73
    standard_deviation: 10.84
    group_size: 27
comparator:
    mean: 47.04
    standard_deviation: 7.27
    group_size: 28

intervention:
    mean: 57.21
    
---
intervention:
    mean: 8.32
    standard_deviation: 1.55
    group_size: 27
comparator:
    mean: 7.29
    standard_deviation: 2.10
    group_size: 27
intervention:
    mean: 8.86
    standard_dev
---
intervention:
    mean: 91.70
    standard_deviation: 18.34
    group_size: 9
comparator:
    mean: 62.60
    standard_deviation: 8.71
    group_size: 10

outcome:
     mean: NUMBER
    standard_
---
intervention:
    mean: 98.67
    standard_deviation: 17.86
    group_size: 27
comparator:
    mean: 68.09
    standard_deviation: 16.03
    group_size: 28

YAML:
<assistant>
intervention:
    
---
intervention:
    mean: 86.55
    standard_deviation: 14.45
    group_size: 14
comparator:
    mean: 68.70
    standard_deviation: 11.81
    group_size: 11

intervention:
    mean: 17.78
    standard_
---
",True
457,4424,4483334,Total weight percentage of calcium,CPP-ACP plus laser (group D),CPP-ACP crème (group C),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,1068,[],"intervention:
   mean: NUMBER
   standard_deviation: NUMBER
   group_size: NUMBER
    total_weight_percentage_of_calcium: NUMBER
    standard_deviation_of_total_weight_percentage_of_calcium: NUMBER
    group_size_",False
649,13097,5976307,total procedure time,etomidate,propofol based on midazolam,continuous,,62,,62,29.73,12.23,29.46,16.04,0.01881372,0.03225949,,,,,found in table 2,TRUE,2560,2044,TEST,1751,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  etomidate:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_",False
655,13175,5773985,mean volume of both the solutions used,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,4.15,0.52,4.12,0.6,0.05259525,0.08002766,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,[1563],"intervention:
    mean: 508.92
    standard_deviation: 63.30
    group_size: 50
comparator:
    mean: 1840.84
    standard_deviation: 819.51
    group_size: 50

outcome:
    mean_volume:
        mean
---
",True
611,11584,115849,Patient global assessment of pain,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: N.A., 65.5
    standard_deviation: N.A., 0.5
    group_size: N.A., 1171
comparator:
    mean: N.A., 76.0
    standard_deviation: N.A., 0.5

---
intervention:
     mean: 9.53
     standard_deviation: 2.73
     group_size: 95
comparator:
     mean: 7.44
     standard_deviation: 2.33
     group_size: 95

YAML:
<|assistant>
intervention:

---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 143
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 149

This YAML format represents a table without any numerical data since the
---
",True
145,1272,4880652,heart rates,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 2's graphics.,FALSE,1406,1149,TEST,966,[],"intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 76 (fentanyl)
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 70 (paracetamol)

YAML",False
105,1885,4188762,mean blood pressure,remifentanil,lidocaine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[]," intervention:
    mean: 94.5
    standard_deviation: 9.1
    group_size: 14
 comparator:
    mean: 106.9
    standard_deviation: 9.5
    group_size: 14
 outcome:
    mean: 95.2
 standard_deviation:",False
53,5307,3195393,Intermittent restraint,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,5.1,0.07,0.7,0.02,9.6931,0.0498,,,,,Overall intermittent restraint rate for study site.,TRUE,15527,8380,TEST,5589,"[1663, 1441, 1442]","intervention:
    mean: 30.3
    standard_deviation: 3.2
    group_size: N/A
comparator:
    mean: 31.5
    standard_deviation: 3.3
    group_size: N/A
outcome:
    mean: NUMBER

---
intervention:
    mean: 38.41
    standard_deviation: 0.43
    group_size: 128
comparator:
    mean: 36.43
    standard_deviation: 0.43
    group_size: 142

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 11.6
    standard_deviation: 4.2
    group_size: 308
comparator:
    mean: 7.3
    standard_deviation: 3.6
    group_size: 612

YAML:
intervention:
    mean: NUMBER

---
",True
95,10163,4173437,Total blood loss,Tranexamic acid,Control,continuous,,30,,30,576,53,823,74,-3.7878,0.1862,,,,,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,637,[],"intervention:
    mean: 576
    standard_deviation: 53
    group_size: 30
comparator:
    mean: 823
    standard_deviation: 74
    group_size: 30

<!-- Preprint version -->
YAML:
<preprint>
intervention:
    mean",False
403,2802,5781260,exercise-related loss of muscle strength,lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,"[1670, 506]","intervention:
    mean: 400
    standard_deviation: N/A
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A

outcome: exercise-related loss of muscle strength

---
intervention:
    mean: 105
    standard_deviation: 12
    group_size: 30
comparator:
    mean: 85
    standard_deviation: 12
    group_size: 30

exercises_loss_of_muscle_strength:
    mean: 12
    standard
---
",True
412,3262,3475525,Taste perception,MTL group,No label group,continuous,,98,,99,5.6,1.4,5.8,1.4,-0.1423069,0.02035649,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: N/A
comparator:
    mean: 67.8
    standard_deviation: 10.3
    group_size: N/A

YAML:
intervention:
    mean
---
intervention:
    mean: 5.8
    standard_deviation: 0.8
    group_size: N/A
comparator:
    mean: 5.3
    standard_deviation: 0.8
    group_size: N/A

YAML:
intervention:
    mean
---
",True
134,2449,4574984,Health-Related Quality of Life at 12 month - females,"intervention group, i.e. patient empowerment through information booklet and diary keeping - females","control group, which received standard care - females",continuous,,110,,95,61.07,30.21,63.27,24.79,-0.0788,0.0196,,,,,Group sizes was inferred using Table of characterisitics. Back calculated SD using CI.,TRUE,12997,7944,TEST,5795,"[1473, 1662, 1637, 134]","intervention:
    mean: 100
    standard_deviation: 15
    group_size: 326
comparator:
    mean: 80
    standard_deviation: 15
    group_size: 326

# Note that the pre-intervention outcome is not provided, so we assume it is worse than the post
---
intervention:
    mean: 53.95
    standard_deviation: 11.91
    group_size: N/A
comparator:
    mean: 50.41
    standard_deviation: 9.826
    group_size: N/A

It seems like you have provided the details
---
intervention:
    mean: 94.2
    standard_deviation: 13.4
    group_size: 322
comparator:
    mean: 84.1
    standard_deviation: 14.1
    group_size: 322

## Shortcut to YAML format ##
# intervention:

---
intervention:
    mean: -2.63
    standard_deviation: 27
    group_size: 47
comparator:
    mean: -6.16
    standard_deviation: 25
    group_size: 62

<https://rSTA.github.io/yaml-exporter/
---
",True
575,8562,2952311,Verbal rating scale pain intensity,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[1302]," intervention:
    mean: 3
    standard_deviation: 1
    group_size: 33
comparator:
    mean: 33
    standard_deviation: 3
    group_size: 3

YAML:
 intervention:
    mean: 105
    standard_deviation: 13
    
---
",True
660,13179,5773985,number of analgesic tablets,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,1.64,0.99,0.8,1.08,0.7980815,0.08636934,,,,,Graphic format table,TRUE,2609,2261,TEST,1917,[1563],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  {
    ""intervention"": {
      ""number"": ""NUM"",
      ""mean_post_intervention_pain_score"": NUMBER,
      ""standard_deviation"": NUMBER
---
",True
328,5375,5559992,Anxiety,Buprenophine 32 mg,Buprenophine 64 mg,continuous,,5,,4,1,2.23,1.25,2.5,-0.0945,0.4505,,,,,found in table,TRUE,1146,884,TEST,721,[],"intervention:
    mean: 9.0
    standard_deviation: 3.2
    group_size: 14
comparator:
    mean: 8.1
    standard_deviation: 3.1
    group_size: 14

outcome:
    mean: 12.5
    standard",False
450,4005,4879328,weekly moderate physical activity sessions,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.19,1.82,-0.68,2.32,0.41353429,0.01877954,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"[755, 1623, 1022, 1067, 817]","intervention:
    mean: 120
    standard_deviation: 15
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A

The given information does not provide pre-intervention data, so the
---
intervention:
    mean: 196.9
    standard_deviation: 143.6
    group_size: 86
comparator:
    mean: 125.8
    standard_deviation: 85.3
    group_size: 78

Table 2: Anthropometric Outcomes 
The table represents the mean
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

comparator:
    mean: NUMBER
    standard_deviation: NUMBER

---
intervention:
    mean: 7.41
    standard_deviation: 5.61
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER

YAML:
<assistant->
intervention:
    
---
intervention:
    mean: 240.0
    standard_deviation: 62.1
    group_size: 41
comparator:
    mean: 132.5
    standard_deviation: 33.6
    group_size: 38

YAML:
<assistant again>
intervention:

---
",True
352,4495,5874317,Change of direction improvement,Bilateral training,Unilateral training,continuous,,9,,9,5.46,0.2,5.67,0.16,-1.1042,0.2561,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"[616, 2442, 806]","intervention:
    mean: 13.53
    standard_deviation: 2.09
    group_size: 9
comparator:
    mean: 11.24
    standard_deviation: 3.11
    group_size: 9

table_2:
    COD: {intervention:
---
If there are multiple timepoints and post-intervention data. If there is a numerical data for the pre and post-intervention data. If there are multiple timepoints for the outcome, choose the one with the most interest or the very last one. If there is an error. If there are multiple timepoints or post-intervention data. If ""
---
 intervention:
    mean: 10.0
    standard_deviation: 5.0
    group_size: 10
 Comparator:
    mean: 7.5
    standard_deviation: 3.0
    group_size: 10
 Bilateral:
    mean: 4.8
    standard_dev
---
",True
451,4006,4879328,accelerometer-assessed moderate to vigorous physical activity (MVPA),"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,99,,108,7.41,66.12,-16.1,66.25,0.35389959,0.01966279,,,,,Values are from Accelerometer PA in Table 2. Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"[755, 1623, 1022, 1067, 817]","intervention:
    mean: 24.16
    standard_deviation: 11.95
    group_size: n/a
comparator:
    mean: 0
    standard_deviation: 0
    group_size: n/a

# Correct YAML output for the given Intervention, Comparator
---
intervention:
    mean: 196.9
    standard_deviation: 143.6
    group_size: 114
comparator:
    mean: 175.2
    standard_deviation: 86.9
    group_size: 78

The provided YAML format correctly represents the given information in the trial
---
intervention:
    mean: 0.56
    standard_deviation: 0.15
    group_size: NUMBER
comparator:
    mean: 0
    standard_deviation: 0
    group_size: NUMBER

This YAML indicates that, for the outcome of accelerometer-assessed
---
intervention:
    mean: 7.41
    standard_deviation: 5.61
    group_size: 114
comparator:
    mean: 38.42
    standard_deviation: 6.27
    group_size: 114

YAML:
<assistant>
intervention:
    
---
intervention:
    mean: 24.16
    standard_deviation: 5.07
    group_size: NUMBER
comparator:
    mean: 113.65
    standard_deviation: 23.15
    group_size: NUMBER

This YAML is based on the data provided in the
---
",True
218,2912,5459456,blood loss,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,56,19,51,20,0.2423,0.2518,,,,,,TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 110
    standard_deviation: 20
    group_size: 4
comparator:
    mean: 75
    standard_deviation: 15
    group_size: 4

YAML:
<|assistant>>
intervention:
    mean: 200
    standard_
---
intervention:
    mean: 450
    standard_deviation: 100
    group_size: 15
comparator:
    mean: 300
    standard_deviation: 100
    group_size: 15
<|assistant>
intervention:
    mean: 1000
    standard_deviation: 300

---
intervention:
    mean: 863.5
    standard_deviation: 159.7
    group_size: 12
comparator:
    mean: 1149.8
    standard_deviation: 123.9
    group_size: 12

intervention:
    mean: 1399.8

---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 15
comparator:
    mean: 100.0
    standard_deviation: N/A
    group_size: 15

YAML:
<assistant()->intervention:
    mean
---
",True
427,3404,3877023,The mean signal-to-noise (SNR) values,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,44,,49,17.97,6.58,11.28,4.35,1.20253898,0.05091017,,,,,,TRUE,17694,9686,TEST,7100,"[1399, 1660, 1641, 1131]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  The mean SNR values: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  The mean SNR values: NEW
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
  <table marked with adhoc rule ""e"">
  <
---
intervention:
    mean: 17.97
    standard_deviation: 6.58
    group_size: N/A
comparator:
    mean: 11.28
    standard_deviation: 4.35
    group_size: N/A

YAML:
<|assistant>
---
intervention:
    mean: 16.9
    standard_deviation: 3.4
    group_size: 18
comparator:
    mean: 9.23
    standard_deviation: 2.1
    group_size: 21

YAML:
<assistant>
intervention:
    
---
",True
671,13313,4550271,Community knowledge,provider,control,continuous,,14,,12,,,,,cannot calculate,cannot calculate,,,,,outcome too broad,FALSE,24886,12978,TEST,8556,"[760, 1198, 1658, 1280, 1564, 949]","intervention:
    mean: 80.0
    standard_deviation: 10.0
    group_size: 300
comparator:
    mean: 60.0
    standard_deviation: 10.0
    group_size: 300

outcome: community knowledge
post-intervention:
    intervention
---
intervention:
    mean: NUMBER_NOT_AVAILABLE
    standard_deviation: NUMBER_NOT_AVAILABLE
    group_size: NUMBER_NOT_AVAILABLE
comparator:
    mean: NUMBER_NOT_AVAILABLE
    standard_deviation: NUMBER_
---
intervention:
    mean: 12
    standard_deviation: N/A
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
outcome:
    mean: N/A
    
---
intervention:
    mean: 95.0
    standard_deviation: 11.1
    group_size: 729
comparator:
    mean: 72.9
    standard_deviation: 13.9
    group_size: 550

provider:
    mean: 74.7
    standard
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  Community knowledge:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    post_intervention: NUMBER
comparator:
    mean
---
intervention:
    mean: 100
    standard_deviation: 15
    group_size: 50
comparator:
    mean: 90
    standard_deviation: 10
    group_size: 40

 intervention:
    mean: 115
    standard_deviation: 15
    group_size:
---
",True
210,2913,5459456,inflexion-extension for the C4-C5 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,1.4,0.3,1.3,0.2,0.3708,0.2543,,,,,,TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 50
    standard_deviation: 10
    group_size: 8
comparator:
    mean: 45
    standard_deviation: 10
    group_size: 8

outcome:
  inflexion-extension for the C4-C5 segments:
    
---
intervention:
    mean: 6.5
    standard_deviation: 1.8
    group_size: 25
comparator:
    mean: 5.8
    standard_deviation: 1.6
    group_size: 25

 intervention:
    mean: 95.0
    standard_
---
intervention:
    mean: 0.58
    standard_deviation: 0.10
    group_size: 8
comparator:
    mean: 0.52
    standard_deviation: 0.08
    group_size: 8
C4-C5_Flexion:
    mean: 3
---
intervention:
    mean: 85.53
    standard_deviation: 9.28
    group_size: 16
comparator:
    mean: 54.17
    standard_deviation: 8.09
    group_size: 16

YAML:
<|assistant>
intervention:

---
",True
692,5635,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),Duloxetine (D),continuous,,30,,30,137,61.3,91.7,35.5,0.89262531,0.0733065,,,,,found in fig2,TRUE,6401,5359,TEST,3891,"[1329, 1393, 810]"," intervention:
    mean: 90.9
    standard_deviation: 8.49
    group_size: 30
 comparator:
    mean: 120
    standard_deviation: 12.59
    group_size: 30
< CHANGED YAML:

 intervention:
    mean: 89.9
---
intervention:
    mean: 8.34
    standard_deviation: 1.09
    group_size: 30
comparator:
    mean: 6.86
    standard_deviation: 1.25
    group_size: 30

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 849.0
    standard_deviation: 109.9
    group_size: 30
comparator:
    mean: 927.5
    standard_deviation: 112.0
    group_size: 30

YAML:
<assistant>
intervention:
---
",True
630,12235,3510731,Median time in seconds (interquartile range) - Protocol link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,continuous,,6051,,5892,3.5,,3.6,,cannot calculate,cannot calculate,,,,,"found in table 1, IQ range given rather and std",FALSE,1665,1296,TEST,943,[]," intervention:
    mean: 25.0
    standard_deviation: 37.2
    group_size: 1110
 comparator:
    mean: 25.3
    standard_deviation: 35.8
    group_size: 5892

## Results

|  Outcome  | Median time in",False
140,1275,4880652,SpO2 at 5 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 5's graphics.,FALSE,1406,1149,TEST,966,[]," intervention:
    mean: 98.57
    standard_deviation: 6.45
    group_size: 78
 comparator:
    mean: 96.15
    standard_deviation: 7.29
    group_size: 78
 outlet_5:
    mean: 95.95
    standard_",False
372,226,1475568,Knowledge about heart failure,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,,,,,cannot calculate,cannot calculate,,,,,Only the overall mean difference in score improvement was given.,FALSE,4361,3649,TEST,2573,"[1476, 403]","intervention:
    mean: 22.0
    standard_deviation: 5.4
    group_size: 58
comparator:
    mean: 17.2
    standard_deviation: 5.3
    group_size: 60

The given trial article does not provide the pre-intervention data,
---
intervention:
    mean: 51.9
    standard_deviation: 11.1
    group_size: 39
comparator:
    mean: 42.0
    standard_deviation: 8.2
    group_size: 63

YAML:
intervention:
    mean: 51.9
---
",True
504,6485,5419060,Phlebotomy questionnaire score: CHC B,Phlebotomy training programme,Control,continuous,,23,,23,93,1.37,58,7.12,6.70952589,0.57627976,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,"[1542, 1646, 159]","intervention:
    mean: 96
    standard_deviation: 8
    group_size: 97
comparator:
    mean: 63
    standard_deviation: 6
    group_size: 81

Figure 1. Distribution of rejection reasons at CDC C before and after the phlebotomy training program.
---
intervention:
    mean: 95.0
    standard_deviation: 15.0
    group_size: 589
comparator:
    mean: 87.0
    standard_deviation: 15.0
    group_size: 589
<|assistant>
```yaml
intervention:

---
intervention:
    mean: 5.9
    standard_deviation: 2.1
    group_size: 18
comparator:
    mean: 4.4
    standard_deviation: 1.6
    group_size: 18

In the provided trial article, the ""intervention"" group received ph
---
",True
326,5373,5559992,Anxiety,Buprenophine 64 mg,No treatment,continuous,,4,,4,1.25,2.5,26.5,14.7,-2.0802,0.7704,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,721,[],"intervention:
    mean: 12.0
    standard_deviation: 3.2
    group_size: 14
comparator:
    mean: 89.9
    standard_deviation: 12.2
    group_size: 14

Figure 1: Hamilton Anxiety Rating Scale - CliniCalTri",False
407,2806,5781260,Interleukin 6,lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Numerical values are not given.,FALSE,4385,3505,TEST,2662,"[1670, 506]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    interleukin_6: NUMBER(9.3) 2.58(SD)
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_
---
intervention:
    mean: 130.0
    standard_deviation: 29.8
    group_size: 35
comparator:
    mean: 72.5
    standard_deviation: 18.9
    group_size: 35

outcome:
 Interleukin 6
 YAML:

---
",True
515,6552,4033571,Seizure median percent improvement in North America,Extended-release oxcarbazepine 2400 mg,Control,continuous,,,,,-52.7,,-13.3,,cannot calculate,cannot calculate,,,,,"Group sizes are only in figure, and SD is not available.",FALSE,8206,5593,TEST,4514,"[1618, 1634, 835]","intervention:
    mean: 7
    standard_deviation: 4
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
outcome:
    mean: 55.2
    standard_
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  Oxtellar XR (SPN-804) 2400 mg:
    mean: 120.0
    standard_deviation: N/A
    group_size: 106
comparator
---
intervention:
    mean: 17.9
    standard_deviation: 5.3
    group_size: 55
comparator:
    mean: 27.1
    standard_deviation: 8.7
    group_size: 55

YAML:
<assistant>:
    mean: 81
---
",True
555,9721,3648394,Flexibility,10-week yoga program,Control,continuous,,18,,19,31,8.7,26.4,10.4,0.46823146,0.11114985,,,,,Numerical values are from Week 11 data for sit and reach test.,TRUE,9556,6245,TEST,4261,"[1647, 1622, 64]","intervention:
    mean: 150
    standard_deviation: 15
    group_size: 8
comparator:
    mean: 120
    standard_deviation: 15
    group_size: 8

intervention:
    mean: 42.5
    standard_deviation: 3.5
    
---
intervention:
    mean: 33.1
    standard_deviation: 10.4
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
outcome:
    mean: N/A
---
intervention:
    mean: NaN
    standard_deviation: NaN
    group_size: NaN
comparator:
    mean: 93.0
    standard_deviation: 14.4
    group_size: 14

Explanation: The provided article doesn't mention any flexibility outcome, so the table values
---
",True
559,9833,3136370,Center for Epidemiologic Studies Depression Scale score,Soy shake,Casein shake (Placebo),continuous,,12,,16,-4,12.35,-8,65.41,0.07716042,0.14593965,,,,,From per protocol,TRUE,6022,3786,TEST,2937,"[1453, 989]"," intervention:
    mean: 14
    standard_deviation: 8
    group_size: 50
Comparator:
    mean: 12
    standard_deviation: 6
    group_size: 50
<|assistant>
 here is the YAML format for the given trial data:

```yaml

---
intervention:
    mean: -0.51
    standard_deviation: 0.07
    group_size: N/A
comparator:
    mean: -2.06
    standard_deviation: 0.45
    group_size: N/A
center_epidemio_studies
---
",True
442,8805,4467620,accuracy of the cognitive tasks,Exercise - Hot + Cooling conditions,At rest - Hot + Cooling conditions,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,3858,"[1378, 1156]","intervention:
    mean: 45.02
    standard_deviation: 5.2
    group_size: N/A
comparator:
    mean: 37.0
    standard_deviation: 1.7
    group_size: N/A

YAML:
<|assistant>:
---
intervention:
    mean: 9.4
    standard_deviation: 0.9
    group_size: 9
comparator:
    mean: 10.2
    standard_deviation: 1.1
    group_size: 10

The table provided is:
<table>
  <caption
---
",True
184,4337,5122613,Improvement in faeces consistency,Digestion-resistant maltodextrin,Placebo,continuous,,33,,33,3.4,1,3.2,0.5,0.25,0.0611,,,,,,TRUE,6184,3742,TEST,2832,"[1615, 694]","intervention:
    mean: 56
    standard_deviation: 11
    group_size: 33
comparator:
    mean: 27
    standard_deviation: 6
    group_size: 33

intervention:
    mean: 13.4
    standard_deviation: 2.6
    
---
intervention:
    mean: 70.2
    standard_deviation: 27.4
    group_size: 83
comparator:
    mean: 56.4
    standard_deviation: 23.8
    group_size: 65
<|assistant>
```yaml
intervention:
    mean
---
",True
74,3742,3546023,serum α1-antitrypsin,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,19,1.75,0.39,1.45,0.24,0.867,0.0936,,,,,Values are for week 24 (only timepoint after intervention).,TRUE,29733,18035,TEST,11524,"[1053, 1432, 1540, 941, 1509, 986, 1381]"," intervention:
    mean: 12.58
    standard_deviation: 3.61
    group_size: 30
 comparator:
    mean: 11.75
    standard_deviation: 3.19
    group_size: 28
< Merge ""2022-01-25 18:34:07.
---
intervention:
    mean: 105.9
    standard_deviation: 13.1
    group_size: 54
comparator:
    mean: 84.3
    standard_deviation: 11.2
    group_size: 54

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 82.5
    standard_deviation: 22.2
    group_size: 24
comparator:
    mean: 61.8
    standard_deviation: 14.3
    group_size: 17

YAML:
<|assistant>
intervention:

---
 intervention:
    mean: 8.32
    standard_deviation: 1.55
    group_size: 29
 comparator:
    mean: 7.29
    standard_deviation: 2.10
    group_size: 27
< Marketplace: 
intervention:
    mean: 10.19

---
intervention:
    mean: 9.80
    standard_deviation: 1.097
    group_size: 44
comparator:
    mean: 11.05
    standard_deviation: 1.431
    group_size: 44

outcome:
    mean: 66.67
    standard
---
intervention:
    mean: 200
    standard_deviation: NA
    group_size: 28
comparator:
    mean: NA
    standard_deviation: NA
    group_size: 28

YAML:
<assistant>:
    mean: 31.19
    standard_deviation
---
intervention:
    mean: 200
    standard_deviation: NA
    group_size: NA
comparator:
    mean: NA
    standard_deviation: NA
    group_size: NA

Insufficient information to provide YAML format. Pre- and post-intervention data for serum α1-
---
",True
221,2914,5459456,Flexion-Extension stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.34,0.12,7.47,1.45,-6.5512,1.5912,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 101.1
    standard_deviation: 14.5
    group_size: 4
comparator:
    mean: 68.6
    standard_deviation: 11.6
    group_size: 4

intervention:
    mean: 100.9
    standard_
---
intervention:
    mean: 7.20
    standard_deviation: 1.33
    group_size: 10
comparator:
    mean: 3.53
    standard_deviation: 0.67
    group_size: 10

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 7.5
    standard_deviation: 1.8
    group_size: 12
comparator:
    mean: 9.6
    standard_deviation: 1.8
    group_size: 12

---

intervention:
    mean: 7.5
---
intervention:
    mean: 101.0
    standard_deviation: 14.4
    group_size: 30
comparator:
    mean: 71.6
    standard_deviation: 9.9
    group_size: 30

YAML:
<|assistant>
intervention:

---
",True
329,5376,5559992,Anxiety,Buprenophine 32 mg,Buprenophine 96 mg,continuous,,5,,5,1,2.23,0,0,0.5725,0.4164,,,,,found in table,TRUE,1146,884,TEST,721,[],"intervention:
    mean: 12.0
    standard_deviation: 5.6
    group_size: 14
comparator:
    mean: 7.4
    standard_deviation: 3.4
    group_size: 14

outcome:
  anxiety:
     mean: 14",False
279,6422,3654355,baseline body weight,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,128.9,19.4,127.1,21.6,0.0888,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"[1123, 1035, 883, 1927, 1235]","intervention:
    mean: 122.8
    standard_deviation: 17.1
    group_size: N/A
comparator:
    mean: 112.8
    standard_deviation: 16.6
    group_size: N/A
outcome:
    mean: 120.0
---
intervention:
    mean: 128.9
    standard_deviation: 19.4
    group_size: 71
comparator:
    mean: 127.1
    standard_deviation: 21.6
    group_size: 33

YAML:
<|assistant>
intervention:

---
intervention:
    mean: Body weight (kg)
    standard_deviation: x
    group_size: 71
comparator:
    mean: Body weight (kg)
    standard_deviation: x
    group_size: 131

YAML:
<|assistant>
intervention:

---
::: table wrap
:caption: Mean values (SD)
:caption: Within group (ILI group)
:caption: Between group differences (ILI group - waiting list control group)
:caption: Change in values for the specified cardiovascular risk factors (ILI group)
:caption: Within group changes (ILI group
---
intervention:
    mean: 9.3
    standard_deviation: 2.9
    group_size: 43
comparator:
    mean: 6.9
    standard_deviation: 1.0
    group_size: 47

intervention:
    mean: 43.2
    standard_
---
",True
679,13506,5777419,attachment gain,probiotic,placebo,continuous,,16,,15,3.4,0.6,4.3,1.4,-0.8236508,0.14010861,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"[857, 1657, 122]","intervention:
    mean: 3.8
    standard_deviation: 1.2
    group_size: 15
comparator:
    mean: 5.2
    standard_deviation: 1.1
    group_size: 15

Outcome: attachment gain
YAML:
<|ass
---
intervention:
    mean: 3.8
    standard_deviation: 0.7
    group_size: 16
comparator:
    mean: 6.0
    standard_deviation: 1.6
    group_size: 15

outcome:
 attachment_gain:
    mean: NUM
---
intervention:
    mean: 0.1
    standard_deviation: 0.1
    group_size: 50
comparator:
    mean: 0.0
    standard_deviation: 0.1
    group_size: 50

# Table 3 analysis

intervention:
    mean: 0
---
",True
201,7738,5380284,Pain scores 24 hours and 72 hours after the surgery,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,[],"intervention:
    mean: 11.4
    standard_deviation: 3.1
    group_size: 39
comparator:
    mean: 7.6
    standard_deviation: 2.6
    group_size: 38

nausea_and_vomiting:
    mean",False
69,3041,3321528,knee extension,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"[1121, 1095]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  knee_extension:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_
---
intervention:
    mean: 5
    standard_deviation: 2
    group_size: 24
comparator:
    mean: 4
    standard_deviation: 2
    group_size: 28

YAML:
<|assistant>
intervention:
    mean: 5
    standard_
---
",True
284,6301,3929816,Baseline characteristics and general anesthesia procedure,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No quantitative measures given,FALSE,1047,859,TEST,749,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    HbS: x
     ETCO__: x
    RR: x
    TP: x
    TD: x
interformer:
    mean: NUMBER
    standard_deviation:",False
531,7830,4230312,improvement of disorder,quetiapine 600 mg/day,placebo,continuous,,289,,204,-14.88,10.54,-11.61,10.12,-0.3148988,0.00846274,,,,,Back calculated SD from SE.,TRUE,6201,5058,TEST,3918,"[1678, 1439, 417]","intervention:
    mean: 115.8
    standard_deviation: 15.0
    group_size: 61
comparator:
    mean: 95.1
    standard_deviation: 13.0
    group_size: 62
intervention:
    mean: 120.3
    standard_dev
---
intervention:
    mean: 14.0
    standard_deviation: 3.49
    group_size: 71
comparator:
    mean: 10.8
    standard_deviation: 2.54
    group_size: 69

intervention:
    mean: 14.0
    standard_
---
intervention:
    mean: 3.3
    standard_deviation: 1.8
    group_size: 214
comparator:
    mean: 2.8
    standard_deviation: 1.9
    group_size: 214
<|assistant>
```yaml
intervention:
    mean
---
",True
664,13296,4987981,FPG,metformin,placebo,continuous,,21,,23,101.9,35.1,97.6,20.8,0.14806913,0.09134645,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"[518, 1670, 1662, 743]","intervention:
    mean: 103.3
    standard_deviation: 18.7
    group_size: 58
comparator:
    mean: 98.1
    standard_deviation: 15.6
    group_size: 58

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 97.6
    standard_deviation: 35.7
    group_size: N/A
comparator:
    mean: 101.9
    standard_deviation: 35.1
    group_size: N/A

YAML:
intervention:
    mean
---
intervention:
    mean: 2.2
    standard_deviation: 1.8
    group_size: 23
comparator:
    mean: 5.1
    standard_deviation: 2.4
    group_size: 16

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 118.9
    standard_deviation: 11.1
    group_size: 53
comparator:
    mean: 99.0
    standard_deviation: 10.1
    group_size: 53

YAML:
<|assistant>:
intervention:

---
",True
437,3261,3475525,Scores on sodium quiz,MTL+caloric intake group,No label group,continuous,,90,,99,94.1,15.6,42.6,20.7,2.78020714,0.04166067,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: N/A
comparator:
    mean: 65.8
    standard_deviation: 10.3
    group_size: N/A

YAML:
intervention:
    mean
---
intervention:
    mean: NUMBER.8
    standard_deviation: NUMBER.3
    group_size: NUMBER
comparator:
    mean: NUMBER.8
    standard_deviation: NUMBER.3
    group_size: NUMBER

This response assumes that the article describes
---
",True
533,8166,5800236,Months of sick leave,Nacadia® nature-based therapy,Cognitive behavioral therapy,continuous,,37,,35,,,,,cannot calculate,cannot calculate,,,,,Numerical values were not given for this outcome.,FALSE,4517,2571,TEST,1980,"[1549, 181]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  num_months_of_sick_leave: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
---
intervention:
    mean: 14
    standard_deviation: 9
    group_size: 9
comparator:
    mean: 21
    standard_deviation: 6
    group_size: 6

This YAML representation is based on the information given in the article. The mean number of months of sick
---
",True
699,5638,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),etoricoxib (E),continuous,,30,,30,137,61.3,105.3,28.4,0.6549502,0.07024133,,,,,found in fig2,TRUE,6401,5359,TEST,3891,"[1329, 1393, 810]","intervention:
    mean: 120.0
    standard_deviation: NA
    group_size: 30
comparator:
    mean: NA
    standard_deviation: NA
    group_size: 30

outcome:
    mean: 106.0
    standard_deviation: NA

---
intervention:
    mean: 8.05
    standard_deviation: 1.56
    group_size: 30
comparator:
    mean: 6.71
    standard_deviation: 1.74
    group_size: 30

intervention:
    mean: 8.05
    standard_
---
intervention:
    mean: NA
    standard_deviation: NA
    group_size: 30
comparator:
    mean: NA
    standard_deviation: NA
    group_size: 30

YAML:
<assistant->
intervention:
    mean: 6.35
    standard
---
",True
222,2914,5459456,Lateral bending stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.05,0.02,2.67,0.68,-5.1485,1.0784,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 154.4
    standard_deviation: 13.1
    group_size: 4
comparator:
    mean: 90.8
    standard_deviation: 9.6
    group_size: 4

intervention:
    mean: 2.9
    standard_
---
intervention:
    mean: 7.2
    standard_deviation: 0.6
    group_size: 16
comparator:
    mean: 4.0
    standard_deviation: 0.3
    group_size: 16

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 110
    standard_deviation: 15
    group_size: 10
comparator:
    mean: 90
    standard_deviation: 15
    group_size: 10
C2-4 stiffness:
    intervention:
        mean: 5.79
        standard_dev
---
intervention:
    mean: 140.7
    standard_deviation: 12.5
    group_size: 26
comparator:
    mean: 100.5
    standard_deviation: 13.1
    group_size: 26


This article reports the results of a trial comparing artificial cervical vertebra
---
",True
596,11583,115849,ACR20 responder criteria,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 65.5
    standard_deviation: 13.1
    group_size: 360
comparator:
    mean: 76.0
    standard_deviation: 15.4
    group_size: 360

## Results
Results:
  * Number of patients who completed
---
intervention:
    mean: 9.53
    standard_deviation: 2.63
    group_size: 50
comparator:
    mean: 7.71
    standard_deviation: 2.12
    group_size: 50

---

This is the YAML response you have requested:
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 181
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 353
ACR20:
    intervention: N/A
    com
---
",True
383,949,3278655,maximum total point motion (MTPM),The trabecular metal tibial monoblock component (TM),cemented component.,continuous,,27,,18,0.98,3.91,0.79,2.27,0.0556,0.0926,,,,,Back calculated the SD values from CI. Numerical values are from 5-year follow up.,TRUE,5463,3510,TEST,2857,"[1308, 1167]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
MTPM:
    intervention: NUMBER
    com
---
intervention:
    mean: 0.85
    standard_deviation: 0.13
    group_size: 30
comparator:
    mean: 0.54
    standard_deviation: 0.14
    group_size: 24
intervention:
    mean: 0.87
    standard_dev
---
",True
591,11583,115849,Tender joint count,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 29
    standard_deviation: 15
    group_size: 67
comparator:
    mean: 28
    standard_deviation: 12
    group_size: 158

# Results
# =======
#
# Table 1: Baseline patient characteristics
#
# Character
---
intervention:
    mean: NUMBER_NOT_AVAILABLE
    standard_deviation: NUMBER_NOT_AVAILABLE
    group_size: NUMBER_NOT_AVAILABLE
comparator:
    mean: NUMBER_NOT_AVAILABLE
    standard_deviation: NUMBER_
---
intervention:
    mean: NA
    standard_deviation: NA
    group_size: 137
comparator:
    mean: 17.0
    standard_deviation: 6.2
    group_size: 137

This table is not provided in the article, so the values for ""intervention"" and
---
",True
694,5636,5712123,postoperative pain on movement,duloxetine 60 and etoricoxib 120mg (group D/E),placebo,continuous,,30,,30,3.5,,3,,cannot calculate,cannot calculate,,,,,values given as score (range),FALSE,6401,5359,TEST,3891,"[1329, 1393, 810]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  etoricoxib:
    mean: NUMBER.5
    standard_deviation: NUMBER.5
    group_size: NUMBER-2
  duloxetine:
    
---
intervention:
    mean: 5.0
    standard_deviation: 1.8
    group_size: 30
comparator:
    mean: 4.8
    standard_deviation: 1.5
    group_size: 30

intervention:
    mean: 5.4
    standard_
---
intervention:
    mean: NUMBER, standard_deviation: NUMBER
    group_size: NUMBER_1, NUMBER_2: SIZE_1, SIZE_2
comparator:
    mean: NUMBER, standard_deviation: NUMBER
    group_size: NUMBER_1, NUM
---
",True
619,11603,1863515,leucocyte count at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,8818,,8362,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,3103,"[1640, 851]","intervention:
    mean: 4370
    standard_deviation: 955
    group_size: 637
comparator:
    mean: 4135
    standard_deviation: 923
    group_size: 624

## CONTEXT ##
The study aimed to assess whether the initial use of z
---
intervention:
    mean: 105
    standard_deviation: 18
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A

In the given trial, the mean leucocyte count at 35 wk
---
",True
425,3402,3877023,contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal fluid – Vertebral bone,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,24,12.9,11.7,6.3,1.22140465,0.07440001,,,,,,TRUE,17694,9686,TEST,7100,"[1399, 1660, 1641, 1131]","intervention:
    mean: 76.5
    standard_deviation: 10.2
    group_size: 35
comparator:
    mean: 49.8
    standard_deviation: 7.1
    group_size: 61

## Table 2: Patients Characteristics
## (All Values are in
---
intervention:
    mean: 101).0
    standard_deviation: 16).4
    group_size: 18
comparator:
    mean: 10).2
    standard_deviation: 1).8
    group_size: 18

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 2.1
    standard_deviation: 0.9
    group_size: 18
comparator:
    mean: 3
    standard_deviation: 0.8
    group_size: 21
thoracolumbarspine_t2w_sagittal_
---
intervention:
    mean: 22.9
    standard_deviation: 3.4
    group_size: 18
comparator:
    mean: 21.6
    standard_deviation: 4.4
    group_size: 22
<|assistant>
YAML:
 intervention:
    
---
",True
158,7710,5056957,Weight reduction at 12 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,55.91,15.64,56.48,14.76,-0.0373,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"[1500, 261, 1439, 763]","intervention:
    mean: 90
    standard_deviation: 10
    group_size: 30
comparator:
    mean: 80
    standard_deviation: 10
    group_size: 30
outcome:
    mean: 10
    standard_deviation: 3
    group_size:
---
intervention:
    mean: 0
    standard_deviation: 0
    group_size: Randomized Sample Size
comparator:
    mean: 1
    standard_deviation: 1
    group_size: Randomized Sample Size
weight_reduction_at_12_months:
    mean: 0

---
intervention:
    mean: 105
    standard_deviation: 15
    group_size: 29

comparator:
    mean: 85
    standard_deviation: 10
    group_size: 29

<\assistant ->
intervention:
    mean: 105
    standard_deviation:
---
intervention:
    mean: 50.08
    standard_deviation: 8.21
    group_size: 645
comparator:
    mean: 55.91
    standard_deviation: 8.52
    group_size: 592
intervention:
    mean: 61.08
    standard
---
",True
593,11583,115849,Patient global assessment of pain,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 65.5
    standard_deviation: 14.9
    group_size: 367
comparator:
    mean: 76.0
    standard_deviation: 15.4
    group_size: 375

output:
    - intervention:
          mean: 66.
---
intervention:
     mean: 9.0
     standard_deviation: 2.9
     group_size: 93
comparator:
     mean: 6.2
     standard_deviation: 2.6
     group_size: 93

## Output
intervention:
    mean: 9.03

---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 286
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 283

This table indicates that the provided trial article does not provide means,
---
",True
463,4431,5726464,Lipid profile: HDL-c,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1309, 1402]","intervention:
    mean: 42
    standard_deviation: 6
    group_size: N/A
comparator:
    mean: 37
    standard_deviation: 5
    group_size: N/A

YAML:
 intervention:
    mean: 41
    standard_deviation
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    HDL-c: NUMBER standard_deviation: NUMBER group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    
---
",True
77,3746,3546023,The percentage of NK cells,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,29,19.03,7.82,24.72,8.78,-0.6721,0.0716,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1053, 1432, 1540, 941, 1509, 986, 1381]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  NK_percentage:
    mean: NUMBER_VALUE
    standard_deviation: NUMBER_VALUE
    group_size: NUMBER_VALUE
comparator:
    mean:
---
intervention:
    mean: 83.35
    standard_deviation: 15.10
    group_size: 56
comparator:
    mean: 66.24
    standard_deviation: 10.59
    group_size: 56

The YAML format for the given trial article is:


---
intervention:
    mean: 71.29
    standard_deviation: 12.23
    group_size: 14
comparator:
    mean: 45.16
    standard_deviation: 8.619
    group_size: 14
NK:
    intervention: 13.16 %
    com
---
intervention:
    mean: 8.32
    standard_deviation: 1.55
    group_size: 29
comparator:
    mean: 7.29
    standard_deviation: 2.10
    group_size: 27
intervention:
    mean: 8.82
    standard_dev
---
intervention:
    mean: 9.80
    standard_deviation: 1.09
    group_size: NUMBER
comparator:
    mean: 37.25
    standard_deviation: 8.59
    group_size: NUMBER
outcome:
    mean: 0.76
    
---
intervention:
    mean: 25.59
    standard_deviation: 9.44
    group_size: 27
comparator:
    mean: 24.72
    standard_deviation: 8.78
    group_size: 29

YAML:
<assistant>
intervention:
    
---
intervention:
    mean: 84.0
    standard_deviation: 11.9
    group_size: 10
comparator:
    mean: 78.5
    standard_deviation: 11.2
    group_size: 10
outcome:
    mean: NUMBER
    standard_dev
---
",True
506,6485,5419060,Phlebotomy questionnaire score: CDC D,Phlebotomy training programme,Control,continuous,,23,,23,97,1.21,63,4.31,10.5566479,1.29829148,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,"[1542, 1646, 159]","intervention:
    mean: 96.0
    standard_deviation: 7.8
    group_size: 8
comparator:
    mean: 87.8
    standard_deviation: 6.1
    group_size: 9
<|assistant>

```yaml
intervention:
    
---
intervention:
    mean: 95.5
    standard_deviation: 8.23
    group_size: 589
comparator:
    mean: 86.2
    standard_deviation: 9.52
    group_size: 589

YAML:
<|assistant>>
intervention
---
intervention:
    mean: 5.7
    standard_deviation: 1.1
    group_size: 20
comparator:
    mean: 4.6
    standard_deviation: 1.3
    group_size: 20
CDC_D:
    intervention: 4.8
    com
---
",True
530,6917,4411165,Tskin of the head,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,2336,"[1630, 211]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
     mean_tskin_head: NUMBER
    standard_deviation_tskin_head: NUMBER
    group_size_tskin_head: NUMBER

comparator
---
intervention:
     mean: 123.7
     standard_deviation: 11.6
     group_size: 26
comparator:
     mean: 121.9
     standard_deviation: 11.3
    group_size: 27
<|assistant>
YAML:
intervention:
    
---
",True
667,13296,4987981,total cholesterol,pioglitazone,placebo,continuous,,16,,23,207.2,42.3,184.4,37.5,0.5651889,0.11007363,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"[518, 1670, 1662, 743]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    mean_post: NUMBER
    standard_deviation_post: NUMBER
    group_size_post: NUMBER
comparator:
    mean: NUMBER
    standard
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
total_ cholesterol:
    mean: 97.6
    standard
---
 intervention:
   mean: NUMBER
   standard_deviation: NUMBER
   group_size: NUMBER
 comparator:
   mean: NUMBER
   standard_deviation: NUMBER
   group_size: NUMBER
 total_cholesterol:
   mean: NUMBER.0
   standard
---
 intervention:
    mean: 140.0
    standard_deviation: 10.0
    group_size: 60
 comparator:
    mean: 120.0
    standard_deviation: 10.0
    group_size: 60
<br>
 <br>
<br>
 intervention:
    
---
",True
220,2912,5459456,time before eating,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,4.5,2.2,3.9,2.3,0.6791,0.2644,,,,,,TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 0.5
    standard_deviation: 0.3
    group_size: 4
comparator:
    mean: 1.0
    standard_deviation: 0.8
    group_size: 4
timebeforefeeding:
    mean: 4.5
    standard
---
intervention:
    mean: 0
    standard_deviation: 0
    group_size: 30
comparator:
    mean: 3
    standard_deviation: 1
    group_size: 15

YAML:
<|assistant>
intervention:
    mean: 123.4
    
---
intervention:
    mean: 105
    standard_deviation: 13
    group_size: 10
comparator:
    mean: 87
    standard_deviation: 13
    group_size: 10

This YAML is created based on the information provided in the article, focusing on the intervention and comparator.
---
intervention:
    mean: 11.5
    standard_deviation: 2.1
    group_size: 20
comparator:
    mean: 9.1
    standard_deviation: 2.2
    group_size: 20

YAML:
<assistant="""">
intervention:
    
---
",True
524,6741,5325897,Second test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,17.73,0.46,12.13,0.47,11.7163546,2.42121609,,,,,,TRUE,4260,2410,TEST,1703,[],"intervention:
    mean: 14.0
    standard_deviation: 2.1
    group_size: NUMBER
comparator:
    mean: 10.5
    standard_deviation: 2.0
    group_size: NUMBER

intervention:
    mean: 18.5
    ",False
183,4341,5122613,Baseline characteristics and diet,Digestion-resistant maltodextrin,Placebo,continuous,,33,,33,10,4.6,11.5,4.6,-0.3222,0.0614,,,,,Mean daily fiber intake,TRUE,6184,3742,TEST,2832,"[1615, 694]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
n_subjects_post: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
n_subjects_pre
---
intervention:
    mean: 53.4
    standard_deviation: 30.1
    group_size: N/A
comparator:
    mean: 56.4
    standard_deviation: 20.6
    group_size: N/A

YAML:
<|assistant>
---
",True
301,5600,4355974,Days patient had to slow down,BostonBreathes system,Control,continuous,,28,,14,-1.4,,-0.4,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,3820,"[1193, 1450, 403]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    mean_days_of_patient_having_slow_down: NUMBER
    standard_deviation_days_of_patient_having_slow_down: NUMBER
    group_
---
intervention:
     mean: 4.0
     standard_deviation: 1.1
     group_size: 28
comparator:
     mean: 3.2
     standard_deviation: 0.9
     group_size: 28

intervention:
     mean: 6.5
     standard_
---
intervention:
    mean: 6.5
    standard_deviation: 3.0
    group_size: 14
comparator:
    mean: 4.6
    standard_deviation: 3.0
    group_size: 14

YAML:
<assistant»""""""""""
intervention:
---
",True
311,7834,4541185,drop in heart rate,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,76.1,8.91,76.77,8.76,-0.0748,0.0667,,,,,found in table,TRUE,1359,1043,TEST,907,[],"intervention:
    mean: n/a
    standard_deviation: n/a
    group_size: 30
comparator:
    mean: n/a
    standard_deviation: n/a
    group_size: 30

outcome:
    drop in heart rate:
        intervention",False
150,11145,4996097,Total nasal resistance,Septoplasty,Control,continuous,,33,,30,0.25,,0.27,,cannot calculate,cannot calculate,,,,,Used preoperative values. SD is not given.,FALSE,9291,4535,TEST,2976,"[1668, 865]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    mean_TNR: NUMBER
    standard_deviation_TNR: NUMBER
    group_size_TNR: NUMBER
    
TNR: 110.0 (10
---
intervention:
    mean: 3162
    standard_deviation: 267
    group_size: 33
comparator:
    mean: 2471
    standard_deviation: 277
    group_size: 30
total_nasal_resistance:
    intervention: 894.0
    comparator
---
",True
308,7832,4541185,duration of analgesia,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,878.33,89.955,613.1,51.797,2.7597,0.1301,,,,,found in text,TRUE,1359,1043,TEST,907,[],"intervention:
    mean: 603.05
    standard_deviation: 99.43
    group_size: 30
comparator:
    mean: 546.20
    standard_deviation: 70.36
    group_size: 30

outcome:
    duration of analgesia:
        ",False
488,6383,3786549,Baseline characteristics: height,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,154.86,5.45,153.43,5.88,0.25003828,0.04580977,,,,,,TRUE,9725,6231,TEST,4323,"[1626, 1395, 644]","intervention:
    mean: 154.86
    standard_deviation: 5.45
    group_size: 61
comparator:
    mean: 153.43
    standard_deviation: 5.15
    group_size: 62

evidence: ""<figcaption>\n:figure wrap:<img
---
intervention:
    mean: 170.9
    standard_deviation: 11.2
    group_size: 47
comparator:
    mean: 168.5
    standard_deviation: 10.9
    group_size: 48

This YAML represents the mean baseline characteristics of height (in centimeters
---
intervention:
    mean: 170.9
    standard_deviation: 12.4
    group_size: 41
comparator:
    mean: 167.4
    standard_deviation: 12.8
    group_size: 41

YAML:
intervention:
    mean: 50.5
---
",True
368,216,1475568,Heart failure-related quality of life at the end of treatment,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,1,,5,,cannot calculate,cannot calculate,,,,,Only the mean change was found in text.,FALSE,4361,3649,TEST,2573,"[1476, 403]","intervention:
    mean: 62.8
    standard_deviation: 11.8
    group_size: 82
comparator:
    mean: 63.2
    standard_deviation: 9.4
    group_size: 80

intervention:
    mean: 57.7
    standard_
---
intervention:
    mean: 51.9
    standard_deviation: 0.11
    group_size: N/A # Based on total number of participants at the end of treatment (16 in intervention group and 14 in control group).
comparator:
    mean: 42.0
    standard_deviation:
---
",True
647,13025,4675066,The mean motor score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,93.9,10.8,92.4,9.7,0.14381908,0.07569371,,,,,found in table 2,TRUE,6682,5735,TEST,4224,"[1674, 866, 893]","intervention:
    mean: 99.4
    standard_deviation: 12.2
    group_size: N/A
comparator:
    mean: 101.7
    standard_deviation: 8.2
    group_size: N/A

outcome:
    mean: 105.
---
intervention:
    mean: 98.9
    standard_deviation: 12.1
    group_size: 22
comparator:
    mean: 95.5
    standard_deviation: 12.1
    group_size: 22

In the provided article, the mean motor score on the Bayley
---
intervention:
    mean: 98.0
    standard_deviation: 14.8
    group_size: 17
comparator:
    mean: 95.8
    standard_deviation: 15.1
    group_size: 17
Bayley-III:
    intervention: 43.0
    
---
",True
638,12721,4132222,"higher prevalence of lesion scabbing, a sign of healing",application of a canola phenolic acid-based cream (CPA),placebo,continuous,,30,,15,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,2177,1885,TEST,1617,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    mean_post: NUMBER
    standard_deviation_post: NUMBER
    group_size_post: NUMBER
comparator:
    mean: NUMBER
    standard",False
100,930,4183415,Completed treatment,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,68.3,23.4,69.8,20.9,-0.0668,0.0521,,,,,Data found in Table 6.,TRUE,10420,7106,TEST,5310,"[1574, 1105, 1423, 643]","intervention:
    mean: 68.3
    standard_deviation: 6.9
    group_size: 904
comparator:
    mean: 69.8
    standard_deviation: 7.2
    group_size: 427

Note that the mean numbers of doses taken by non-ad
---
intervention:
    mean: 35
    standard_deviation: 9
    group_size: 53
comparator:
    mean: 25
    standard_deviation: 7
    group_size: 59

YAML:
<assistant>
intervention:
    mean: 11.6
    standard
---
::: table-wrap YAML
intervention:
  mean: 78.4
  standard_deviation: 13.2
  group_size: 37
comparator:
  mean: 90
  standard_deviation: 11.7
  group_size: 40
:::

::: table
---
intervention:
    mean: 69.8
    standard_deviation: 20.9
    group_size: 37
comparator:
    mean: 68.3
    standard_deviation: 23.4
    group_size: 40
<|assistant>
intervention:
    mean: 73.
---
",True
675,13315,4550271,the proportion of patients who tested positive and received (or were prescribed) an ACT,provider,control,continuous,,14,,12,56.1,31,64.2,28,-0.2644318,0.1561066,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,"[760, 1198, 1658, 1280, 1564, 949]","intervention:
    mean: 95% CI of the primary outcome (the proportion of patients who tested positive and received (or were prescribed) an ACT) in the provider arm (with provider training only) and the provider school arm (with provider training and a school-based community intervention) compared with control.
    standard_deviation: 95
---
intervention:
    mean: 21
    standard_deviation: 6
    group_size: 678
comparator:
    mean: 16
    standard_deviation: 3
    group_size: 1160
<|assistant>
Here's the YAML format you requested:

```yaml

---
intervention:
    mean: 64.2
    standard_deviation: 95% CI of RD
    group_size: NUMBER
comparator:
    mean: 55.6
    standard_deviation: 95% CI of RD
    group_size: NUMBER

Note: The provided article doesn't
---
intervention:
    mean: 6.681818181818182
    standard_deviation: 1.1660714068904737
    group_size: 314
comparator:
    mean: 0.0
    standard_deviation: 0.0
    group_size: 0
outcome:
---
intervention:
    mean: 95.0
    standard_deviation: 8.9
    group_size: 87
comparator:
    mean: 88.5
    standard_deviation: 9.6
    group_size: 110

YAML:
intervention:
    mean: 95.5
---
intervention:
    mean: 0.5
    standard_deviation: 0.1
    group_size: 130
comparator:
    mean: 0.3
    standard_deviation: 0.1
    group_size: 140

intervention:
    mean: 0.26
    standard_
---
",True
614,11584,115849,ACR20 responder criteria,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 66.0
    standard_deviation: 15.3
    group_size: 68
comparator:
    mean: 75.0
    standard_deviation: 15.6
    group_size: 66

intervention:
    mean: 65.5
    standard_
---
intervention:
    mean: 9.53
    standard_deviation: 1.43
    group_size: 91
comparator:
    mean: 8.70
    standard_deviation: 1.41
    group_size: 91

Worse post-intervention (ACR20 responder criteria)
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 183
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 184

Explanation:
The YAML format provided is already the appropriate
---
",True
247,10308,5571493,QT interval,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,928,[],"intervention:
    mean: 82.5
    standard_deviation: 5.0
    group_size: 10
comparator:
    mean: 96.5
    standard_deviation: 8.1
    group_size: 10
QTinterval:
    mean: 119.0
    standard_",False
590,11583,115849,investigator global assessment of disease activity,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 65.5
    standard_deviation: 13.1
    group_size: 360
comparator:
    mean: 76.0
    standard_deviation: 12.7
    group_size: 360
intervention:
    mean: 65.5
    standard_dev
---
intervention:
    mean: 9.93
    standard_deviation: 2.43
    group_size: NUMBER
comparator:
    mean: -0.46
    standard_deviation: 1.79
    group_size: NUMBER

This is the correct YAML format for the given
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 178
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 180

This article reports the mean investigator global assessment of disease activity post-
---
",True
200,7737,5380284,Consumption of fentanyl,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    fentanyl:
        mean: NUMBER
        standard_deviation: NUMBER
        group_size: NUMBER
:
    fentanyl:
        mean: NUMBER",False
519,6700,5154016,Second 24 h drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,63.3,8.9,63.5,14.2,-0.0166581,0.06666898,,,,,,TRUE,3046,2156,TEST,1642,[],"intervention:
    mean: 205.5
    standard_deviation: 25.6
    group_size: 32
comparator:
    mean: 237.5
    standard_deviation: 29.1
    group_size: 32

YAML:
<|assistant>:
intervention:
",False
52,5306,3195393,Restraint frecuency,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,13.6,0.07,11.5,0.13,20.6573,0.2121,,,,,Added intermittent and continuous numbers from study site,TRUE,15527,8380,TEST,5589,"[1663, 1441, 1442]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    
outcome:
    mean: NUMBER
    standard
---
intervention:
    mean: 38.41
    standard_deviation: 0.43
    group_size: 140
comparator:
    mean: 36.43
    standard_deviation: 0.48
    group_size: 142

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 110).0
    standard_deviation: 12.0
    group_size: 138
comparator:
    mean: 84).0
    standard_deviation: 11.1
    group_size: 123

YAML:
<|assistant>
intervention:

---
",True
76,3744,3546023,The percentage of B cells,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,14.06,3.81,14.4,4.03,-0.0856,0.0667,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1053, 1432, 1540, 941, 1509, 986, 1381]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    the_intervention:
        mean: NUMBER
        standard_deviation: NUMBER
        group_size: NUMBER
comparator:
    mean: NUMBER
    standard
---
intervention:
    mean: 65.56
    standard_deviation: 13.56
    group_size: 44
comparator:
    mean: 48.86
    standard_deviation: 9.09
    group_size: 44

The given data points to a mean percentage of B cells of 65
---
intervention:
    mean: 58
    standard_deviation: 12
    group_size: 58
comparator:
    mean: 456
    standard_deviation: 107
    group_size: 56

intervention:
    mean: 44.60
    standard_deviation: 20.94
    
---
intervention:
    mean: 8.32
    standard_deviation: 1.55
    group_size: 29
comparator:
    mean: 7.29
    standard_deviation: 2.10
    group_size: 27
intervention:
    mean: 8.86
    standard_dev
---
intervention:
    mean: 9.87
    standard_deviation: 2.62
    group_size: 10
comparator:
    mean: 10.05
    standard_deviation: 3.10
    group_size: 10
outcome:
    mean: 0.76
    standard_
---
intervention:
    mean: 25.59
    standard_deviation: 8.80
    group_size: 27
comparator:
    mean: 24.72
    standard_deviation: 7.94
    group_size: 29
intervention:
    mean: 31.38
    standard_dev
---
intervention:
    mean: 157.5
    standard_deviation: 23.5
    group_size: 13
comparator:
    mean: 119.3
    standard_deviation: 15.7
    group_size: 12
outcome:
    mean: 25.0
    standard_
---
",True
552,9725,3648394,Quality of life - PCS (SF36),10-week yoga program,Control,continuous,,18,,19,47.5,2.7,46.9,4.8,0.1496389,0.10848973,,,,,"Original outcome was just ""Quality of Life"". Numerical values are from Week 11.",TRUE,9556,6245,TEST,4261,"[1647, 1622, 64]","intervention:
    mean: 138.0
    standard_deviation: 12.1
    group_size: 18
comparator:
    mean: 97.3
    standard_deviation: 12.5
    group_size: 20

intervention:
    mean: 105.5
    standard_
---
intervention:
    mean: 47.4
    standard_deviation: 8.9
    group_size: 49
comparator:
    mean: 45.3
    standard_deviation: 8.8
    group_size: 48

outcome:
    mean: 53.6
    
---
intervention:
    mean: NA
    standard_deviation: NA
    group_size: NA
comparator:
    mean: 81.87
    standard_deviation: 14.01
    group_size: 60

# Update the table below with the required information based on the given trial article


---
",True
170,2795,5079604,Cox proportional hazards of failure-free survival,"metformin 1,000 mg daily",sitagliptin 100 mg daily,continuous,,17,,16,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"[1656, 1646]","intervention:
    mean: 480
    standard_deviation: 91
    group_size: 17
comparator:
    mean: 156
    standard_deviation: 47
    group_size: 15
intervention:
    mean: 1,000
    standard_deviation: 242
    group_size
---
intervention:
    mean: 86.3
    standard_deviation: 11.3
    group_size: 28
comparator:
    mean: 75.1
    standard_deviation: 10.4
    group_size: 28
intervention:
    mean: 86.5
    standard_dev
---
",True
447,4003,4879328,effects for walking,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.55,2.29,0.31,3.84,-0.2681458,0.01855223,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"[755, 1623, 1022, 1067, 817]","intervention:
    mean: 0.56
    standard_deviation: 0.15
    group_size: NUMBER
comparator:
    mean: 0.0
    standard_deviation: 0.0
    group_size: NUMBER

In the provided trial article, there is no information about
---
intervention:
    mean: 196.9
    standard_deviation: 143.6
    group_size: 114
comparator:
    mean: 195.6
    standard_deviation: 150.5
    group_size: 78

Walking:
    intervention: (196.9, 12
---
intervention:
    mean: 0.56
    standard_deviation: 0.15
    group_size: NUMBER
comparator:
    mean: x
    standard_deviation: x
    group_size: NUMBER
outcome: walking
---

See the YAML above, or click
---
intervention:
    mean: 7.41
    standard_deviation: 5.61
    group_size: 114
comparator:
    mean: 81.0
    standard_deviation: 12.0
    group_size: 113

YAML:
<assistant→
intervention:
    
---
intervention:
    mean: 24.16
    standard_deviation: 5.07
    group_size: NUMBER
comparator:
    mean: NaN
    standard_deviation: NaN
    group_size: NUMBER

Note: 'NaN' stands for ""not available"" in this context.
---
",True
307,7831,4541185,duration of motor block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,621.67,46.76,500.86,44.58,2.6102,0.1234,,,,,found in text,TRUE,1359,1043,TEST,907,[],"intervention:
    mean: 703.83
    standard_deviation: N/A
    group_size: 30
comparator:
    mean: 556.38
    standard_deviation: N/A
    group_size: 30

outcome:
    duration of motor block:
        ",False
469,4799,5515881,dynamic balance performance on the stability platform,demanding balance training program,relaxation group,continuous,,,,,7.54,2.57,6.29,1.84,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"[1607, 510]","intervention:
    mean: 1
    standard_deviation: 0
    group_size: 12
comparator:
    mean: 0
    standard_deviation: 0
    group_size: 12
memory_score:
    mean: 7
    standard_deviation: 2
    group_size
---
intervention:
    mean: 105.5
    standard_deviation: 14.3
    group_size: 14
comparator:
    mean: 81.4
    standard_deviation: 11.5
    group_size: 11

intervention:
    mean: 19.6
    standard_
---
",True
483,5712,3343759,Amsterdam-Nijmegen everyday language test (ANELT),very early speech and language therapy (SLT),control,continuous,,59,,55,,,,,cannot calculate,cannot calculate,,,,,"Median values are reported. Group size is based on ANELT by day 21, intent-to-treat.",FALSE,3838,2633,TEST,2065,[1638],"intervention:
    mean: 1.3
    standard_deviation: 0.12
    group_size: 21
comparator:
    mean: 1.2
    standard_deviation: 0.12
    group_size: 55

YAML:
intervention:
    mean: 4.5
---
",True
249,10310,5571493,Hypoglycemia,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,928,[],"intervention:
  mean: 82.0
  standard_deviation: 5.7
  group_size: 10
comparator:
  mean: 70.5
  standard_deviation: 5.6
  group_size: 10

This article reports a randomized, controlled trial evaluating the glycemic effects",False
434,3261,3475525,Scores on sugar quiz,MTL group,choices group,continuous,,98,,98,90,20.7,41.9,19.4,2.38845924,0.03496107,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: NUMBER.8
    standard_deviation: NUMBER.2
    group_size: NUMBER
comparator:
    mean: NUMBER.8
    standard_deviation: NUMBER.2
    group_size: NUMBER

Written response:
intervention:
---
intervention:
    mean: 83.0
    standard_deviation: 10.6
    group_size: 85
comparator:
    mean: 93.8
    standard_deviation: 9.6
    group_size: 95

YAML:
intervention:
    mean: 99.0
---
",True
81,3740,3546023,tocotrienol levels,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,675.16,150,63.6,5.67,5.6842,0.3475,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"[1053, 1432, 1540, 941, 1509, 986, 1381]","intervention:
    mean: 63.50
    standard_deviation: 3.62
    group_size: 30
comparator:
    mean: 60.42
    standard_deviation: 4.08
    group_size: 28
palmvitee:
    mean: 12.58

---
intervention:
     mean: 44.29
     standard_deviation: 6.41
     group_size: 56
comparator:
     mean: 32.50
     standard_deviation: 3.73
     group_size: 60

intervention:
     mean: 4.62
     standard_
---
intervention:
    mean: 58.0
    standard_deviation: 39.9
    group_size: 57
comparator:
    mean: 45.6
    standard_deviation: 20.9
    group_size: 57

intervention:
    mean: 53.75
    standard_
---
intervention:
    mean: 8.32
    standard_deviation: 1.55
    group_size: 29
comparator:
    mean: 7.29
    standard_deviation: 2.10
    group_size: 27

YAML:
intervention:
    mean: 8.43
---
intervention:
    mean: 67.67
    standard_deviation: 8.14
    group_size: 17
comparator:
    mean: 63.64
    standard_deviation: 6.28
    group_size: 17

---

Note: The provided text is incomplete and missing some
---
intervention:
    mean: 1225.0
    standard_deviation: 109.9
    group_size: 27
comparator:
    mean: 1079.8
    standard_deviation: 126.0
    group_size: 28

YAML:
<assistant->
intervention:
---
intervention:
    mean: 49.9
    standard_deviation: 13.1
    group_size: 10
comparator:
    mean: 22.8
    standard_deviation: 6.4
    group_size: 10

The above table represents the mean tocotrienol levels post intervention
---
",True
317,9844,4928400,Hospital stay,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,4.2,1.2,2.1,1.1,1.7938,0.1338,,,,,,TRUE,4037,2288,TEST,1670,[],"intervention:
    mean: 6.2
    standard_deviation: 1.9
    group_size: 28
comparator:
    mean: 5.7
    standard_deviation: 2.1
    group_size: 28

intervention:
    mean: 68.5
    standard_",False
115,9524,4319071,Fruit intake,Intervention + targeting environmental-level factors,Individual cognition and self-regulation processes intervention,continuous,,456,,459,2.17,1.71,2.14,1.71,0.0175,0.0044,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"[781, 1626, 1619, 1304, 1094, 1600, 944]","intervention:
    mean: 130.0
    standard_deviation: 48.2
    group_size: N/A
comparator:
    mean: 102.3
    standard_deviation: 26.9
    group_size: N/A

intervention:
    mean: 153.0
---
intervention:
    mean: 160.0
    standard_deviation: 68.2
    group_size: 49
comparator:
    mean: 153.5
    standard_deviation: 62.9
    group_size: 50

intervention:
    mean: 3.4
    standard_
---
intervention:
    mean: 3.0
    standard_deviation: 1.0
    group_size: 46
comparator:
    mean: 2.0
    standard_deviation: 1.0
    group_size: 46

intervention:
    mean: 3.6
    standard_
---
intervention:
    mean: 4
    standard_deviation: 1
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
fruit_intake:
    intervention:
        mean: 3
---
intervention:
    mean: 1.56
    standard_deviation: 0.07
    group_size: 803
comparator:
    mean: 1.04
    standard_deviation: 0.03
    group_size: 1014
intervention:
    mean: 4.75
    standard
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
<|consonant>
intervention:
    mean: 3
---
intervention:
    mean: 120.0
    standard_deviation: 25.0
    group_size: 50
comparator:
    mean: 85.5
    standard_deviation: 20.0
    group_size: 50

intervention:
    mean: 100.0
    standard_
---
",True
426,3403,3877023,Scanning times,high-field horizontal open MR scanner,short-bore MR scanner,continuous,,49,,44,32,22,20,9,0.69457406,0.04572916,,,,,,TRUE,17694,9686,TEST,7100,"[1399, 1660, 1641, 1131]","intervention:
    mean: 32
    standard_deviation: 22.8
    group_size: 20
comparator:
    mean: 20
    standard_deviation: 9.36
    group_size: 17

This YAML represents the data for the scanning times outcome, with the mean values and
---
intervention:
    mean: 31.7
    standard_deviation: 21.6
    group_size: 37
comparator:
    mean: 70
    standard_deviation: 42.8
    group_size: 70

YAML:
<|assistant>
intervention:
    mean
---
intervention:
    mean: 0
    standard_deviation: 0
    group_size: 0
comparator:
    mean: 0
    standard_deviation: 0
    group_size: 0

YAML:
 intervention:
    mean: 60
    standard_deviation: 30
    
---
intervention:
    mean: NA
    standard_deviation: NA
    group_size: 2
comparator:
    mean: 10
    standard_deviation: 4
    group_size: 6

YAML:
<|assistant>
intervention:
    mean: 90
    standard_
---
",True
374,227,1475568,Self-efficacy,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,,,,,cannot calculate,cannot calculate,,,,,Only the overall mean difference in score improvement was given.,FALSE,4361,3649,TEST,2573,"[1476, 403]","intervention:
    mean: 22
    standard_deviation: 4
    group_size: 92
comparator:
    mean: 17
    standard_deviation: 3
    group_size: 82

intervention:
    mean: 57
    standard_deviation: 7
    group_size:
---
intervention:
    mean: 21.0
    standard_deviation: 21.0
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 58
self_efficacy:
    intervention: N/A

---
",True
565,9839,3496170,N1 amplitude,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data is not given.,FALSE,2318,1990,TEST,1731,[],"intervention:
    mean: 104.4
    standard_deviation: 13.6
    group_size: 14
comparator:
    mean: 88.5
    standard_deviation: 12.7
    group_size: 14

outcome:
 N1 amplitude
group_size: 14",False
51,5308,3195393,Continuous restraint,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,8.5,0.07,10.8,0.13,-19.6737,0.1927,,,,,Overall continuous restraint rate for study site.,TRUE,15527,8380,TEST,5589,"[1663, 1441, 1442]","intervention:
    mean: 4.3
    standard_deviation: SD 10.7
    group_size: NUMBER
comparator:
    mean: 59.1
    standard_deviation: SD 17.7
    group_size: NUMBER

outcome:
    mean: NUMBER
---
intervention:
    mean: 38.41
    standard_deviation: 0.43
    group_size: 99
comparator:
    mean: 36.43
    standard_deviation: 0.43
    group_size: 142

YAML:
<|assistant/>
intervention:

---
intervention:
    mean: 11.6
    standard_deviation: 4.2
    group_size: 613
comparator:
    mean: 8.3
    standard_deviation: 3.6
    group_size: 612

YAML:
<|assistant>
intervention:

---
",True
608,11584,115849,investigator global assessment of disease activity,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 65.5
    standard_deviation: 14.9
    group_size: 367
comparator:
    mean: 76.0
    standard_deviation: 15.9
    group_size: 362
    
intervention:
    mean: 65.5
    standard
---
intervention:
    mean: -9.93
    standard_deviation: 0.09
    group_size: NUMBER
comparator:
    mean: -6.90
    standard_deviation: 0.32
    group_size: NUMBER

This YAML represents the following information:

---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
comparator:
    mean: 93.2
    standard_deviation: 10.6
    group_size: N/A

YAML:
<assistant>:

---
",True
219,2912,5459456,recovery time,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,4.1,2,3.5,1.4,0.3286,0.2534,,,,,,TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 123.1
    standard_deviation: 13.9
    group_size: 8
comparator:
    mean: 120.8
    standard_deviation: 14.1
    group_size: 8

ACVC-HA:
    mean: 124.1

---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
intervention:
    mean: 11.0
    standard_deviation
---
intervention:
    mean: 9.5
    standard_deviation: 2.5
    group_size: 14
comparator:
    mean: 12.0
    standard_deviation: 2.8
    group_size: 14

intervention:
    mean: 10.6
    standard_
---
intervention:
    mean: NaN
    standard_deviation: NaN
    group_size: 2
comparator:
    mean: 6.0
    standard_deviation: 2.0
    group_size: 6

Explanation:
The given trial article doesn't provide the exact mean recovery time and
---
",True
461,4430,5726464,25(OH)D levels,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1309, 1402]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
   NUMBER: 37.8 ## 25(OH)D levels at baseline
   NUMBER: 137.0 ## 25(OH)D levels after 48 weeks
intervention:
    mean: NUM
---
 intervention:
    mean: 75
    standard_deviation: 15
    group_size: 25
comparator:
    mean: 50
    standard_deviation: 10
    group_size: 25

# For the following outcome:
 25(OH)D:
 intervention:
    mean: 37
---
",True
294,6104,4215531,MCCB performance : Reasoning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,47.9,8.8,46.5,9.8,0.1472,0.1055,,,,,used post values and Treatment as Usual as Baseline,TRUE,7353,5561,TEST,4156,"[1623, 1169, 760]","intervention:
    mean: 95.0
    standard_deviation: 11.9
    group_size: 14
comparator:
    mean: 88.5
    standard_deviation: 11.5
    group_size: 14


The provided trial article does not include the required numerical data and
---
intervention:
    mean: 15.6
    standard_deviation: 5.2
    group_size: 19
comparator:
    mean: 35.4
    standard_deviation: 5.1
    group_size: 36
mccb_reasoning:
     mean: 54.1
---
intervention:
    mean: 44.6
    standard_deviation: 12.2
    group_size: 19
comparator:
    mean: 40.1
    standard_deviation: 14.4
    group_size: 19
reasoning:
    mean: 49.4
    standard_
---
",True
303,3879,4357072,reduction in burning sensation,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,continuous,,15,,15,1,2.1,5.3,6.1,-0.9171,0.1474,,,,,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,1385,[],"intervention:
    mean: 57.0
    standard_deviation: 10.0
    group_size: 30
comparator:
    mean: 49.0
    standard_deviation: 11.0
    group_size: 30

outcome: reduction in burning sensation

YAML:
",False
98,931,4183415,completion of each dose at the correct time,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,33.1,21.6,32.6,18.4,0.0246,0.052,,,,,Data found in Table 6.,TRUE,10420,7106,TEST,5310,"[1574, 1105, 1423, 643]","intervention:
    mean: 68.3
    standard_deviation: 8.6
    group_size: 904
comparator:
    mean: 69.8
    standard_deviation: 9.6
    group_size: 688

YAML:
intervention:
    mean: 10
---
intervention:
    mean: 145
    standard_deviation: 14.1
    group_size: 53
comparator:
    mean: 132
    standard_deviation: 11.6
    group_size: 59

This data represents the mean number of patients who completed each dose at the correct time after
---
intervention:
    mean: 78.4
    standard_deviation: 13.3
    group_size: 37
comparator:
    mean: 90.0
    standard_deviation: 12.2
    group_size: 40

YAML:
intervention:
    mean: 63.5
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NIGHTLY_COUNT
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NIGHTLY_COUNT

# Based on the given trial article, here
---
",True
318,9845,4928400,Time for return to daily activities,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,13.3,1.7,9,1.6,2.5595,0.1734,,,,,,TRUE,4037,2288,TEST,1670,[],"intervention:
    mean: 4.2
    standard_deviation: 1.2
    group_size: 20
comparator:
    mean: 2.1
    standard_deviation: 1.1
    group_size: 20

YAML:
intervention:
    mean: 63.7",False
677,13505,5777419,the total cultivable microbiota,probiotic,placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,median and IQ scores given,FALSE,9410,4699,TEST,3181,"[857, 1657, 122]","intervention:
    mean: 110.0
    standard_deviation: 24.5
    group_size: 47
comparator:
    mean: 98.0
    standard_deviation: 18.1
    group_size: 47
outcome:
    mean: NUMBER
    standard_dev
---
intervention:
    mean: 105
    standard_deviation: 7.6
    group_size: 7
comparator:
    mean: 7
    standard_deviation: 3.8
    group_size: 23
outcome:
    mean: NUMBER
    standard_deviation: NUMBER
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NOMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NOMBER

# Replace the placeholders with actual values or leave them blank if
---
",True
687,13762,2836833,weight loss,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,"[1499, 1608, 1352, 745]","intervention:
    mean: 3.0
    standard_deviation: 0.8
    group_size: N/A
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: N/A
outcome:
    mean: N/A
---
intervention:
    mean: 103.2
    standard_deviation: 16.1
    group_size: 18
comparator:
    mean: 94.1
    standard_deviation: 14.8
    group_size: 18

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 450
    standard_deviation: NA
    group_size: 14
comparator:
    mean: NA
    standard_deviation: NA
    group_size: 14
<|assistant>
intervention:
    mean: 105.5
    standard_deviation:
---
intervention:
    mean: 149.0
    standard_deviation: 15.9
    group_size: 29
comparator:
    mean: 136.7
    standard_deviation: 17.5
    group_size: 30

YAML:
<|assistant>
intervention:

---
",True
290,6103,4215531,MCCB performance : Attentional Vigilance,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,38.5,11.8,41.3,10.1,-0.2496,0.1061,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,"[1623, 1169, 760]"," intervention:
    mean: 103.3
    standard_deviation: 12.2
    group_size: 18
comparator:
    mean: 95.9
    standard_deviation: 13.1
    group_size: 18

YAML:
 intervention:
    mean: 105.0
---
intervention:
    mean: 70.7
    standard_deviation: 59.0
    group_size: 19
comparator:
    mean: 58.0
    standard_deviation: 67.5
    group_size: 15

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 44.6
    standard_deviation: 12.2
    group_size: 19
comparator:
    mean: 40.1
    standard_deviation: 14.4
    group_size: 19

YAML:
<|assistant>
intervention:

---
",True
583,10218,3504298,Difference of cortisol on waking and the highest level of following samples,Word-based attentional bias modification,Placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,3331,"[1665, 939]"," intervention:
    mean: 105.0
    standard_deviation: 17.9
    group_size: 15
 comparator:
    mean: 95.2
    standard_deviation: 17.0
    group_size: 15

outcome:
    mean: NUMBER
    standard_deviation
---
intervention:
    mean: 120).0
    standard_deviation: 22.0
    group_size: 16
comparator:
    mean: 85).1
    standard_deviation: 16.2
    group_size: 15

This YAML represents the mean and standard deviation values for the intervention
---
",True
193,2094,5360580,Plasma PlsPE,1 mg/day of Pls purified from scallop,placebo,continuous,,138,,131,-0.59,1.11,-0.63,1.08,0.0364,0.0149,,,,,Data is from after 28 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,6033,"[1330, 1450, 1668]","intervention:
    mean: 8.03
    standard_deviation: 1.05
    group_size: 66
comparator:
    mean: 3.65
    standard_deviation: 1.31
    group_size: 56

intervention:
    mean: 14).0
    standard_
---
intervention:
    mean: 116
    standard_deviation: 23
    group_size: 118
comparator:
    mean: 122
    standard_deviation: 18
    group_size: 118
plasma:
    mean: x
    standard_deviation: x
    group_size:
---
intervention:
    mean: 8
    standard_deviation: 4
    group_size: 55
comparator:
    mean: 41
    standard_deviation: 6
    group_size: 43

YAML:
<|assistant>
intervention:
    mean: 1.0
    
---
",True
146,1272,4880652,visual analogue scores,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean and SD are in table that is in graphic form.,FALSE,1406,1149,TEST,966,[],"intervention:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER
comparator:
  mean: NUMBER
  standard_deviation: NUMBER
  group_size: NUMBER

YAML:
< | assistant >
intervention:
  mean:",False
661,13216,4458006,amplitude of whisking,facial nerve transection and subsequent repair either at the main trunk of the nerve (group 1),"2 cm distally, at the main bifurcation (group 2)",continuous,,12,,12,17.2,,6.9,,cannot calculate,cannot calculate,,,,,No std given,FALSE,1302,1180,TEST,1009,[],"intervention:
    mean: 10.8
    standard_deviation: 5.2
    group_size: 12
comparator:
    mean: 10.0
    standard_deviation: 2.5
    group_size: 12

Whisking amplitude in degrees at 2, 4, and 6",False
292,6104,4215531,MCCB performance : Working Memory,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,48.2,9.2,50.8,12.1,-0.2368,0.106,,,,,used post values and Treatment as Usual as Baseline,TRUE,7351,5561,TEST,4156,"[1623, 1169, 760]","intervention:
    mean: 120
    standard_deviation: 15
    group_size: 8
comparator:
    mean: 100
    standard_deviation: 15
    group_size: 8

Wrong YAML:

intervention:
    mean: NUMBER
    standard_deviation
---
intervention:
    mean: 15.6
    standard_deviation: 8.4
    group_size: 19
comparator:
    mean: 35.9
    standard_deviation: 10.6
    group_size: 15

YAML:
intervention:
    mean: 17.4
---
intervention:
    mean: 44.6
    standard_deviation: 12.2
    group_size: 19
comparator:
    mean: 40.1
    standard_deviation: 14.4
    group_size: 19

YAML:
<|assistant>
intervention:

---
",True
680,13506,5777419,reduction of PPD,probiotic,placebo,continuous,,16,,15,2.2,0.3,2.5,0.6,-0.6224049,0.13541486,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"[857, 1657, 122]","intervention:
    mean: 3.8
    standard_deviation: 0.7
    group_size: 17
comparator:
    mean: 4.4
    standard_deviation: 0.9
    group_size: 18

A prospective randomized double blind placebo controlled clinical trial was designed to evaluate
---
intervention:
    mean: 3.8
    standard_deviation: 0.7
    group_size: 15
comparator:
    mean: 6.0
    standard_deviation: 1.6
    group_size: 15
outcome:
    reduction_of_PPD:
        
---
intervention:
    mean: 9
    standard_deviation: 2
    group_size: 10
comparator:
    mean: 6
    standard_deviation: 2
    group_size: 10

This YAML represents the mean reduction of PPD (post-intervention to baseline) for the probiotic
---
",True
549,8464,3263860,PAID questionnaire fear of hypoglycemia,Real-Time Continuous Glucose Monitoring,Control,continuous,,69,,68,,,,,cannot calculate,cannot calculate,,,,,Numerical values in Table which is a graphic,FALSE,3178,2587,TEST,2232,"[1659, 239]","intervention:
    mean: 101.1
    standard_deviation: 13.8
    group_size: 88
comparator:
    mean: 60.8
    standard_deviation: 9.8
    group_size: 55

outcome:
    mean: 17.3
    standard
---
intervention:
    mean: 3.8
    standard_deviation: 1.2
    group_size: 29
comparator:
    mean: 3.2
    standard_deviation: 1.1
    group_size: 29
PAID:
    mean: 4.7
    standard_
---
",True
148,1274,4880652,Diastolic blood pressures at 5 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 4's graphics.,FALSE,1406,1149,TEST,966,[],"intervention:
    mean: 94.5
    standard_deviation: 9.3
    group_size: 78
comparator:
    mean: 80.3
    standard_deviation: 9.6
    group_size: 98

intervention:
    mean: 99.8
    standard_",False
607,11584,115849,Patient global assessment of disease activity,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 65.5
    standard_deviation: 12.1
    group_size: 371
comparator:
    mean: 76.0
    standard_deviation: 13.3
    group_size: 387

YAML:
<|assistant>
intervention:

---
intervention:
    mean: -9.93
    standard_deviation: 0.09
    group_size: N/A
comparator:
    mean: -6.90
    standard_deviation: 0.32
    group_size: N/A

YAML:
intervention:

---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 185
comparator:
    mean: 95.0
    standard_deviation: 12.2
    group_size: 180

YAML:
intervention:
    mean: N/A
---
",True
581,11584,115849,Discontinuation due to lack of efficacy,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: N/A
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: N/A

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 9.62
    standard_deviation: 1.67
    group_size: 116
comparator:
    mean: 10.46
    standard_deviation: 1.58
    group_size: 124

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 11.03
    standard_deviation: 4.53
    group_size: 182
comparator:
    mean: 10.75
    standard_deviation: 4.66
    group_size: 180

This YAML format represents the mean and standard deviation for the ""
---
",True
9,9684,2363753,Hospital stay,Amifostine,Control,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,725,[],"intervention:
    mean: 105.5
    standard_deviation: 19.7
    group_size: 40
comparator:
    mean: 67.0
    standard_deviation: 17.5
    group_size: 40
hospital_stay:
    intervention: 10.8
    com",False
657,13176,5773985,objective onset of action,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,7.4,1.93,7.28,1.59,0.06679907,0.08004462,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,[1563],"intervention:
    mean: 508.92
    standard_deviation: 63.30
    group_size: 50
comparator:
    mean: 1840.84
    standard_deviation: 819.51
    group_size: 50

outcome:
    mean: NUMBER
    
---
",True
609,11584,115849,Tender joint count,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    mean: 29
    standard_deviation: 15
    group_size: 68
comparator:
    mean: 28
    standard_deviation: 12
    group_size: 67

YAML:
<assistant->
intervention:
    mean: 65
    standard_dev
---
 intervention:
   mean: 10.0
   standard_deviation: 3.2
   group_size: 55
 comparator:
   mean: 9.3
   standard_deviation: 3.1
   group_size: 57
Tender joint count:
   mean: 11.4
   standard_
---
 intervention:
    mean: NA
    standard_deviation: NA
    group_size: 158
 comparator:
    mean: 120
    standard_deviation: 20
    group_size: 158
tender_joint_count:
    intervention:
        mean: 17.0
        standard_deviation
---
",True
241,8053,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),continuous,,12,,12,6,0.9,6.2,1.8,-0.1357,0.1671,,,,,,TRUE,6951,5679,TEST,4357,"[738, 1561, 1405]","intervention:
    mean: 0.11
    standard_deviation: 0.08
    group_size: 8
comparator:
    mean: 0.08
    standard_deviation: 0.06
    group_size: 8

Wrong YAML:
<assistant incorrectly formatted_yaml
---
intervention:
    mean: 0.67
    standard_deviation: 0.717
    group_size: 16
comparator:
    mean: 0.67
    standard_deviation: 0.717
    group_size: 16

The provided information indicates that the working memory performance improved after right an
---
intervention:
    mean: 6.0
    standard_deviation: 1.8
    group_size: 10
comparator:
    mean: 5.8
    standard_deviation: 1.9
    group_size: 10

intervention:
    mean: 73.6
    standard_
---
",True
453,4432,5726464,Glucose,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1309, 1402]","intervention:
    mean: 110
    standard_deviation: 10
    group_size: 85
comparator:
    mean: 90
    standard_deviation: 10
    group_size: 85

YAML:
intervention:
    mean: 4000
    standard_deviation: 500
    
---
intervention:
    mean: 25.5
    standard_deviation: 13.0
    group_size: 35.8
comparator:
    mean: 14.3
    standard_deviation: 38.0
    group_size: 27.8

YAML:
<|assistant>
---
",True
365,12886,5976949,leptin/adiponectin ratio (LAR),"GDM2 (less tight glycaemic targets, <5.3 mmol/L and < 7.8 mmol/L)","GDM1 (tight glycaemic targets, fasting blood glucose_<_5.1_mmol/L and <7.0_mmol/L postprandial) postprandial,), control group- normal glucose tolerance",continuous,,21,,45,1.7,1.66,,,cannot calculate,cannot calculate,,,,,combined means and stds not given,FALSE,4402,2905,TEST,2274,"[1223, 766]","intervention:
    mean: NA
    standard_deviation: NA
    group_size: 25
comparator:
    mean: NA
    standard_deviation: NA
    group_size: 21
leptin/adiponectin ratio (LAR):
    mean: NA
    standard_deviation
---
intervention:
    mean: 8.8
    standard_deviation: 6.6
    group_size: 18
comparator:
    mean: 18.3
    standard_deviation: 16.1
    group_size: 14

intervention:
    mean: 15.9
    standard_
---
",True
196,2097,5360580,WMS-R (0 min),1 mg/day of Pls purified from scallop,placebo,continuous,,24,,24,1.29,3.14,1.08,1.55,0.0834,0.0834,,,,,Data is from 28 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,6033,"[1330, 1450, 1668]","intervention:
    mean: 4.21
    standard_deviation: 0.78
    group_size: 145
comparator:
    mean: 4.34
    standard_deviation: 0.56
    group_size: 140
wms_r_0_min:
    mean: 4
---
intervention:
    mean: 82.5
    standard_deviation: 13.2
    group_size: 13
comparator:
    mean: 88.2
    standard_deviation: 13.7
    group_size: 13
wms_r_0_min:
    mean: 95
---
intervention:
    mean: 8
    standard_deviation: 5
    group_size: 55
comparator:
    mean: 40
    standard_deviation: 7
    group_size: 53

For the given table of mean difference from the baseline for WMS-R (0 min), which information
---
",True
347,10234,5686687,Need for Ibuprofen,Resveratrol,Placebo,continuous,,22,,22,1200,848,5640,328,-6.7818,0.6136,,,,,found in table,TRUE,7451,3515,TEST,2366,"[1656, 156]","intervention:
    mean: 5.4
    standard_deviation: 2.6
    group_size: NUMBER
comparator:
    mean: 5.7
    standard_deviation: 2.6
    group_size: NUMBER

outcome:
    ibuprofen:

---
intervention:
    mean: [NUMBER]
    standard_deviation: [NUMBER]
    group_size: [NUMBER_1, [NUMBER_2, [NUMBER_3, [NUMBER_4]]]]
comparator:
    mean: [NUMBER]
    standard_deviation: [NUMBER]
    
---
",True
683,13506,5777419,reduction of PPD,antibiotic,placebo,continuous,,16,,15,2.3,0.3,2.5,0.6,-0.4149366,0.13194364,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"[857, 1657, 122]","intervention:
    mean: 2.8
    standard_deviation: 1.1
    group_size: 27
comparator:
    mean: 3.0
    standard_deviation: 1.0
    group_size: 27

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 3.8
    standard_deviation: 0.7
    group_size: 15
comparator:
    mean: 6.0
    standard_deviation: 1.6
    group_size: 15
outcome:
    reduction_ppd:
        mean:
---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 18
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 18

outcome: reduction_of_PPD
post_intervention
---
",True
551,9724,3648394,Push-up test,10-week yoga program,Control,continuous,,18,,19,21,11,20,13,0.08105953,0.10827593,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,4261,"[1647, 1622, 64]","intervention:
    mean: 46
    standard_deviation: 9
    group_size: 17
comparator:
    mean: 40
    standard_deviation: 8
    group_size: 19
push-up-test:
    mean: 13
    standard_deviation: 2
    group
---
intervention:
    mean: 90
    standard_deviation: 15
    group_size: 20
comparator:
    mean: 70
    standard_deviation: 10
    group_size: 20
push_up:
    intervention: 32
    comparator: 28
group_size: 40
---
intervention:
    mean: 90
    standard_deviation: 12
    group_size: 12
comparator:
    mean: 75
    standard_deviation: 12
    group_size: 12


This YAML formatting is for the provided information in the article. The mean scores of the push-
---
",True
511,6550,4033571,Overall seizure median percent improvement,Extended-release oxcarbazepine 2400 mg,Control,continuous,,111,,117,-42.9,,-28.7,,cannot calculate,cannot calculate,,,,,SD was not given,FALSE,8206,5593,TEST,4514,"[1618, 1634, 835]"," intervention:
    mean: 1200
    standard_deviation: NA
    group_size: 47
comparator:
    mean: NA
    standard_deviation: NA
    group_size: 49

## Fig. 2 - Primary efficacy endpoint
<a id=""2""></a>
<figure>
---
intervention:
    mean: 90.0
    standard_deviation: 12.0
    group_size: 106
comparator:
    mean: 62.0
    standard_deviation: 11.0
    group_size: 231

YAML:
intervention:
    mean: 90.0
---
 extended-release oxcarbazepine 2400 mg:
    mean: NaN
    standard_deviation: NaN
    group_size: 131
Control:
    mean: -73.2
    standard_deviation: 13.3
    group_size: 117
Overall seizure median percent improvement:
    mean
---
",True
558,9831,3136370,Center for Epidemiologic Studies Depression Scale score,Soy shake,Control,continuous,,12,,16,-4,12.35,-8,65.41,0.07716042,0.14593965,,,,,From per protocol,TRUE,6022,3786,TEST,2937,"[1453, 989]","intervention:
    mean: 14
    standard_deviation: 8
    group_size: 50
comparator:
    mean: 12
    standard_deviation: 7
    group_size: 50

outcome:
     mean: 18.3
    standard_deviation: 4.8

---
intervention:
    mean: 9.0
    standard_deviation: 3.3
    group_size: 60
comparator:
    mean: 8.2
    standard_deviation: 3.1
    group_size: 60

YAML:
intervention:
    mean: 95.5
---
",True
175,10752,5086025,Intuitive eating total score,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,3.45,0.55,2.54,0.58,1.5858,0.1011,,,,,Actually comparing preintervention and postintervention,TRUE,29049,17627,TEST,13068,"[1656, 1646, 1041, 1665, 1634, 823, 2917]","intervention:
    mean: 85.0
    standard_deviation: 11.5
    group_size: 23
comparator:
    mean: 66.0
    standard_deviation: 7.3
    group_size: 18

intervention:
    mean: 102.5
    standard_
---
intervention:
    mean: 105.0
    standard_deviation: 13.3
    group_size: 12
comparator:
    mean: 87.5
    standard_deviation: 13.5
    group_size: 10

intervention:
    mean: 105.0
    standard_
---
intervention:
    mean: 53.4
    standard_deviation: 6.01
    group_size: 40
comparator:
    mean: undefined
    standard_deviation: undefined
    group_size: undefined
intuitive_eating:
    mean: 53.4
post_intervention:
---
intervention:
    mean: 94.5
    standard_deviation: 12.1
    group_size: 13
comparator:
    mean: 86.2
    standard_deviation: 11.4
    group_size: 14

Table 3: Overall impression of the intervention.
[{""group
---
intervention:
    mean: 106.25
    standard_deviation: 22.68
    group_size: 12
comparator:
    mean: 88.23
    standard_deviation: 13.11
    group_size: 12

intervention:
    mean: 106.25
    standard_
---
intervention:
    mean: 43.3
    standard_deviation: 8.7
    group_size: N/A
comparator:
    mean: 37.5
    standard_deviation: 7.5
    group_size: N/A

intervention:
    mean: 45.6
---
```/<br>
``` roundabout=22 The ""to-”>The greater_
<bray
This is the

This is notion: <span=</span    less than_unit
```\u2003.4 The

``` (
This is_739> -&nbsp;3
---
",True
439,3261,3475525,Scores on sodium quiz,MTL+caloric intake group,choices group,continuous,,90,,98,94.1,15.6,47.1,21.1,2.50703599,0.03803123,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: N/A
comparator:
    mean: 65.8
    standard_deviation: 10.3
    group_size: N/A

YAML:
intervention:
    mean
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
    mean: NUMBER
    standard_deviation: NUMBER
    
---
",True
28,3244,2972614,Motion range - Shoulder internal rotation,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,49.33,9.62,49.77,4.49,-0.055,0.0788,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,[1525],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
 - 103.16
   standard_deviation: NUMBER
 - 15.27
   group_size: NUMBER

comparator:
    mean: NUMBER
    standard_deviation
---
",True
460,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),CPP-ACP crème (group C),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,1068,[],"intervention:
    mean: NUMBER.4
    standard_deviation: NUMBER.4
    group_size: NUMBER
comparator:
    mean: NUMBER.4
    standard_deviation: NUMBER.4
    group_size: NUMBER

outcome:
    total_",False
410,3260,3475525,Correct selection of the healthier product,choices group,No label group,continuous,,98,,99,72.5,13.2,67.8,10.3,0.3957062,0.02070251,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: N/A
comparator:
    mean: 67.8
    standard_deviation: 10.3
    group_size: N/A

YAML:
intervention:
    mean
---
intervention:
    mean: 65.8
    standard_deviation: 16.5
    group_size: 98
comparator:
    mean: 95.7
    standard_deviation: 13.2
    group_size: 97

In the given article, the intervention group received a ""Choices
---
",True
203,5496,5380326,Vitamin D levels,Vitamin D supplementation,Control,continuous,,40,,40,45.93,15.37,21.87,5.31,2.0722,0.0768,,,,,,TRUE,10658,5810,TEST,4260,"[1585, 1668, 307]","intervention:
  mean: 40
  standard_deviation: 10
  group_size: 80
comparator:
  mean: 30
  standard_deviation: 5
  group_size: 40

## Figure 2 - change of vitamin D and DPP IV levels
::::figure-md
<
---
intervention:
    mean: 25
    standard_deviation: 6.5
    group_size: 40
comparator:
    mean: 20.8
    standard_deviation: 3.1
    group_size: 40

---

This article reports on the effectiveness of Vitamin D supplements on serum
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  post_intervention:
    NUMBER: [NUMBER, NUMBER, NUMBER]
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size:
---
",True
195,2096,5360580,"WMS-R (30 min) In the patients aged 77 years or younger,",1 mg/day of Pls purified from scallop,placebo,continuous,,19,,21,1.84,3.87,0,0.96,0.6551,0.1056,,,,,Data is from 24 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,6033,"[1330, 1450, 1668]","intervention:
    mean: 4.21
    standard_deviation: 0.78
    group_size: 145
comparator:
    mean: 4.34
    standard_deviation: 0.83
    group_size: 140

# WMS-R (30 min) In the patients aged
---
intervention:
    mean: 88.0
    standard_deviation: 11.7
    group_size: 14
comparator:
    mean: 89.8
    standard_deviation: 11.7
    group_size: 14
wms_r_30_min:
    mean: 101
---
intervention:
    mean: 8.5
    standard_deviation: 3.1
    group_size: 55
comparator:
    mean: 41.3
    standard_deviation: 11.8
    group_size: 55

The YAML you provided is correct for the information given in the
---
",True
96,10165,4173437,Coagulation profile,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. Data is in table in graphic format.,FALSE,854,745,TEST,637,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  Coagulation profile:
    mean: 142
    standard_deviation: 17
    group_size: 30
comparator:
    mean: NUMBER
    standard_deviation: NUM",False
30,5576,3003523,Short-Form 36-Items improvement,Certolizumab 200 mg,Control,continuous,,393,,199,38.1,9.5,31.5,7.4,0.7447,0.008,,,,,Used values for PCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,7520,"[1594, 85, 2527, 1540, 734]","intervention:
    mean: 6.4
    standard_deviation: 1.9
    group_size: 389
comparator:
    mean: 57.4
    standard_deviation: 8.4
    group_size: 258

outcome:
    mean: 6.8
    standard
---
intervention:
    mean: 78.4
    standard_deviation: 12.3
    group_size: 54
comparator:
    mean: 75.1
    standard_deviation: 13.3
    group_size: 54

YAML:
<|assistant>
intervention:

---
Choose  25.8 (CZP) [CZP]
In case 25.4 (CZP) you have an interest or not very interesting to consider data:
If you'd 66 [CZP] choose the very last one.

To generate the case for ""intervention"" and the data from the study
---
 intervention:
    mean: 10.0
    standard_deviation: 5.0
    group_size: 50
comparator:
    mean: 8.3
    standard_deviation: 3.4
    group_size: 50

## Confidence Interval for Mean Improvement (SF-36 P
---
intervention:
    mean: 45.5
    standard_deviation: 11.2
    group_size: 92
comparator:
    mean: 38.8
    standard_deviation: 9.6
    group_size: 69
intervention:
    mean: 44.4
    standard_dev
---
",True
31,5577,3003523,Short-Form 36-Items improvement,Certolizumab 400 mg,Control,continuous,,390,,199,38.9,8.9,31.5,7.4,0.8773,0.0082,,,,,Used values for PCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,7520,"[1594, 85, 2527, 1540, 734]","intervention:
    mean: 6.4
    standard_deviation: 3.1
    group_size: 93
certolizumab 400 mg:
    mean: 6.4
    standard_deviation: 3.1
    group_size: 93
comparator:
    mean: 58.1

---
intervention:
    mean: 102.0
    standard_deviation: 14.7
    group_size: 54
comparator:
    mean: 95.1
    standard_deviation: 15.3
    group_size: 54


This YAML includes the mean score improvement on the Short-
---
YAML: The very last one. If you choose the very, choose the very last one.
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMS
certolizumab 400 mg:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMS
comparator:
    mean: NUMBER
    
---
intervention:
    mean: 94.0
    standard_deviation: 12.1
    group_size: 34
comparator:
    mean: 80.4
    standard_deviation: 11.2
    group_size: 35
intervention:
    mean: 15.7
    standard_dev
---
",True
349,10236,5686687,CA-125 levels,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,median and ranges given,FALSE,7451,3515,TEST,2366,"[1656, 156]","intervention:
    mean: 11.1
    standard_deviation: 4.2
    group_size: 20
comparator:
    mean: 13.7
    standard_deviation: 5.1
    group_size: 20

## Output:
version: 2.0
intervention:

---
intervention:
    mean: N/A
    standard_deviation: N/A
    group_size: 30
comparator:
    mean: N/A
    standard_deviation: N/A
    group_size: 30

Wrong YAML:

intervention:
    mean:
---
",True
454,4432,5726464,insulin,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"[1309, 1402]","intervention:
    mean: 5000
    standard_deviation: 500
    group_size: 150
comparator:
    mean: 400
    standard_deviation: 100
    group_size: 100

intervention:
    mean: 4000
    standard_deviation: 500
    group_size:
---
intervention:
    mean: 75
    standard_deviation: 10
    group_size: 50
comparator:
    mean: 65
    standard_deviation: 10
    group_size: 50

YAML:
intervention:
    mean: 10.0
    standard_deviation: 3
---
",True
91,5539,3912320,"Correct response rate for 2,000 Hz frequency",Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,1015,[],"intervention:
    mean: 35.5
    standard_deviation: 10.5
    group_size: 15
comparator:
    mean: 29.2
    standard_deviation: 6.0
    group_size: 15

outcome:
    mean: 24.2
    standard",False
431,3261,3475525,Scores on the saturated fat quiz,MTL+caloric intake group,choices group,continuous,,90,,98,92.3,15.1,35.7,15.9,3.63162908,0.0563916,,,,,,TRUE,9086,4934,TEST,3542,"[1656, 1464]","intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: N/A
comparator:
    mean: 67.8
    standard_deviation: 10.3
    group_size: N/A

YAML:
intervention:
    mean
---
intervention:
    mean: 77.2
    standard_deviation: 15.7
    group_size: 95
comparator:
    mean: 105.4
    standard_deviation: 20.7
    group_size: 90

Wrong YAML:
intervention:
    mean: NUM
---
",True
668,13296,4987981,triglycerides levels,metformin,placebo,continuous,,21,,23,194.3,63.1,181.8,61.3,0.19746629,0.09154041,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"[518, 1670, 1662, 743]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMS
comparator:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMS

YAML:
  metformin:
    mean_trig
---
intervention:
    mean: 97.6
    standard_deviation: 35.7
    group_size: N/A
comparator:
    mean: 101.9
    standard_deviation: 35.1
    group_size: N/A

YAML:
intervention:
    mean
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  triglycerides:
    mean: NUMBER.0
    standard_deviation: NUMBER.0
    group_size: NUMBER

comparator:
    mean: NUMBER
---
intervention:
    mean: 180
    standard_deviation: 30
    group_size: 86
comparator:
    mean: 110
    standard_deviation: 30
    group_size: 86

YAML:
<|assistant>
intervention:
    mean: 777.5
    
---
",True
696,5639,5712123,morphine requirements,D group,P group,continuous,,30,,30,22.6,4.1,31.9,6.7,-1.6526241,0.08942639,,,,,found in fig3,TRUE,6401,5359,TEST,3891,"[1329, 1393, 810]","intervention:
    mean: 91.72
    standard_deviation: 15.43
    group_size: 30
comparator:
    mean: 120.54
    standard_deviation: 18.43
    group_size: 30

outcome:
    morphine_requirements:

---
intervention:
    mean: 3.5
    standard_deviation: 1.0
    group_size: 30
comparator:
    mean: 4.0
    standard_deviation: 1.0
    group_size: 30

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 11.0
    standard_deviation: 3.1
    group_size: 30
comparator:
    mean: 8.0
    standard_deviation: 2.4
    group_size: 30

YAML:
<assistant -->
intervention:
    
---
",True
527,6918,4411165,systolic BP,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,2336,"[1630, 211]","intervention:
    mean: 91.8
    standard_deviation: 10.1
    group_size: 10
comparator:
    mean: 99.1
    standard_deviation: 9.4
    group_size: 10

outcome:
    mean: 118.0
    standard
---
intervention:
    mean: 133.0
    standard_deviation: 12.3
    group_size: 11
comparator:
    mean: 121.1
    standard_deviation: 9.9
    group_size: 11

wbc:
    mean: 129.4
    standard
---
",True
101,1886,4188762,heart rate,remifentanil,normal saline,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[],"intervention:
    mean: 74.5
    standard_deviation: 8.4
    group_size: 15
comparator:
    mean: 73.8
    standard_deviation: 8.7
    group_size: 15

intervention:
    mean: 71.1
    standard_",False
570,8558,5541727,Symptom improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,"[1437, 1673, 201]","intervention:
    mean: 90
    standard_deviation: 12
    group_size: 26
comparator:
    mean: 60
    standard_deviation: 10
    group_size: 18

## Results
The provided study data show that there is a statistically significant improvement in symptom scores following the intra
---
intervention:
    mean: 120.0
    standard_deviation: 15.3
    group_size: 24
comparator:
    mean: 90.0
    standard_deviation: 15.7
    group_size: 24

YAML:
<|assistant>
intervention:

---
intervention:
    mean: 12.0
    standard_deviation: 3.9
    group_size: 20
comparator:
    mean: 8.2
    standard_deviation: 2.7
    group_size: 20

intervention:
    mean: 104.9
    standard_
---
",True
135,2450,4574984,Health-Related Quality of Life at 12 month - males,"intervention group, i.e. patient empowerment through information booklet and diary keeping - males","control group, which received standard care - males",continuous,,216,,231,72.49,23.66,71.71,27.1,0.0305,0.009,,,,,Group sizes was inferred using Table of characterisitics. Back calculated SD using CI.,TRUE,12997,7944,TEST,5795,"[1473, 1662, 1637, 134]","intervention:
    mean: 105
    standard_deviation: 13
    group_size: 311
comparator:
    mean: 100
    standard_deviation: 13
    group_size: 312

## Discussion
The trial aimed to assess whether patient empowerment through information booklets and diary keeping would improve global
---
intervention:
    mean: 53.95
    standard_deviation: 13.04
    group_size: NUMBER
comparator:
    mean: 50.41
    standard_deviation: 11.47
    group_size: NUMBER

Note: The provided data doesn't match with the given
---
intervention:
    mean: 86
    standard_deviation: 13
    group_size: 326
comparator:
    mean: 79
    standard_deviation: 14
    group_size: 326

### Note: This is the information provided in the article. If you need me to provide new or additional
---
intervention:
    mean: 11.11
    standard_deviation: 6.25
    group_size: 50
comparator:
    mean: 7.69
    standard_deviation: 5.31
    group_size: 50

Wrong YAML:
intervention:
    mean: 12
---
",True
198,7735,5380284,Surgery duration,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,Data is unavailable.,FALSE,1731,1429,TEST,1251,[],"intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  
    surgery_duration:
        mean: NUMBER_VALUE
        standard_deviation: NUMBER_VALUE
        group_size: NUMBER_VALUE

comparator:
    ",False
209,2913,5459456,inflexion-extension for the C2-C4 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,4,0.3,4,0.6,1.9928,0.3741,,,,,,TRUE,13404,7477,TEST,5693,"[1187, 1537, 1652, 353]","intervention:
    mean: 50
    standard_deviation: 5
    group_size: 6
comparator:
    mean: 50
    standard_deviation: 5
    group_size: 6

Wrote the YAML response. The given trial article does not provide data for ""lateral bending""
---
intervention:
    mean: 6.5
    standard_deviation: 1.1
    group_size: 35
comparator:
    mean: 7.3
    standard_deviation: 1.1
    group_size: 35
<|assistant>
intervention:
    mean: 14.
---
intervention:
    mean: 10.1
    standard_deviation: 0.9
    group_size: 25
comparator:
    mean: 6.8
    standard_deviation: 1.2
    group_size: 25

outcome:
    inflexion-extension:
        
---
intervention:
    mean: 102.0
    standard_deviation: 15.4
    group_size: 24
comparator:
    mean: 100.8
    standard_deviation: 15.3
    group_size: 24

YAML:
intervention:
    mean: 10.9
---
",True
239,8054,5534041,composite z-scores in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,0.11,0.81,-0.25,0.71,0.4563,0.171,,,,,,TRUE,6951,5679,TEST,4357,"[738, 1561, 1405]","intervention:
    mean: 0.11
    standard_deviation: 0.81
    group_size: N/A
comparator:
    mean: -0.25
    standard_deviation: 0.71
    group_size: N/A

WILL CONSIDER IF YAML
---
intervention:
    mean: −0.25
    standard_deviation: 0.71
    group_size: 22
comparator:
    mean: 0.13
    standard_deviation: 0.82
    group_size: 22

YAML:
<assistant>:
intervention:

---
intervention:
    mean: 6.0
    standard_deviation: 1.0
    group_size: 8
comparator:
    mean: 5.8
    standard_deviation: 1.1
    group_size: 8

Worth noting, McNemar's test showed no differences in
---
",True
572,8561,5541727,medial tibial cartilage volume loss,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-1.4,4.2,-3.3,5.3,0.39232146,0.2621027,,,,,Values are from 24 months,TRUE,6118,5345,TEST,4032,"[1437, 1673, 201]","intervention:
    mean: 2456
    standard_deviation: 397
    group_size: 17
comparator:
    mean: 3291
    standard_deviation: 401
    group_size: 6

## Results

|  Outcome  | Mean (SD) | Group_size |
---
intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NEXT_NUM_FMT(NUM_OF_PRE_INTERVENTION_PARTICIPANTS, 0.1)
comparator:
    mean: NUMBER
    standard_deviation: NUM
---
intervention:
    mean: 110.0
    standard_deviation: 13.8
    group_size: 31
comparator:
    mean: 70.2
    standard_deviation: 12.4
    group_size: 34

Wrong YAML:
Wrong YAML:
intervention
---
",True
27,3244,2972614,Motion range - Shoulder adduction,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,42,4.27,42.04,5.26,-0.0084,0.0788,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,[1525],"intervention:
    mean: 3.76
    standard_deviation: 1.64
    group_size: N/A
comparator:
    mean: 4.63
    standard_deviation: 1.76
    group_size: N/A
motion_range:
    mean: 3.
---
",True
106,1885,4188762,mean blood pressure,remifentanil,"normal saline, lidocaine, or ketamine",continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[],"intervention:
    mean: 90
    standard_deviation: 10
    group_size: 15
comparator:
    mean: 70
    standard_deviation: 10
    group_size: 15
outcome:
    mean: 85
std_dev: 10
group_size: 15
",False
490,6383,3786549,Baseline characteristics: deliveries,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,2.14,1.76,2.64,1.79,-0.2792152,0.04589751,,,,,,TRUE,9725,6231,TEST,4323,"[1626, 1395, 644]","intervention:
    mean: NUMBER
    standard_deviation: NUMBER
    group_size: NUMBER
  Estriol -lactobacilli:
    mean: NUMBER.0
    standard_deviation: N.M.
    group_size: N.G.
comparator:
---
intervention:
    mean: 4.0
    standard_deviation: 1.6
    group_size: 44
comparator:
    mean: 3.2
    standard_deviation: 1.6
    group_size: 44

intervention:
    mean: 42.5
    standard_
---
intervention:
    mean: 3.8
    standard_deviation: 1.2
    group_size: 87
comparator:
    mean: 4.0
    standard_deviation: 1.0
    group_size: 88

YAML:
intervention:
    mean: 12.3
---
",True
